col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


1463 Results       Page 1

 [1] 
Elsevier: Vaccine
  original article Date Title Authors   All Authors
1 [GO] 2025―Apr―23 2023-2024 COVID-19 vaccine uptake among immunocompromised individuals in two US states Leah J. McGrath, Farid L. Khan, Santiago M.C. Lopez, Matthew A. Brouillette, Kathleen M. Andersen, Tiange Yu, et al. (+3)
2 [GO] 2025―Apr―18 Nationwide population-based surveillance of invasive pneumococcal disease in children in Japan (2014-2022): Impact of 13-valent pneumococcal conjugate vaccine and COVID-19 pandemic Noriko Takeuchi, Bin Chang, Naruhiko Ishiwada, Yoshiaki Cho, Junichiro Nishi, Kenji Okada, et al. (+8)
3 [GO] 2025―Apr―16 Evaluating concurrency and gaps between self-report and vaccine card data for COVID-19 vaccination Marie C.D. Stoner, Jenna Michaels, Jacob B. Stocks, Noah Mancuso, Zachary Soberano, Erica Browne, et al. (+9)
4 [GO] 2025―Apr―16 Antiviral humoral immunity against SARS-CoV-2 omicron JN.1 subvariants induced by JN.1 recombinant protein vaccine Keiya Uriu, Yu Kaku, Minoru Kihara, Kei Sato
5 [GO] 2025―Apr―14 Hybrid, vaccine-induced and natural immunity against SARS-CoV-2 in traditional food markets in Bolivia (2020-2022): A cross-sectional analysis of a serological survey Christine Leyns, Elliot McClenaghan, Patricia Rodriguez, Patrick Nguipdop-Djomo, Carla Ascarrunz, Daniel Eid Rodriguez, et al. (+2)
6 [GO] 2025―Apr―11 Development and validation of a clinical prediction tool for non-receipt of updated COVID-19 vaccines Katia J. Bruxvoort, Lina S. Sy, Richard Contreras, Bruno Lewin, Vennis Hong, Lei Qian, et al. (+3)
7 [GO] 2025―Apr―11 Behaviors, perceptions, and impact of the COVID-19 pandemic and vaccination on oncology patients in New Mexico with substantial representation of racial minorities and rural residents S. Sasankan, D. Gathers, A. Bellerose, V.S. Pankratz, B. Tawfik
8 [GO] 2025―Apr―10 Regional cooperation on pandemic preparedness and vaccine equity from an economic, regulatory and legal perspective Mei Xuan Jessalyn Chan, Olivier J. Wouters, Hui Yun Chan, Petro Terblanche, Nakorn Premsri, Jerome H. Kim, et al. (+3)
9 [GO] 2025―Apr―08 COVID-19 vaccine decision-making and the role of institutions across the pandemic in UK Black African and Black Caribbean communities Christina Shearn, Gianina-Ioana Postavaru, Lorna Hylton, Howard Morris, Noelle Robertson, Eva M. Krockow
10 [GO] 2025―Apr―08 “Better to die trying”: Vaccine perceptions and COVID-19 experiences in rural Namibian pastoralists Sean Prall, Aparicio Lopes
11 [GO] 2025―Apr―07 Reasons for COVID-19 vaccination late in the pandemic: A qualitative study Kimberly A. Fisher, Lydia Goldthwait, Ollie Desrochers, Melanie Zemel, Cassandra Saphirak, Jeremy Malin, et al. (+4)
12 [GO] 2025―Apr―06 Live-attenuated pandemic H1N1 influenza vaccines expressing computationally optimized broadly reactive antigens (COBRAs) are immunogenic and protective in mice and ferrets Po-Ling Chen, Robert A. Richardson, Samuel Rovito, Guohua Yang, Haley N. Writt, Chet Ojha, et al. (+9)
13 [GO] 2025―Apr―06 COVID-19 vaccination uptake in people experiencing homelessness during the first three years of the global COVID-19 vaccination effort: A systematic review and meta-analysis Laura K. McCosker, Brett Dyer, Terra Sudarmana, Holly Seale, Robert S. Ware
14 [GO] 2025―Apr―06 COVID-19 vaccination rates among pregnant women in France: A nationwide cohort study Clément Bernard, Jérôme Drouin, Stéphane Le Vu, Jérémie Botton, Laura Semenzato, Marion Bertrand, et al. (+5)
15 [GO] 2025―Apr―06 A national cross-sectional study of dentists' vaccine hesitancy and intention to provide HPV vaccines following emergency COVID-19 vaccination authorization Priscilla M. Flynn, Cynthia Stull, Vedushi M. Jain, Michael D. Evans
16 [GO] 2025―Apr―05 Effectiveness of 2023-2024 COVID-19 vaccines against COVID-19-associated hospitalizations among adults aged ≥18 years with end stage kidney disease - United States, September 2023-April 2024 Amanda B. Payne, Shannon Novosad, Heng-Ming Sung, Yue Zhang, Ryan Wiegand, Carla S. Gomez Victor, et al. (+8)
17 [GO] 2025―Apr―04 Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trial Gonzalo Perez Marc, Lorena M. Coria, Ana Ceballos, Juan Manuel Rodriguez, Mónica E. Lombardo, Laura Bruno, et al. (+54)
18 [GO] 2025―Apr―04 Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: Primary day-28 analysis of a phase 2/3 open-label study Katia Alves, Alex Kouassi, Joyce S. Plested, Raj Kalkeri, Katherine Smith, Muneer Kaba, et al. (+6)
19 [GO] 2025―Apr―04 Effectiveness of BNT162b2 and Ad26.COV2.S vaccines against COVID-19-related hospitalisation amongst adult members of a private health insurance plan in South Africa during the Delta and Omicron periods: A test-negative case-control study Siobhan L. Johnstone, Daniel Shapiro, Nicola Chiwandire, Lundi Matoti, Carmen Whyte, Jolene Bultinck-Human, et al. (+7)
20 [GO] 2025―Apr―04 Exploring TLR agonists as adjuvants for COVID-19 oral vaccines Paulo Félix, Alexandra A. Melo, João Panão Costa, Mariana Colaço, Dina Pereira, Jisette Núñez, et al. (+2)
21 [GO] 2025―Apr―02 A replicon-based COVID-19 vaccine candidate delivered by tobacco mosaic virus-like particles Sweta Karan, Patrick Opdensteinen, Yifeng Ma, Jessica Fernanda Affonso De Oliveira, Nicole F. Steinmetz
22 [GO] 2025―Mar―31 Estimation of trajectory of COVID-19 vaccines effectiveness against infection Jialiang Jiang, Kwok Fai Lam, Eric Ho Yin Lau, Guosheng Yin, Yun Lin, Benjamin John Cowling
23 [GO] 2025―Mar―31 A rapid cycle analytics framework for vaccine safety surveillance within a real-world data network: Experience with enhanced surveillance of the Janssen COVID-19 vaccine E. Claire Newbern, Azza Shoaibi, Kevin Haynes, Clair Blacketer, Corinne Willame, Frank DeFalco, et al. (+8)
24 [GO] 2025―Mar―30 Sociodemographic and health-related predictors of COVID-19 booster uptake among fully vaccinated adults Yordanos M. Tiruneh, Jihye Choi, Paula M. Cuccaro, Journey Martinez, Jing Xie, Mark Owens, Jose-Miguel Yamal
25 [GO] 2025―Mar―24 Sociodemographic differences in parental hesitancy to the COVID-19 vaccine Courtney K. Blackwell, Traci Bekelman, Shivani Bakre, Lisa P. Jacobson, Nissa R. Towe-Goodman, Johnnye Lewis, et al. (+4)
26 [GO] 2025―Mar―23 Adverse events among early caregivers' COVID-19 vaccination correlated inversely with intention to vaccinate their children R.D. Goldman, R.J. Hart, J.N. Bone, M. Seiler, P.G. Olson, K. Keitel, et al. (+16)
27 [GO] 2025―Mar―23 A rapid human vaccine process development map outlining lessons learnt from ChAdOx1 nCoV-19 vaccine during the COVID-19 pandemic Michael James Francis
28 [GO] 2025―Mar―22 Alcohol consumption does not influence SARS-CoV-2 vaccine immunogenicity: A stop the spread Ottawa cohort analysis Alicia Vachon, Alexa Keeshan, Yannick Galipeau, Angela M. Crawley, Marc-André Langlois, Curtis L. Cooper
29 [GO] 2025―Mar―21 Concordance between parent-reported and documented COVID-19 vaccination status among hospitalized children and adolescents: Implications for vaccine effectiveness estimates, May 2021-October 2023 Sarah Hamid, Regina M. Simeone, Margaret M. Newhams, Natasha Halasa, Katherine E. Fleming-Dutra, Amber O. Orzel-Lockwood, et al. (+4)
30 [GO] 2025―Mar―21 Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19 Tianxiao Hao, Gerard E. Ryan, Michael J. Lydeamore, Deborah Cromer, James G. Wood, Jodie McVernon, et al. (+3)
31 [GO] 2025―Mar―20 Challenges and enablers to establishing COVID-19 vaccine effectiveness studies in the World Health Organization Africa region: A mixed-methods evaluation of the African region monitoring vaccine effectiveness (AFRO-MoVE) network Adam W. Crawley, Katherine Murphy, Ian D. Plumb, Grace Adjoa Ocansey, Isaac Baffoe-Nyarko, Norman Nyazema, et al. (+2)
32 [GO] 2025―Mar―19 Anti-vaccine attitudes and COVID-19 vaccine status at the end of the U.S. public health emergency Jasmin Choi, Jonathan Feelemyer, Karen Choe, Kathleen Lynch, Courtney McKnight, Lawrence H. Yang, et al. (+2)
33 [GO] 2025―Mar―19 Socio-demographic differences in citizen' preferences for distributing a scarce, lifesaving resource: A case study using COVID-19 vaccine distribution in Belgium Nele Raskin, Mickaël Hiligsmann, Jeroen Luyten, Sandy Tubeuf, Alexander Grigoriev, Roselinde Kessels
34 [GO] 2025―Mar―14 Targeting the early life stages of SARS-CoV-2 using a multi-peptide conjugate vaccine Lauren Myburgh, Haiko Karsjens, Athanasios Blanas, Aafke de Ligt, Karlijn van Loon, Elisabeth J.M. Huijbers, et al. (+6)
35 [GO] 2025―Mar―14 Applying the health belief model (HBM) to understand COVID-19 vaccine uptake among youth and young adults: Findings from a 6-month follow-up study in the United States Jiayi Xu, Shahin Davoudpour, Gregory Phillips
36 [GO] 2025―Mar―14 Health care institutions and their physicians are the greatest promoters of COVID-19 vaccine acceptance among health care workers Laetitia Ricci, Cécile Fery, Florence Tubach, Nelly Agrinier, Amandine Gagneux-Brunon
37 [GO] 2025―Mar―14 Factors associated with influenza and COVID-19 vaccination among health workers in Lao PDR, 2023 Chansay Patthammavong, Natalie Wodniak, Kongxay Phounphenghack, Chankham Tengbriacheu, Bandith Soumphonphakdy, Viengkhan Phixay, et al. (+10)
38 [GO] 2025―Mar―12 Feasibility of cohort event monitoring and assessment of reactogenicity and adverse events among a cohort of AstraZeneca and Moderna COVID-19 vaccine recipients in Nigeria, 2021 Omotayo Bolu, Oluwafemi D. Alo, Emem Iwara, Ashley T. Longley, Ikwe Hadley, Comfort K. Ogar, et al. (+28)
39 [GO] 2025―Mar―12 Childhood vaccination coverages in rural Guinea-Bissau before and during the early COVID-19 pandemic, a cohort study Julie Odgaard Vedel, Oides Furtado, Laerte Lima Almeida, Kimberly Raisa Nehal, Line Møller Nanque, Sabine Margarete Damerow, et al. (+3)
40 [GO] 2025―Mar―11 Effectiveness of COVID-19 vaccines against laboratory-confirmed SARS-CoV-2 infection amongst health workers, Windhoek, Namibia Kaveto Sikuvi, Natasha Nghitukwa, Ndiitodino Kakehongo, Ismael Katjitae, Carolina Matos, Philip Oedi, et al. (+3)
41 [GO] 2025―Mar―10 A review of Canadian online resources providing information on COVID-19 vaccination for caregivers of children aged 5-11 years Costanza Di Chiara, Elahe Karimi-Shahrbabak, Joelle Peresin, Daniel S. Farrar, Brooke Low, Sarah Abu Fadaleh, et al. (+5)
42 [GO] 2025―Mar―10 Second booster doses of adenoviral- and mRNA-based COVID-19 vaccines increase protection against COVID-19 hospitalization: Final analysis from the REFORCO-Brazil real-world effectiveness study during Omicron Wilhelmine Meeraus, Abigail Postema, Christen M. Gray, Andrew Lee, Andre Santa Maria, Bárbara Emoingt Furtado, et al. (+7)
43 [GO] 2025―Mar―09 Efficacy of BCG vaccination on incidence, severity and clinical progression of COVID-19: A BCG-REVAC population analysis Ramon Andrade de Souza, Florisneide Rodrigues Barreto, Carla Cristina Oliveira de Jesus Lima, Marcio Santos da Natividade, Carlos Antônio de Souza Teles Santos, Maria Yury Ichihara, et al. (+6)
44 [GO] 2025―Mar―09 Comparison of Streptococcus pneumoniae nasopharyngeal colonization, serotype-specific and protein-specific antibody and cytokine levels in young children prior to, during and post COVID-19 pandemic Naoko Fuji, Eduardo Gonzalez, Frank N. Salamone, Peter Bajorski, Ravinder Kaur, Michael Pichichero
45 [GO] 2025―Mar―07 Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics Giulia Dowgier, Agnieszka Hobbs, David Greenwood, Marianne Shawe-Taylor, Phoebe Stevenson-Leggett, James Bazire, et al. (+13)
46 [GO] 2025―Mar―07 COVID-19 vaccination status and associated factors among patients presenting with COVID-19-like symptoms in Uganda Sylvia Kusemererwa, Violet Ankunda, Terry A. Ongaria, Andrew Abaasa, Ayoub Kakande, Deogratius Ssemwanga, et al. (+13)
47 [GO] 2025―Mar―07 mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice Diana Wing Lee, Arshan Nasir, Sayda Elbashir, Hardik Jani, Tessa Speidel, Amy Gorrie, et al. (+9)
48 [GO] 2025―Mar―06 SARS-CoV-2 conjugate vaccine elicits robust immune responses that can protect against evolving variants. Melanie Carroll, Heather B. Fox, Anh Tran, Gowri Chellappan, Leonardo V. Rojas, Geetha Karengil, et al. (+9)
49 [GO] 2025―Mar―06 Development of broadly protective coronavirus vaccines: A joint NIAID-CEPI workshop report. Jennifer L. Gordon, Erin L. Boespflug, Amanda Coleman, Kimberly Taylor, Nadia Cohen, In-Kyu Yoon, M. Cristina Cassetti
50 [GO] 2025―Mar―06 Effectiveness of COVID-19 vaccine against SARS-CoV-2 infection among symptomatic COVID-19 patients in Uganda Andrew M. Abaasa, Sylvia Kusemererwa, Violet Ankunda, Terry A. Ongaria, Bernadette Nayiga, Ayoub Kakande, et al. (+12)
51 [GO] 2025―Mar―05 Durability of COVID-19 vaccine and infection induced immunity: A systematic review and meta-regression analysis Mia Moore, Larissa Anderson, Joshua T. Schiffer, Laura Matrajt, Dobromir Dimitrov
52 [GO] 2025―Mar―03 Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Results of a randomized vaccine-controlled phase I ADAPTCOV trial in Brazil Érique José Farias Peixoto de Miranda, Rodrigo T. Calado, Fernanda Castro Boulos, José Alfredo de Sousa Moreira, Fabiane Fernandes Machado, Maria Aparecida Alves Leite Dos Santos Almeida, et al. (+15)
53 [GO] 2025―Mar―03 Enhanced sulfate pseudo-affinity chromatography using monolith-like particle architecture for purifying SARS-CoV-2 Kenji Kadoi, Junya Toba, Ayana Uehara, Norikazu Isoda, Yoshihiro Sakoda, Eri Iwamoto
54 [GO] 2025―Mar―03 Global spatio-temporal distribution of coronavirus disease 2019 vaccine hesitancy between 2020 and 2022: A meta-analysis Tianshuo Zhao, Qingsong Xu, Xianming Cai, Mingting Wang, Le Ao, Tingting Wei, et al. (+10)
55 [GO] 2025―Mar―03 Comparative analysis of fourteen COVID-19 vaccine injury compensation systems and claim approval rates Chao-Fang Chu, Tzu-Hao Chang, Jen-Ji Ho
56 [GO] 2025―Mar―02 Increasing confidence for pediatric COVID-19 and influenza vaccines using messages affirming parental autonomy: A randomized online experiment Lynne M. Cotter, Molecula Hopkins-Sheets, Sijia Yang, Susan R. Passmore, Mahima Bhattar, Emma Henning, et al. (+3)
57 [GO] 2025―Mar―01 Factors associated with mortality among patients aged 12 years and above requiring hospitalization for severe respiratory illness (SRI): Findings from the COVID-19 vaccine effectiveness evaluation in Kenya and Mali, 2022-2023 Brian O. Onyando, Bryan O. Nyawanda, Daniel Onguru, Fadima C. Haidara, Collins Okello, Raphael O. Anyango, et al. (+27)
58 [GO] 2025―Mar―01 Cost-effectiveness of routine COVID-19 adult vaccination programmes in England Matt J. Keeling, Edward M. Hill, Stavros Petrou, Phuong Bich Tran, May Ee Png, Sophie Staniszewska, et al. (+4)
59 [GO] 2025―Feb―26 COVID-19 vaccination integration, innovations and key populations: Results from a global survey Ishani Mathur, Anika Ruisch, Maeve Conlin, Ibironke Oyatoye, Ulla Griffiths, Damian G. Walker, Christian Suharlim
60 [GO] 2025―Feb―26 Assessing the risks of current COVID-19 challenge trials systematically Nir Eyal, David Wendler
61 [GO] 2025―Feb―26 COVID-19 and influenza hospitalizations and the role of COVID-19 vaccination in the post-pandemic period: A cross-sectional study from Saudi Arabia Haytham A. Sheerah, Ahmed H. Al-Jedai, Nawfal A. Al-Jerian, Maram A. Al-Otaiby, Ahad F. Al-Seraihi, Saad A. Al-Huzami, et al. (+2)
62 [GO] 2025―Feb―24 A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults ≥18 years old Oyeniyi Diya, Juleen Gayed, Francine S. Lowry, Hua Ma, Vishva Bangad, Federico Mensa, et al. (+15)
63 [GO] 2025―Feb―22 Global perspectives on COVID-19 vaccination: Impacts on well-being and inequality David Leblang, Michael D. Smith, Dennis Wesselbaum
64 [GO] 2025―Feb―21 Correction to “Recombinant Spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2” [Vaccine 2023 Sep 22 41(41) 6025-6035. Doi: 10.1016/j.vaccine.2023.08.054] Shiho Chiba, Peter J. Halfmann, Shun Iida, Yuichiro Hirata, Yuko Sato, Makoto Kuroda, et al. (+4)
65 [GO] 2025―Feb―21 Attitudes of California school personnel on potential COVID-19 vaccine mandates and state law SB277 to remove nonmedical vaccine exemptions Matthew Z. Dudley, Alexander J. Zapf, Paul Delamater, Tina M. Proveaux, Holly B. Schuh, Alison M. Buttenheim, et al. (+6)
66 [GO] 2025―Feb―20 What three years of COVID-19 vaccine administration reveals about the incidence of shoulder injury related to vaccine administration (SIRVA). Laura Jane Mackenzie, Jaquelin Anne Bousie, Phillip Newman, John Cunningham, Andrew P. Woodward, Joshua Silk-Jones, et al. (+2)
67 [GO] 2025―Feb―20 A counterfactual analysis quantifying the COVID-19 vaccination impact in Sweden Fanny Bergström, Felix Günther, Tom Britton
68 [GO] 2025―Feb―20 SARS-CoV-2 seroreversion and all-cause mortality in nursing home residents and staff post-primary course vaccination in Belgium between February and December 2021 Eline Meyers, Liselore De Rop, Ellen Deschepper, Els Duysburgh, Tine De Burghgraeve, Pauline Van Ngoc, et al. (+11)
69 [GO] 2025―Feb―20 Estimating neutralising antibody responses against emerging SARS-CoV-2 variants utilising convalescent sera before the roll-out of XBB-lineage vaccines Ana Atti, Anna England, Julia Sung, Sarah Foulkes, Jasmin Islam, Ashley Otter, et al. (+5)
70 [GO] 2025―Feb―18 Global production capacity of seasonal and pandemic influenza vaccines in 2023 Jessica Taaffe, Shoshanna Goldin, Philipp Lambach, Erin Sparrow
71 [GO] 2025―Feb―18 COVID-19 vaccine initiation in pregnancy and risk for adverse neonatal outcomes among United States military service members, January-December 2021 Clinton Hall, Jackielyn Lanning, Celeste J. Romano, Anna T. Bukowinski, Gia R. Gumbs, Ava Marie S. Conlin
72 [GO] 2025―Feb―15 Cost-effectiveness models assessing COVID-19 booster vaccines across eight countries: A review of methods and data inputs Darvin S. Smith, Maarten Postma, David Fisman, Joaquin Mould-Quevedo
73 [GO] 2025―Feb―12 Shielding the immunocompromised: COVID-19 prevention strategies for patients with primary and secondary immunodeficiencies Giulio Olivieri, Donato Amodio, Emma Concetta Manno, Veronica Santilli, Nicola Cotugno, Paolo Palma
74 [GO] 2025―Feb―11 Impact in the humoral and cellular immune response to SARS-CoV-2 variants after primary vaccination with AZD1222/COVISHIELD protocol in healthy adults Artur Capão, Mia Ferreira Araújo, Luis Fernando Lopez Tort, Thais Stelzer Toledo, Any Caroline Alves Oliveira, Braulia Costa Caetano, et al. (+9)
75 [GO] 2025―Feb―11 Intention to receive new vaccines post-COVID-19 pandemic among adults and health workers in Lusaka, Zambia Anjali Sharma, Andrew D. Kerkhoff, Mwiza Haambokoma, Bertha Shamoya, Kombatende Sikombe, Sandra S. Simbeza, et al. (+5)
76 [GO] 2025―Feb―10 Effectiveness and coverage of COVID-19 vaccination among the infection-naive population: A community-based retrospective cohort study in China Yaqun Fu, Zhihu Xu, Quan Wang, Jiawei Zhang, Peien Han, Zhijie Nie, et al. (+9)
77 [GO] 2025―Feb―10 SARS-CoV-2 spike antibody levels in lung transplantation recipients versus the spectrum in non-immunocompromised persons Michael Y. Shino, F. Javier Ibarrondo, Otto O. Yang
78 [GO] 2025―Feb―07 Co-administration of seasonal quadrivalent influenza and COVID-19 vaccines leads to enhanced immune responses to influenza virus and reduced immune responses to SARS-CoV-2 in naive mice Anass Abbad, Joshua Yueh, Temima Yellin, Gagandeep Singh, Juan Manuel Carreño, Jordan J. Clark, et al. (+7)
79 [GO] 2025―Feb―06 Impacts of vaccination, school attendance, and nutrition on SARS-CoV-2 antibody titer in a prospective birth cohort in Brazil. Moin S Vahora, Otávio Leão, Mariângela Freitas da Silveira, Marlos Rodrigues Domingues, Pedro C Hallal, Alicia N.M. Kraay
80 [GO] 2025―Feb―06 Pregnant women's experiences of and attitudes toward COVID-19 vaccination: A qualitative descriptive study Hee Sun Kang, So Youn Kim, Jennie C. De Gagne, Sun-Mi Chae
81 [GO] 2025―Feb―05 Leveraging COVID-19 vaccine allergy evaluations with coincident drug allergy delabelling: Effectiveness and impact on quality of life Andy K.C. Kan, Hugo W.F. Mak, Valerie Chiang, Jackie S.H. Yim, Weihong Shi, Philip H. Li
82 [GO] 2025―Feb―05 Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults Yoshikazu Honda-Okubo, Dimitar Sajkov, Bruce Wauchope, Joseph V. Turner, Brendan Vote, Anna Antipov, et al. (+3)
83 [GO] 2025―Jan―31 Efficacy, immunogenicity, and safety of the Novavax COVID-19 vaccine in immunocompromised patients: A targeted literature review Manuela H. Gschwend, Anthony M. Marchese, Dirk Poelaert, Brandy Warren, Matthew D. Rousculp, Freddy Caldera
84 [GO] 2025―Jan―31 A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine Ismail Cem Yilmaz, Emre Mert Ipekoglu, Berfu Saraydar Golcuklu, Tugce Bildik, Aslı Gulce Bartan Aksoy, Irem Evcili, et al. (+14)
85 [GO] 2025―Jan―31 Implementing behavioural science-informed letter interventions to increase COVID-19 vaccination uptake in London residents. A difference-in-difference study in London, United Kingdom Kate Grailey, Roberto Fernandez Crespo, Lena Woldmann, Matthew Chisambi, Kirstie Black, Bahram Hassanpourfard, et al. (+4)
86 [GO] 2025―Jan―31 COVID-19 in Canada: The Canadian COVID-19 experiences project and beyond Helena C. Maltezou
87 [GO] 2025―Jan―31 How to accelerate the supply of vaccines to all populations worldwide? Part III: Reflections after the pandemic Mic McGoldrick, Tran Ba Quang Truong, Cristiana Campa, Murtuza Ali, Antonio Guzzi, Mark Van Ooij, et al. (+2)
88 [GO] 2025―Jan―30 Impact of the COVID-19 pandemic on routine immunization coverage of children and teenagers in Ontario, Canada Catherine Ji, Arrani Senthinathan, Jemisha Apajee, Vinita Dubey, Milena Forte, Jeffrey C. Kwong, et al. (+4)
89 [GO] 2025―Jan―30 Estimating COVID-19 associated hospitalizations, ICU admissions, and in-hospital deaths averted in the United States by 2023-2024 COVID-19 vaccination: A conditional probability, causal inference, and multiplier-based approach Ryan E. Wiegand, Owen Devine, Megan Wallace, Ismael R. Ortega-Sanchez, Huong T. Pham, Diba Khan, et al. (+6)
90 [GO] 2025―Jan―30 COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United States, 2019-2022 Akram Khan, Yuwei Zhu, Hilary M. Babcock, Laurence W. Busse, Abhijit Duggal, Matthew C. Exline, et al. (+25)
91 [GO] 2025―Jan―28 Safety comparison between Pfizer BNT162b2, Moderna mRNA-1273, and AstraZeneca AZD1222 in a Nationwide prospective cohort survey at the beginning of the severe acute respiratory syndrome coronavirus 2 vaccination in Japan Suminobu Ito, Nao Tsuchida, Susumu Kusunoki, Yoshihiro Kaneko, Toshio Naito, Satoshi Hori, Morikuni Tobita
92 [GO] 2025―Jan―22 A cross-country network analysis of disease infodemics: Looking through the lens of the COVID-19 pandemic Peter Adu, Tosin Popoola, Naved Iqbal, Anja Roemer, Oleg N. Medvedev, Colin R. Simpson
93 [GO] 2025―Jan―21 The cost-effectiveness of vaccination against COVID-19 illness during the initial year of vaccination Lisa A. Prosser, Janamarie Perroud, Grace S. Chung, Acham Gebremariam, Cara B. Janusz, Kerra Mercon, et al. (+4)
94 [GO] 2025―Jan―18 Impairment of the T cell memory response in chronic lymphocytic leukemia patients after SARS-CoV-2 vaccination Davide Raineri, Camilla Barbero Mazzucca, Riccardo Moia, Riccardo Bruna, Natasa Kustrimovic, Giuseppe Cappellano, et al. (+4)
95 [GO] 2025―Jan―17 Promoting aged care COVID-19 and influenza vaccination through education of Australian residential aged care staff: A mixed methods project evaluation Isaac Tranter, Deborah Judd, Mark Stickley, Bhakti Vasant, Gayle Pollard, Courtney Swindells, Satyamurthy Anuradha
96 [GO] 2025―Jan―16 The impact of vaccination on the length of stay of hospitalized COVID-19 patients in Brazil Cleber Vinicius Brito dos Santos, Lara Esteves Coelho, Tatiana Guimarães de Noronha, Guilherme Tegoni Goedert, Daniel Csillag, Paula Mendes Luz, et al. (+3)
97 [GO] 2025―Jan―16 Childhood opportunity index and vaccine uptake in pediatric COVID-19 hospitalizations Rohan M. Shah, Simon Parzen-Johnson, Shan Sun, Sameer J. Patel
98 [GO] 2025―Jan―14 Impact of SARS-CoV-2 inactivated vaccine on symptoms following omicron variant breakthrough infection Yuqi Zhang, Xinjie Li, Yingxiang Yang, Yue Yin, Yan Zhong, Qiang Xu, et al. (+4)
99 [GO] 2025―Jan―13 Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial Júlia Corominas, Carme Garriga, Antoni Prenafeta, Alexandra Moros, Manuel Cañete, Antonio Barreiro, et al. (+49)
100 [GO] 2025―Jan―08 COVID-19 pediatric vaccine Hesitancy: Themes and interactions with verified twitter accounts Nicolette Le, Tiana J. McMann, Christine Wenzel, Zhuoran Li, Qing Xu, Raphael E. Cuomo, et al. (+2)
101 [GO] 2025―Jan―08 Post-COVID symptoms after SARS-CoV-2 omicron infection and the effect of booster vaccination: A population-based cohort study Ida Henriette Caspersen, Siri N. Skodvin, Kristine Blix, Anna Hayman Robertson, Ida Laake, Berit Feiring, et al. (+3)
102 [GO] 2025―Jan―05 Association between underlying conditions, multimorbidity, and COVID-19 vaccination status of adults aged ≥80 years old in Beijing, China Yuping Duan, Luodan Suo, Xiaomei Li, Chengxu Bai, Mingyu Xu, Jiang Wu, et al. (+9)
103 [GO] 2024―Dec―31 Letter to the editor: SARS-CoV-2 vaccination in children and adolescents with neurodevelopmental or psychiatric disorders Arnaud Fernandez, Florence Askenazy, Susanne Thümmler
104 [GO] 2024―Dec―30 Mucosal vaccination against SARS-CoV-2 using recombinant influenza viruses delivering self-assembling nanoparticles Devaki Pilapitiya, Wen Shi Lee, Mai N. Vu, Andrew Kelly, Rosela H. Webster, Marios Koutsakos, et al. (+4)
105 [GO] 2024―Dec―28 Corrigendum to The risk of pregnancy-related adverse outcomes after COVID-19 vaccination: propensity score-matched analysis with influenza vaccination Yu Jung Choi, Jaehun Jung, Minsun Kang, Min Joo Choi, Won Suk Choi, Yu Bin Seo, et al. (+13)
106 [GO] 2024―Dec―25 Relative effectiveness of the second booster COVID-19 vaccines against laboratory confirmed SARS-CoV-2 infection in healthcare workers: VEBIS HCW VE cohort study (1 October 2022-2 May 2023) Camelia Savulescu, Albert Prats-Uribe, Kim Brolin, Anneli Uusküla, Colm Bergin, Catherine Fleming, et al. (+30)
107 [GO] 2024―Dec―25 Tortured confessions? Potentially erroneous statistical inferences may underpin misleading claims of harms in reanalyses of COVID-19 and HPV vaccines David Robert Grimes
108 [GO] 2024―Dec―24 “They need to speak a language everyone can understand”: Accessibility of COVID-19 vaccine information for Canadian adults with intellectual and developmental disabilities Sabrina Campanella, Tiziana Volpe, Yousef Safar, Yona Lunsky
109 [GO] 2024―Dec―24 Trust in government vaccine recommendations during the Covid-19 pandemic in Singapore: A longitudinal survey study Anita Sheldenkar, Tng Pei Ling, Peter Johannes Schulz, Mark I-Cheng Chen, May Oo Lwin
110 [GO] 2024―Dec―20 Corrigendum to Assessment of the Bnt162b2 covid-19 vaccine immune response in Brazilian indigenous adolescents. Vaccine Volume 43, Part 1, 1 January 2025, 126494 Laís Albuquerque de Oliveira, Isa Rita Brito de Morais, Silvana Beutinger Marchioro, Gabriel Barroso de Almeida, Gleyce Hellen de Almeida de Souza, Tiago da Silva Ferreira, et al. (+6)
111 [GO] 2024―Dec―20 The Safety and Efficacy of inactivated COVID-19 vaccination in couples undergoing assisted reproductive technology: A prospective cohort study Juan Yang, Ying-Ling Yao, Xing-Yu Lv, Li-Hong Geng, Yue Wang, Enoch Appiah Adu-Gyamfi, et al. (+7)
112 [GO] 2024―Dec―18 Timing of rejection events preceded by Covid-19 mRNA vaccination in recipients of solid organ transplants Quentin Perrier, Johan Noble, Agnès Bonadona, Caroline Augier, Thomas Jouve, Aude Boignard, et al. (+5)
113 [GO] 2024―Dec―18 Describing COVID-19 immunizations for First Nations people on-reserve in Alberta using real-time integration of point of care and provincial data Dean T. Eurich, Olivia Weaver, Cathleen McDermott, Allison Soprovich, Lisa A. Wozniak, Beth Woytas, et al. (+8)
114 [GO] 2024―Dec―18 Risk of adverse events after Omicron XBB-adapted BNT162b2 COVID-19 vaccination in the United States Jenny W. Sun, Laura E. Dodge, Eric J. Kim, Li Zhou, Susan Mather, Henry Goebe, et al. (+4)
115 [GO] 2024―Dec―18 Evidence on trends in uptake of childhood vaccines and association with COVID-19 vaccination rates Ali Moghtaderi, Timothy Callaghan, Qian Luo, Matt Motta, Tina Q. Tan, Laura Hillard, et al. (+4)
116 [GO] 2024―Dec―14 Everyone, everywhere, all the time: Ten lessons yet to be learned from the SARS-CoV-2 pandemic Gregory A. Poland
117 [GO] 2024―Dec―14 Predictors of severity of SARS-CoV-2 infections in Brazil: Post hoc analyses of a randomised controlled trial Kerry Conlin, Daniel Jenkin, Philip de Whalley, Lily Yin Weckx, Pedro M. Folegatti, Sagida Bibi, et al. (+5)
118 [GO] 2024―Dec―12 Mental illness and antibody responses after COVID-19 vaccination in a prospective population-based study in Catalonia Marianna Karachaliou, Ana Espinosa, Xavier Farré, Natalia Blay, Gemma Castaño-Vinyals, Susana Iraola-Guzmán, et al. (+10)
119 [GO] 2024―Dec―07 Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer Amy Body, Luxi Lal, Sriganesh Srihari, C. Raina MacIntyre, Jim Buttery, Elizabeth Stephanie Ahern, et al. (+10)
120 [GO] 2024―Dec―07 Predictors of HPV vaccination coverage among adolescents in Tennessee during the COVID-19 pandemic: A cross-sectional study J. Cunningham-Erves, M. Sanderson, S.W. Jin, J. Davis, H.M. Brandt
121 [GO] 2024―Dec―06 Vaccine safety surveillance in South Africa through COVID-19: A journey to systems strengthening Chenoa Sankar, Johanna C. Meyer, Marione Schönfeldt, Hannah Gunter, Halima Dawood, Victoria Sekiti, et al. (+11)
122 [GO] 2024―Dec―05 The trend in national childhood immunization program coverage throughout Serbian communities in Kosovo and Metohija from 2003 to 2022: pre-COVID-19 period vs. COVID-19 pandemic Jelena Filimonovic, Maja Stosic, Tatjana Gazibara, Jelena Dotlic, Bojan Joksimovic, Aleksandar Subaric, et al. (+8)
123 [GO] 2024―Dec―05 Local and systemic reactogenicity after mRNA and protein-based COVID-19 vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomized phase 2 trial (COV-BOOST) Anthony M. Marchese, Hadi Beyhaghi, Matthew D. Rousculp, Vivian Huang, Xinxue Liu, Seth Toback, Saul N. Faust
124 [GO] 2024―Nov―30 COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study Pierre-Philippe Piché-Renaud, Samantha S.M. Drover, Peter C. Austin, Shaun K. Morris, Sarah A. Buchan, Sharifa Nasreen, et al. (+7)
125 [GO] 2024―Nov―30 The effectiveness of vaccines against COVID-19 in Mexico: A time series approach D. Flores, E.M. Luna
126 [GO] 2024―Nov―29 COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients Nicolas Gemander, Delphine Kemlin, Stéphanie Depickère, Natasha S. Kelkar, Shilpee Sharma, Pieter Pannus, et al. (+18)
127 [GO] 2024―Nov―29 Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial Vu Dinh Thiem, Dang Duc Anh, Vu Hai Ha, Nguyen Van Thom, Tran Cong Thang, Jose Mateus, et al. (+13)
128 [GO] 2024―Nov―27 Determinants of COVID-19 and non-COVID-19 vaccine confidence in low- and middle-income countries: A systematic review of qualitative evidence and thematic synthesis Alice Blukacz, Alexandra Obach, Paola Vásquez, Carla Campaña, Catalina Huerta, Yanara Bernal, Báltica Cabieses
129 [GO] 2024―Nov―26 Effectiveness of BNT162b2 and CoronaVac against COVID-19-related severe outcomes among children and adolescents: A Brazilian nationwide cohort study Eliandra da Silveira de Lima, Marcos Otávio Brum Antunes, Jesuely Spieckert de Souza, Marcus H. Jones, Renato T. Stein, Leonardo A. Pinto, et al. (+2)
130 [GO] 2024―Nov―25 The risk of pregnancy-related adverse outcomes after COVID-19 vaccination: Propensity score-matched analysis with influenza vaccination Yu Jung Choi, Jaehun Jung, Minsun Kang, Min Joo Choi, Won Suk Choi, Yu Bin Seo, et al. (+13)
131 [GO] 2024―Nov―22 COVID-19 vaccine acceptance and 5C psychological antecedents amid the omicron surge in South Korea and China Minjung Lee, Chenyuan Qin, Yubin Lee, Jie Deng, Myoungsoon You, Jue Liu
132 [GO] 2024―Nov―20 Assessment of the BNT162B2 COVID-19 vaccine immune response in Brazilian indigenous adolescents Laís Albuquerque de Oliveira, Isa Rita Brito de Morais, Silvana Beutinger Marchioro, Gabriel Barroso de Almeida, Gleyce Hllen de Almeida de Souza, Tiago da Silva Ferreira, et al. (+6)
133 [GO] 2024―Nov―18 How text message reminders increase COVID-19 booster vaccine uptake: Two randomized controlled trials Arne Meeldijk, Lisa Vandeberg, Reinier Akkermans, Jeannine Hautvast
134 [GO] 2024―Nov―11 Exposure to objective/sensationalist information moderates associations between psychological factors and COVID-19 anti-vaccination attitudes: An experimental study Aldo Aguirre-Camacho, Beatriz Hidalgo, Joshua A. Rash
135 [GO] 2024―Nov―10 Modification and validation of a vaccine hesitancy scale for adolescent COVID-19 vaccination Annette K. Regan, Marie-Claude Couture, Timothy Callaghan, Brianna Agnew, Jillian Baker, Onyebuchi A. Arah
136 [GO] 2024―Nov―10 Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 “Patria” recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico Constantino López-Macías, Martha Torres, Brenda Armenta-Copca, Niels H. Wacher, Laura Castro-Castrezana, Andrea Alicia Colli-Domínguez, et al. (+25)
137 [GO] 2024―Nov―09 Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations in South Korea Eunseon Gwak, Seung-Ah Choe, Erdenetuya Bolormaa, Young June Choe, Chengbin Wang, Jonathan Fix, et al. (+2)
138 [GO] 2024―Nov―08 Proteomic signatures of vaccine-induced and breakthrough infection-induced host responses to SARS-CoV-2 Erin Williams, Felipe Echeverri Tribin, Juan Manuel Carreño, Florian Krammer, Michael Hoffer, Suresh Pallikkuth, Savita Pahwa
139 [GO] 2024―Nov―08 The association between service experience in vaccination centers and expectation confirmation as a driver of future vaccination intentions: Results from a survey among users of a Swiss mass COVID-19 vaccination center Franziska Mattes, Julia Dratva, Sarah Schmelzer, Aylin Wagner, Florian Liberatore
140 [GO] 2024―Nov―07 Australian parents' experiences with adolescent age-based vaccinations during the COVID-19 pandemic Maryke S. Steffens, Katarzyna T. Bolsewicz, Catherine King, Bianca Bullivant, Ikram Abdi, Frank Beard
141 [GO] 2024―Nov―07 Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023 Nathaniel M. Lewis, Elizabeth J. Harker, Aleda Leis, Yuwei Zhu, H. Keipp Talbot, Carlos G. Grijalva, et al. (+42)
142 [GO] 2024―Nov―07 Variation in the time to complete the primary COVID-19 vaccine series by race, ethnicity, and geography among older US adults Yalin Deng, Kaleen N. Hayes, Yifan Zhao, Preeti Chachlani, Andrew R. Zullo, Djeneba Audrey Djibo, et al. (+3)
143 [GO] 2024―Nov―07 Pandemic-related resilience in HPV vaccination programmes - Perspectives from selected countries in Africa on what it will take to vaccinate 90 % of girls by 2030 Kouakou Séraphin Kouassi, Eric Chisupa, Adolphus Clarke, Innocent Massenon, Christine Miano, Faith Mutuku, et al. (+5)
144 [GO] 2024―Nov―05 Effect of COVID-19 vaccination on the risk of developing post-COVID conditions: The VENUS study Sung-a Kim, Megumi Maeda, Fumiko Murata, Haruhisa Fukuda
145 [GO] 2024―Nov―05 Unraveling COVID-19 vaccine hesitancy in Europeans 50 and older through a lens of preventive practices K. Delaruelle, E. Lermytte, M. Bockstal, P. Vuolanto, P. Bracke
146 [GO] 2024―Nov―02 Parental decisions regarding the vaccination of children and adolescents against SARS-CoV-2 from 2020 to 2023: A descriptive longitudinal study of parents and children in Montreal, Canada Katia Charland, Caroline Quach, Jesse Papenburg, Laura Pierce, Cat Tuong Nguyen, Adrien Saucier, et al. (+5)
147 [GO] 2024―Oct―31 Emerging global patterns of COVID-19 vaccine information fatigue in 23 countries in 2023 Trenton M. White, Jeffrey V. Lazarus, Kenneth H. Rabin, Scott C. Ratzan, Ayman El-Mohandes
148 [GO] 2024―Oct―31 On-time childhood vaccination before and during the COVID-19 pandemic in seven communities: Findings from the New Vaccine Surveillance Network Annika M. Hofstetter, Eileen J. Klein, Bonnie Strelitz, Rangaraj Selvarangan, Jennifer E. Schuster, Julie A. Boom, et al. (+13)
149 [GO] 2024―Oct―31 SARS-CoV-2 spike-based virus-like particles incorporate influenza H1/N1 antigens and induce dual immunity in mice Zalma V. Sanchez-Martinez, Sergio P. Alpuche-Lazcano, Matthew Stuible, Bassel Akache, Tyler M. Renner, Lise Deschatelets, et al. (+10)
150 [GO] 2024―Oct―30 Comparing COVID-19 booster vaccine acceptance in the United Kingdom, Germany, Austria, and Jordan: The role of protection motivation theory, conspiracy beliefs, social media use and religiosity Judith Eberhardt, Walid Al-Qerem, Jonathan Ling
151 [GO] 2024―Oct―30 Exploring risk factors for Raynaud's phenomenon post COVID-19 vaccination Tzu-Chuan Ho, Shih-Chang Chuang, Kuo-Chen Hung, Chin-Chuan Chang, Kuo-Pin Chuang, Cheng-Hui Yuan, et al. (+2)
152 [GO] 2024―Oct―30 The SARS-CoV-2 neutralising antibody profile of New Zealand adults in 2023: Impact of vaccination and infection. Reuben McGregor, Aimee Paterson, Brittany Lavender, Caitlin Hooker, Chris Frampton, Kjesten Wiig, et al. (+4)
153 [GO] 2024―Oct―24 Acute autoimmune hepatitis following COVID-19 mRNA vaccination: A population-based study using electronic health records in Singapore Amelia Jing Jing Ng, Desmond Chun Hwee Teo, Sreemanee Raaj Dorajoo, Aaron Jun Yi Yap, Wan Cheng Chow, Nicholas Kai Ming Ng, Sally Bee Leng Soh
154 [GO] 2024―Oct―23 Safety of mRNA COVID-19 vaccines among persons 15- years and above in Ghana: A cohort event monitoring study Delese Mimi Darko, Seth Kwaku Seaneke, Eric Karikari-Boateng, Edwin Nkansah, Kwame Amponsa-Achiano, Naziru Tanko Mohamed, et al. (+11)
155 [GO] 2024―Oct―23 Risk of major adverse cerebro-cardiovascular events following BNT162b2, CoronaVac, and ChAdOx1 vaccination and SARS-CoV-2 infection: A self-controlled case-series study Norazida Ab Rahman, Teck Long King, Kalaiarasu M. Peariasamy, Sheamini Sivasampu
156 [GO] 2024―Oct―22 Incidence of ischemic stroke after COVID-19 bivalent booster vaccination in an integrated health system Katie A. Sharff, Thomas K. Tandy, Paul F. Lewis, Eric S. Johnson
157 [GO] 2024―Oct―18 The risk of postherpetic neuralgia in COVID-19 vaccination-associated herpes zoster: A retrospective cohort study using TriNetX Sheng-Hsiang Ma, Tai-Li Chen, Wei-Fan Ou, Wen-Cheng Chao, Hsin-Hua Chen, Chen-Yi Wu
158 [GO] 2024―Oct―17 Factors associated with COVID-19 vaccination or intent to be vaccinated across three U.S. states Robert Cockerill, Jennifer A. Horney, Samantha C. Penta, Amber Silver, Lauren Clay
159 [GO] 2024―Oct―17 Pediatric COVID-19 vaccine hesitancy among pregnant and post-partum women: A mixed-method study Tasmiah Nuzhath, Brian Colwell, Timothy Callaghan, Peter Hotez, Sabrina Mousum, Ummul Wara Masud, Annette K. Regan
160 [GO] 2024―Oct―17 Longitudinal safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in children aged 4-11 years with juvenile-onset autoimmune inflammatory rheumatic diseases: A prospective multicenter study Tali Eviatar, Amit Ziv, Amir Oved, Adi Miller-Barmak, Adi Pappo, Ruth Livny, et al. (+8)
161 [GO] 2024―Oct―16 Gender differences in adverse effects following the second dose of AstraZeneca COVID-19 vaccine: a cross-sectional study among healthcare workers Masoud Sedaghat, Badriyeh Karami, Farid Najafi, Fatemeh Khosravi Shadmani, Shahab Rezaeian
162 [GO] 2024―Oct―16 Intranasal booster with SARS-CoV-2 RBD protein fused to E. coli enterotoxin a subunit after primary mRNA vaccination in mice He-Chin Hsieh, Chung-Chu Chen, Wen-Chun Liu, Suh-Chin Wu
163 [GO] 2024―Oct―13 Corrigendum to “A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases” [Vaccine 42 (12) (2024) 3039-3048] Anna Schultze, Ivonne Martin, Davide Messina, Sophie Bots, Svetlana Belitser, Juan José Carreras-Martínez, et al. (+15)
164 [GO] 2024―Oct―09 Direct quantitative comparison of benefits and risks of COVID-19 vaccines used in National Immunization Technical Advisory Groups Guidance during the first two years of the pandemic Pamela Doyon-Plourde, Ruth Farley, Ramya Krishnan, Matthew Tunis, Megan Wallace, Joseline Zafack
165 [GO] 2024―Oct―05 Effective integration of COVID-19 vaccination with routine immunization: A case study from Kinshasa, DRC Guillaume Mwamba, Emily Margaret Gibson, Carla Toko, Christelle Tunda, Yves Rolland Kouabenan, Joseph Musenga, et al. (+7)
166 [GO] 2024―Oct―04 Factors that shape COVID-19 pediatric vaccine decision-making in rural agricultural communities: A qualitative study Kelley M. Pascoe, Sonia Bishop, Xuehan Ci, Magaly Ramirez, Georgina Perez, Genoveva Ibarra, et al. (+10)
167 [GO] 2024―Oct―04 Using regression tree analysis to examine demographic and geographic characteristics of COVID-19 vaccination trends over time, United States, May 2021-April 2022, National Immunization Survey Adult COVID Module Morgan Earp, Lu Meng, Carla L. Black, Rosalind J. Carter, Peng-Jun Lu, James A. Singleton, Terence Chorba
168 [GO] 2024―Oct―04 SpiN-Tec: A T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern Natália S. Hojo-Souza, Júlia T. de Castro, Graziella G. Rivelli, Patrick O. Azevedo, Emiliano R. Oliveira, Lídia P. Faustino, et al. (+17)
169 [GO] 2024―Oct―01 Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials: Experience from the United Kingdom's first COVID-19 vaccine trial Maia Patrick-Smith, Katherine Emary, Susanne H. Hodgson, Tonia M. Thomas, Rebecca te Water Naude, Arabella S.V. Stuart, et al. (+6)
170 [GO] 2024―Sep―29 Validation of the Chinese version of the vaccine conspiracy beliefs scale during COVID-19 pandemic and its correlates Xiaokang Lyu, Xin Liu, Haijuan Hong
171 [GO] 2024―Sep―29 Sociodemographic determinants of COVID-19 vaccination in adolescents in Stockholm, Sweden Adonis Sotoodeh, Pontus Hedberg, Fredrik Granath, Tobias Alfvén, Pontus Nauclér
172 [GO] 2024―Sep―27 Corrigendum to “Immunogenicity during 6 months after SARS-CoV-2 infection is significantly different depending on previous COVID-19 vaccine regimens and a booster dose received” [Vaccine 42 (22) (2024) 126025] Paskorn Sritipsukho, Pakatip Sinlapamongkolkul, Araya Satdhabudha, Chanapai Chaiyakulsil, Surakameth Mahasirimongkol, Waritta Sawaengdee, et al. (+2)
173 [GO] 2024―Sep―25 Variant-specific neutralising antibodies levels induced by the PHH-1 V SARS-CoV-2 vaccine (Bimervax®) by HIPRA Anna England, Julia Sung, Meritxell Deulofeu, Laura Ferrer Soler, Bassam Hallis, Kelly Thomas, Sue Charlton
174 [GO] 2024―Sep―23 Comparison of assays used to detect antibody response in COVID-19 vaccine trials: Results from of a UK multi-Centre randomised controlled trial to determine the immunogenicity responses of COVID-19 vaccines administered concomitantly with seasonal influenza vaccines (ComFluCOV) Rajeka Lazarus, Rosie Harris, Russell Thirard, Sarah Baos, Lucy Culliford, Rachel Todd, et al. (+5)
175 [GO] 2024―Sep―21 Preclinical evaluation in hamster model of the mRNA COVID-19 vaccine candidate AfriVac 2121 (Wuhan) produced under the WHO/MPP mRNA Technology Transfer Programme Ornéllie Bernadin, Maxime Cochin, Jean-Sélim Driouich, Caroline Laprie, Pia Steigler, Gerhardt Boukes, et al. (+3)
176 [GO] 2024―Sep―21 The impact of coronavirus pandemic shutdowns on immunization completion in Hadeetha, Anbar, Iraq: A case-study of vaccine completion in a recovering healthcare system Sara Al-Dahir, Tahseen Abdul Latif Hassan, William Moss, Alaa Khalil, Gilbert Burnham, Maria Deloria Knoll, et al. (+2)
177 [GO] 2024―Sep―20 Detailed review of mortality reported following COVID-19 vaccination in Victoria, Australia: 2021-2023 Ingrid Laemmle-Ruff, Jesse J. Fryk, Priya Shenton, Hazel J. Clothier, Sarah Parsons, Linda Iles, et al. (+4)
178 [GO] 2024―Sep―19 Impact of the 2023/24 autumn-winter COVID-19 seasonal booster campaign in preventing severe COVID-19 cases in Italy (October 2023-March 2024) E.A. Fotakis, E. Picasso, C. Sacco, D. Petrone, M. Del Manso, A. Bella, et al. (+10)
179 [GO] 2024―Sep―18 Risk of death and cardiovascular events following COVID-19 vaccination or positive SARS-CoV-2 test amongst adult Singaporeans during omicron transmission Liang En Wee, Muhammad Ismail Bin Abdul Malek, Janice Tan, Calvin Chiew, Vernon Lee, Derrick Heng, et al. (+3)
180 [GO] 2024―Sep―17 Defining long COVID using a population-based SARS-CoV-2 survey in California Jake M. Pry, Kalyani McCullough, Kristina Wen-Jeh Lai, Esther Lim, Megha L. Mehrotra, Katherine Lamba, Seema Jain
181 [GO] 2024―Sep―11 COVID-19 vaccine uptake in a predominantly minoritized cohort hospitalized during the early pandemic in New York City Jennifer Y. Chang, Michelle Chang, Simian Huang, Joan Bosco, Meredith McNairy, Sade Tukuru, et al. (+10)
182 [GO] 2024―Sep―10 Delivery of SARS-CoV-2 spike and membrane genes in a single Baculoviral vector enhance the immune breadth against SARS-CoV-2 variants of concern Jungmin Chun, Doyoung Yoon, Aleksandra Nowakowska, Hyeon Dong Lee, Chanyeong Lee, Jinha Kim, et al. (+4)
183 [GO] 2024―Sep―09 Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers Michal Canetti, Noam Barda, Yaniv Lustig, Yael Weiss-Ottolenghi, Victoria Indenbaum, Yovel Peretz, et al. (+5)
184 [GO] 2024―Sep―07 Association of SARS-CoV-2 immunoserology and vaccination status with myocardial infarction severity and outcome Ana Blasco, Ana Royuela, Sergio García-Gómez, Natalia Gómez-Lozano, Alberto Sánchez-Arjona, Jorge de la Fuente, et al. (+5)
185 [GO] 2024―Sep―05 Disparities in COVID-19 vaccination receipt by race, ethnicity, and social determinants of health among a large patient population in a network of community-based healthcare centers Holly C. Groom, Frances M. Biel, Bradley Crane, Evelyn Sun, Joanna P. Georgescu, Eric S. Weintraub, et al. (+6)
186 [GO] 2024―Sep―05 Insights from an observational translational research program during the COVID-19 pandemic: Four years of experience Marjorie Rowe, Ai-ris Yonekura Collier, Dan H. Barouch
187 [GO] 2024―Sep―03 Jurisdiction-level costs of the initial phase of the COVID-19 vaccination program in the United States, December 20, 2020-May 31, 2021 Christine Kim, Christopher Dunphy, Christopher Duggar, Jamison Pike
188 [GO] 2024―Sep―03 Using health literacy principles to improve understanding of evolving evidence in health emergencies: Optimisation and evaluation of a COVID-19 vaccination risk-benefit calculator Carissa Bonner, Melody Taba, Michael Anthony Fajardo, Carys Batcup, Ben R. Newell, Amy X. Li, et al. (+3)
189 [GO] 2024―Sep―02 mRNA-based COVID-19 vaccination of lung transplant recipients with prior SARS-CoV-2 infection induces durable SARS-CoV-2-specific antibodies and T cells Siqi Liu, Laura L.A. van Dijk, Yvette den Hartog, Rogier Hoek, Erik Verschuuren, Corine H. Geurtsvankessel, et al. (+3)
190 [GO] 2024―Sep―02 Risk of heavy menstrual bleeding following COVID-19 vaccination: A nationwide case-control study Jérémie Botton, Marion Bertrand, Marie-Joëlle Jabagi, Lise Duranteau, Kim Bouillon, Jérôme Drouin, et al. (+5)
191 [GO] 2024―Sep―02 Canadian health care providers' and education workers' hesitance to receive original and bivalent COVID-19 vaccines Brenda L. Coleman, Iris Gutmanis, Susan J. Bondy, Robyn Harrison, Joanne Langley, Kailey Fischer, et al. (+13)
192 [GO] 2024―Aug―31 Confidence and barriers: Analysis of factors associated with timely routine childhood vaccination in Canada during the COVID-19 pandemic Harry MacKay, Jeremy D. Gretton, Sandra Chyderiotis, Stephanie Elliott, Ana Howarth, Catherine Guo, et al. (+5)
193 [GO] 2024―Aug―30 Predictors of the willingness to accept a free COVID-19 vaccine among households in Nigeria Oghenowede Eyawo, Uchechukwu Chidiebere Ugoji, Shenyi Pan, Patrick Oyibo, Amtull Rehman, Mishel Mahboob, Olapeju Adefunke Esimai
194 [GO] 2024―Aug―28 Lessons from a longitudinal community-based investigation of adherence to guidelines and intent to vaccinate during the COVID-19 pandemic Maria M. Llabre, Kiara R. Timpano, Hannah C. Broos, Rafael O. Leite, Patrice G. Saab
195 [GO] 2024―Aug―27 A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine Shanti Pather, Nicola Charpentier, Frank van den Ouweland, Ruben Rizzi, Andrew Finlayson, Nadine Salisch, et al. (+7)
196 [GO] 2024―Aug―27 COVID-19 vaccine hesitancy: Meaning relations between responses in an epidemiological study and twitter messages Sofia Natalia Ferreira-Silva, Maria Eduarda Muniz Soares, Ricardo Vasconcelos, Carolina Barbieri, Luiz Fujita Junior, Tainah Medeiros, et al. (+3)
197 [GO] 2024―Aug―26 Editorial: ML-driven vaccine against COVID-19: Developmental challenges and foresight Dilbag Singh, Robertas Damaševičius, Vijay Kumar, Fabio Bagnoli, Simone Pecetta, Rino Rappuoli
198 [GO] 2024―Aug―24 Delayed peak antibody titers after the second dose of SARS-CoV-2 vaccine in solid organ transplant recipients: Prospective cohort study Kohei Unagami, Mikiko Yoshikawa, Hiroto Egawa, Satoko Ohfuji, Yoichiro Natori, Rikako Oki, et al. (+26)
199 [GO] 2024―Aug―24 Identification of gene and protein signatures associated with long-term effects of COVID-19 on the immune system after patient recovery by analyzing single-cell multi-omics data using a machine learning approach JingXin Ren, Qian Gao, XianChao Zhou, Lei Chen, Wei Guo, KaiYan Feng, et al. (+3)
200 [GO] 2024―Aug―24 Patterns and predictors of COVID-19 vaccination among young adults at 44 US sites: Secondary analysis of a randomized, controlled, open-label trial, March - December 2021 Nadja A. Vielot, Nicole K. Kelly, Christina Ludema, Molly Rosenberg, Elizabeth R. Brown, Holly E. Janes, et al. (+4)
201 [GO] 2024―Aug―23 Patient-reported outcomes of adverse events after COVID-19 vaccination in Nigeria: A mixed methods study Comfort K. Ogar, Hannah N. Gilbert, Lourens T. Bloem, Christine Leopold, Peter U. Bassi, Yahaya M. Katagum, et al. (+6)
202 [GO] 2024―Aug―22 Co-administration of recombinant BCG and SARS-CoV-2 proteins leads to robust antiviral immunity Mario A. Ramírez, Ricardo A. Loaiza, Yohana Martínez-Balboa, Nicole Bruneau, Eugenio Ramírez, Pablo A. González, et al. (+2)
203 [GO] 2024―Aug―22 Effectiveness of inactivated influenza vaccine in children during the 2023/24 season: The first season after relaxation of intensive COVID-19 measures Masayoshi Shinjoh, Mizuki Yaginuma, Yoshio Yamaguchi, Kazuyo Tamura, Munehiro Furuichi, Yuki Tsumura, et al. (+18)
204 [GO] 2024―Aug―22 Seroprevalence of B. pertussis infection and the changes of specific antibody levels in health care workers during the first two years of COVID-19 in Wuhu, China Qinghong Meng, Bingsong Wang, Qianqian Du, Xianlai Zhang, Zhen Li, Fang He, et al. (+4)
205 [GO] 2024―Aug―17 “REAl LIfe” observational study on the effectiveness of Evusheld prophylaxis against SARS-CoV-2 omicron variants in vaccine non-responder immunocompromised patients (REALISE) Giuliana Lucia Esposito, Federico Fassio, Daniela Girardi, Erica Picasso, Federica Meloni, Simone Montini, et al. (+10)
206 [GO] 2024―Aug―16 Associations of mental health with vaccination readiness in informal caregivers and the vaccination status of their care recipients during the Covid-19 pandemic - A cross sectional analysis Linda Sanftenberg, Felix Bader, Marietta Rottenkolber, Maria Sebastiao, Thomas Kühlein, Christine Eidenschink, et al. (+8)
207 [GO] 2024―Aug―15 Efficacy and safety of Abdala COVID-19 subunit vaccine in children and adolescents: An open-label, single-arm, phase 2 trial (MEÑIQUE) Francisco Hernández-Bernal, Enrique Noa-Romero, Joel Quintana-Guerra, Cristina O. Chávez-Chong, Yenima Martín-Bauta, Laura Alvaré-Alvaré, et al. (+15)
208 [GO] 2024―Aug―13 Uptake of COVID-19 vaccines and association with hospitalisation due to COVID-19 in pregnancy: Retrospective cohort study Gloria Ihenetu, Paul Aylin, Vesselin Novov, Helen Skirrow, Sonia Saxena, Azeem Majeed, Thomas Woodcock
209 [GO] 2024―Aug―09 Influenza vaccine uptake among youth with sickle cell disease who are seen in clinic before and after the COVID-19 pandemic Joseph Walden, Joseph R. Stanek, Jennifer Young, Megan M. Griffith, Leena Nahata, Susan E. Creary
210 [GO] 2024―Aug―08 Pre- and post-Ad26.COV2·S booster dose antibody levels predict COVID-19 disease risk Sanne Roels, Matthias Bruckner, Jerald Sadoff, Vicky Cárdenas, Chan Tang, Stefan Hagedoorn, et al. (+3)
211 [GO] 2024―Aug―08 Understanding structural inequities in Covid-19 vaccine access and uptake among disability, transgender and gender-diverse communities in India Sharin D'souza, Bhakti Ghatole, Harikeerthan Raghuram, Shreyus Sukhija, Satendra Singh, Aqsa Shaikh, et al. (+2)
212 [GO] 2024―Aug―08 Antibody response to non-mRNA SARS-CoV-2 vaccine in kidney transplant recipients Divya Bajpai, Sreyashi Bose, Nikhil Saxena, Bhagyashree Kulkarni, Kruteesh Kumar, Nikhil Rao, et al. (+4)
213 [GO] 2024―Aug―08 The impact of the COVID-19 pandemic on childhood vaccination rates and the role of sociodemographic factors: A cohort study Inés Gómez-Acebo, Ana Barquín-Ruiz, Sandra Llorente, Jéssica Alonso-Molero, Javier Llorca, María J. Cabero-Perez, Trinidad Dierssen-Sotos
214 [GO] 2024―Aug―06 Factors associated with COVID-19 vaccine uptake among south African health care workers Gavin George, Michael Strauss, Emma Lansdell, Phiwe Nota, Remco P.H. Peters, Petra Brysiewicz, et al. (+2)
215 [GO] 2024―Aug―05 Identifying psychological predictors of SARS-CoV-2 vaccination: A machine learning study Michael V. Bronstein, Erich Kummerfeld, Angus MacDonald, Sophia Vinogradov
216 [GO] 2024―Aug―03 Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment Matteo Augello, Isabell Wagenhäuser, Manuel Krone, Nicolas Dauby, Pietro Ferrara, Michela Sabbatucci, et al. (+11)
217 [GO] 2024―Aug―01 A health equity science approach to assessing drivers of COVID-19 vaccination coverage disparities over the course of the COVID-19 pandemic, United States, December 2020-December 2022 Makhabele Nolana Woolfork, Kambria Haire, Oluyemi Farinu, Jasmine Ruffin, Jennifer M. Nelson, Fatima Coronado, et al. (+4)
218 [GO] 2024―Aug―01 Immunization-related stress and stress-related responses of mucosal versus intramuscular COVID-19 vaccination among adults in China Minghuan Jiang, Haijun Zhang, Xuelin Yao, Yang Wang, Xiaozhen Lai, Hai Fang
219 [GO] 2024―Jul―31 Kinetics of SARS-CoV-2 antibody titers after booster vaccinations during an Omicron surge in Japan Naomi Matsumoto, Ayako Sasaki, Tomoka Kadowaki, Toshiharu Mitsuhashi, Soshi Takao, Takashi Yorifuji
220 [GO] 2024―Jul―30 COVID-19 and influenza vaccine uptake in women with criminal-legal system involvement Olabimpe Asupoto, Xinyang Li, Jordana L. Hemberg, Amanda Emerson, Dominique Black, Mugur V. Geana, et al. (+4)
221 [GO] 2024―Jul―30 Genetic and epigenetic analyses of IFN-γ gene proximal promoter region underlying positive correlation between persistently high anti-SARS-CoV-2 IgG and IFN-γ among COVID-19 vaccinated Bangladeshi adults Anika Tahsin, Piyash Bhattacharjee, Abdullah Al Saba, Tahirah Yasmin, A.H.M. Nurun Nabi
222 [GO] 2024―Jul―30 Individual and familial factors associated with mRNA COVID-19 vaccine uptake in pregnancy: A large-scale registry-based linkage study Jovan Elyass, Anteneh Desalegn, Nhung T.H. Trinh, Saima Orangzeb, Mahmoud Zidan, Hedvig Nordeng, Angela Lupattelli
223 [GO] 2024―Jul―27 COVID-19 vaccination reluctance across Europe: Lessons for the future Abdul Suleman, Paula Vicente
224 [GO] 2024―Jul―26 Implementation and adherence to regular asymptomatic testing in a COVID-19 vaccine trial Lucy R. Williams, Katherine R.W. Emary, Daniel J. Phillips, Jodie Hay, Jessica P.J. Larwood, Maheshi N. Ramasamy, et al. (+3)
225 [GO] 2024―Jul―26 Weighing the risks and benefits: Parental perspectives on COVID-19 vaccines for 5- to 11-year-old children Anushka Ataullahjan, Pierre-Philippe Piche-Renaud, Elahe Karimi Shahrbabak, Sarah Abu Fadaleh, Costanza Di Chiara, David Avelar Rodriguez, et al. (+2)
226 [GO] 2024―Jul―26 Impact of vaccination on SARS-CoV-2 evolution and immune escape variants Deepak Jena, Arup Ghosh, Atimukta Jha, Punit Prasad, Sunil Kumar Raghav
227 [GO] 2024―Jul―24 Impact of the emergence of severe acute respiratory syndrome coronavirus 2 omicron variants on routine childhood immunization in japan Yuta Aizawa, Isamu Sato, Yuki Abe, Fujio Sasagawa, Akihiko Saitoh
228 [GO] 2024―Jul―20 Heterologous and homologous COVID-19 mRNA vaccination schemes for induction of basic immunity show similar immunogenicity regarding long-term spike-specific cellular immunity in healthcare workers Isabell Wagenhäuser, Giovanni Almanzar, Franziska Bernhardine Förg, Astrid Stein, Isabella Eiter, Julia Reusch, et al. (+13)
229 [GO] 2024―Jul―20 Aluminum hydroxide and immunostimulatory glycolipid adjuvant combination for enhanced COVID-19 subunit vaccine immunogenicity Guo-Qing Zou, Ke Li, Cheng Yan, Ya-Qian Li, Mao-Ying Xian, Xing Hu, et al. (+2)
230 [GO] 2024―Jul―17 Parental hesitancy about COVID-19, influenza, HPV, and other childhood vaccines Tammy A. Santibanez, Carla L. Black, Tianyi Zhou, Anup Srivastav, James A. Singleton
231 [GO] 2024―Jul―17 Duration of vaccine protection against breakthrough infections during five COVID-19 waves among healthcare workers primarily vaccinated with CoronaVac Alessandra Luna-Muschi, Igor Carmo Borges, Antonio dos Santos Barboza, Elizabeth de Faria, Marina Farrel Cortês, Roseli B. Santos, et al. (+19)
232 [GO] 2024―Jul―16 Effectiveness of COVID-19 bivalent vaccination against SARS-CoV-2 infection among residents of US nursing homes, November 2022 - March 2023 Kelly Hatfield, Ryan Wiegand, Sujan Reddy, Arshiya Patel, James Baggs, Thomas Franceschini, et al. (+4)
233 [GO] 2024―Jul―16 Efficiency of indirect protection of COVID-19 vaccination and interactions between indirect and direct protection on household transmission Yuki Takahashi, Hideo Tanaka, Chie Taniguchi, Tsuyoshi Ogata
234 [GO] 2024―Jul―16 Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial Katie Steenackers, Nikita Hanning, Liesbeth Bruckers, Isabelle Desombere, Arnaud Marchant, Kevin K. Ariën, et al. (+7)
235 [GO] 2024―Jul―14 GP consultations for menstrual disorders after COVID-19 vaccination - A self-controlled cohort study based on routine healthcare data from the Netherlands R. Jajou, T. Lieber, E.P. van Puijenbroek, E. Mulder, J. Overbeek, K. Hek, et al. (+2)
236 [GO] 2024―Jul―14 Mass COVID-19 vaccination center: Optimizing the vaccination pathway during a 12 month timeframe Aurélie Le Bagousse-Bernard, Claude Dussart, Philippe Pin, Karim Tazarourte, Jihane Fattoum
237 [GO] 2024―Jul―14 COVID-19 vaccination-induced antibody responses and waning by age and comorbidity status in a large population-based prospective cohort study C.E. Hoeve, A.J. Huiberts, B. de Gier, S.P. Andeweg, G. den Hartog, H.E. de Melker, et al. (+4)
238 [GO] 2024―Jul―14 Case-cohort design as an efficient approach to evaluating COVID-19 vaccine effectiveness, waning, heterologous immune effect and optimal dosing interval David N. Fisman, Alison E. Simmons, Ashleigh R. Tuite
239 [GO] 2024―Jul―12 Short- and long-term outcomes of cardiac adverse events following COVID-19 immunization managed in a Canadian pediatric center Anne Pham-Huy, Jennifer Bowes, Katherine Russell, Ali Amira, Lillian Lai
240 [GO] 2024―Jul―12 Identifying the intersection of parental HPV and COVID-19 vaccine hesitancy to inform health messaging interventions in community-based settings Samantha Garcia, Michelle Shin, Morgan Gill, Zehui He, Emily Dang, W. Martin Kast, et al. (+3)
241 [GO] 2024―Jul―11 Child COVID-19 vaccine uptake among participants of the 2015 Pelotas (Brazil) Birth Cohort Study Ana Lucia Sartori, Romina Buffarini, Aline Machado da Silva, Otávio Amaral de Andrade Leão, Thaynã Ramos Flores, Andréa Dâmaso Bertoldi, et al. (+2)
242 [GO] 2024―Jul―09 Maternal-infant transfer of SARS-CoV-2 antibodies following vaccination in pregnancy: A prospective cohort study I. Korchinski, C. Marquez, E. McClymont, G. Av-Gay, J. Andrade, C. Elwood, et al. (+7)
243 [GO] 2024―Jul―08 Corrigendum to “Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023-January 2024” [Vaccine 42(19) (2024)] Charlotte Laniece Delaunay, Aryse Melo, Marine Maurel, Clara Mazagatos, Luise Goerlitz, Joan O’Donnell, et al. (+24)
244 [GO] 2024―Jul―08 Mammalian cell expressed recombinant trimeric spike protein is a potent vaccine antigen and confers near-complete protection against SARS-CoV-2 infection in Hamster B. Vikram Kumar, Sneha Singh, Geetika Verma, Reetesh Kumar, Pranaya M. Mishra, Sahil Kumar, et al. (+13)
245 [GO] 2024―Jul―06 Analyzing the 7C psychological antecedents of vaccine acceptance throughout the COVID-19 pandemic among healthcare sector workers in France: A repeated cross-sectional study (CappVac-Cov) Lucia Araujo-Chaveron, Cyril Olivier, Gérard Pellissier, Elisabeth Bouvet, Judith E. Mueller
246 [GO] 2024―Jun―29 Intradermal fractional dose vaccination as a method to vaccinate individuals with suspected allergy to mRNA COVID-19 vaccines Geert V.T. Roozen, Alexandra Granger, Rob S. van Binnendijk, Gerco den Hartog, Meta Roestenberg, Leo G. Visser, Anna H.E. Roukens
247 [GO] 2024―Jun―28 COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies Sita Bhella, Allison M. Wilkin, Katrina Hueniken, Abi Vijenthira, Michael Sebag, Peng Wang, et al. (+17)
248 [GO] 2024―Jun―27 Factors predicting primary and booster COVID-19 vaccination in a community sample of African American men and women in the United States Midwest Jeffrey A. Kelly, Jennifer L. Walsh, Katherine Quinn, Yuri A. Amirkhanian, Monique Plears
249 [GO] 2024―Jun―25 Safety, reactogenicity, and immunogenicity of Ad26.COV2.S as homologous or heterologous COVID-19 booster vaccination: Results of a randomized, double-blind, phase 2 trial Mathieu Le Gars, Jerald Sadoff, Vicky Cárdenas, Dirk Heerwegh, Fisseha Tesfaye, Griet Van Roey, et al. (+7)
250 [GO] 2024―Jun―22 Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study Tiffany Fitzpatrick, Peter Yamoah, Gina Lacuesta, Manish Sadarangani, Victoria Cook, Persia Pourshahnazari, et al. (+24)
251 [GO] 2024―Jun―22 Factors, motivations and barriers associated with eagerness to volunteer in COVID-19 vaccine clinical trials in France: A mixed-method study Aloïs Helary, Elisabeth Botelho-Nevers, Marion Bonneton, Léa Khennouf, Jessica Sambourg, Odile Launay, Amandine Gagneux-Brunon
252 [GO] 2024―Jun―20 Watchful, skeptics, and system distrusters: Characteristics associated with different types of COVID-19 vaccine hesitancy among U.S. working-age adults Xue Zhang, Shannon M. Monnat
253 [GO] 2024―Jun―18 Guillain-Barré syndrome temporally associated with COVID-19 vaccines - Progress over time Ingrid Laemmle-Ruff, Hannah J Morgan, Adele Harris, Veronica Abruzzo, Hazel J Clothier, Joshua Osowicki, et al. (+3)
254 [GO] 2024―Jun―16 Relationship between parental acceptance of the COVID-19 vaccine and attitudes towards measles vaccination for children: A cross-sectional study Xiaoting Jiang, Jingxuan Wang, Conglu Li, Eng Kiong Yeoh, Zihao Guo, Guozhang Lin, et al. (+2)
255 [GO] 2024―Jun―16 Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders Mohammad Yazdan Panah, Saeed Vaheb, Yousef Mokary, Alireza Afshari-Safavi, Aysa Shaygannejad, Narges Ebrahimi, et al. (+2)
256 [GO] 2024―Jun―15 Leveraging a clinical emergency department dataset to estimate two-dose COVID-19 vaccine effectiveness and duration of protection in Canada Daniel K. Ting, Rhonda J. Rosychuk, Jeffrey P. Hau, Christiaan H. Righolt, Jeffrey C. Kwong, Danuta M. Skowronski, Corinne M. Hohl
257 [GO] 2024―Jun―14 Investigating the predictors of COVID-19 vaccine decision-making among parents of children aged 5-11 in the UK Stephanie A. Davey, Claire Hampson, Michaela E. Christodoulaki, Daniel Gaffiero
258 [GO] 2024―Jun―13 The impact of COVID-19 childhood and adolescent vaccination on mortality in Argentina Rodrigo Quiroga, Sofía Gastellu, Braian Fernández, Romina Ottaviani, Johanna Romina Zuccoli, Pablo Daniel Vallecorsa, et al. (+2)
259 [GO] 2024―Jun―12 Gender differences in COVID-19 preventative measures and vaccination rates in the United States: A longitudinal survey analysis Sahan Jayawardana, Mikaela Esquivel, Tin Orešković, Elias Mossialos
260 [GO] 2024―Jun―12 Immunogenicity during 6 months after SARS-CoV-2 infection is significantly different depending on previous COVID-19 vaccine regimens and a booster dose received Paskorn Sritipsukho, Phakatip Sinlapamongkolkul, Araya Satdhabudha, Chanapai Chaiyakulsil, Surakameth Mahasirimongkol, Waritta Sawaengdee, et al. (+2)
261 [GO] 2024―Jun―12 Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series Amy C. Sherman, Simon D. van Haren, Ella Borberg, Zoe Swank, Muneerah Aleissa, Alexandra Tong, et al. (+14)
262 [GO] 2024―Jun―12 Striving for equitable vaccination coverage: Leveraging rapid coverage and community assessments during the COVID-19 pandemic to reach missed populations in Cambodia Raveesha R. Mugali, Hedy Ip, Amos Zikusooka, Lenin Vong, Savy Bou, Sarath Kros, Or Vandine
263 [GO] 2024―Jun―12 Engaging Trusted Messengers to Increase COVID-19 Pediatric Vaccine Uptake in Philadelphia: Lessons from the VaxUpPhillyFamilies program Sarah Badlis, Haolong Yu, Heather Klusaritz, Andy S.L. Tan, Teresa Dooley, Helaine Heggs, et al. (+9)
264 [GO] 2024―Jun―11 COVID-19 vaccine hesitancy, trust, and communication in Sarlahi District, Nepal Porcia Manandhar, Joanne Katz, Tsering Pema Lama, Subarna K. Khatry, William J. Moss, Daniel J. Erchick
265 [GO] 2024―Jun―08 Dynamics of multisystem inflammatory syndrome in children associated to COVID-19 in Chile: Epidemiologic trends during pandemic, before and after children vaccination R. Villena, G. Izquierdo, J. Wilhelm, C. García, M. Acuña, P. Riquelme, et al. (+2)
266 [GO] 2024―Jun―05 Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting Salma Younes, Eleonora Nicolai, Nadin Younes, Massimo Pieri, Sergio Bernardini, Parveen B. Nizamuddin, et al. (+6)
267 [GO] 2024―Jun―04 Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024 Charlotte Laniece Delaunay, Aryse Melo, Marine Maurel, Clara Mazagatos, Luise Goerlitz, Joan O’Donnell, et al. (+24)
268 [GO] 2024―Jun―03 Effectiveness against severe COVID-19 of a seasonal booster dose of bivalent (original/Omicron BA.4-5) mRNA vaccines in persons aged ≥60 years: Estimates over calendar time and by time since administration during prevalent circulation of different Omicron subvariants, Italy, 2022-2023 Massimo Fabiani, Alberto Mateo-Urdiales, Chiara Sacco, Emmanouil Alexandros Fotakis, Serena Battilomo, Daniele Petrone, et al. (+6)
269 [GO] 2024―Jun―01 High vaccine effectiveness against severe COVID-19 outcomes and population preventable fraction during the Omicron era in Luxembourg: A nationwide retrospective risk factor analysis Dritan Bejko, Corinna Ernst, Anne Vergison, Saverio Stranges, Maurice P. Zeegers, Joël Mossong
270 [GO] 2024―May―31 A cost-effectiveness analysis of South Africa’s COVID-19 vaccination programme Ijeoma Edoka, Sheetal Silal, Lise Jamieson, Gesine Meyer-Rath
271 [GO] 2024―May―27 Cultural and social attitudes towards COVID-19 vaccination and factors associated with vaccine acceptance in adults across the globe: A systematic review Tasniah Begum, Nikolaos Efstathiou, Cara Bailey, Ping Guo
272 [GO] 2024―May―27 Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines Yaniv Lustig, Noam Barda, Yael Weiss-Ottolenghi, Victoria Indenbaum, Ili Margalit, Keren Asraf, et al. (+7)
273 [GO] 2024―May―25 Deployment of COVID-19 vaccine in the WHO Eastern Mediterranean Region 2021-23: How do we switch to a life course approach? JeongEun Bak, Quamrul Hasan, John Kissa, Mohammed Osama Mere, Dalia Samhouri, Amaya Gillespie, et al. (+4)
274 [GO] 2024―May―25 Bordetella pertussis infection following relaxation of COVID-19 non-pharmaceutical interventions in 2021-2023 in Vancouver metropolitan area, British Columbia, Canada Frederic Reicherz, Sirui Li, Allison A. Watts, David M. Goldfarb, Pascal M. Lavoie, Bahaa Abu-Raya
275 [GO] 2024―May―25 Impact of the COVID-19 pandemic on routine childhood vaccination in 9 U.S. jurisdictions Ashley Treharne, Bhavini Patel Murthy, Elizabeth R. Zell, Nkenge Jones-Jack, Ona Loper, Arundhati Bakshi, et al. (+9)
276 [GO] 2024―May―24 Changes in vaccination uptake against pneumococcal disease, influenza, and coronavirus disease 2019 (COVID-19) before and after a Head and Neck cancer diagnosis Mads Frederik Eiberg, Omid Rezahosseini, Katrine Brandt Bukan, Bodil Charlotte Arp, Vivian Bui Le, Faiza Ahmad, et al. (+5)
277 [GO] 2024―May―23 Hybrid immunity after BNT162b2 Covid-19 vaccine administration in children aged 5 to 11 years Anne Tsampalieros, Roger Zemek, Nick Barrowman, Marc-André Langlois, Corey Arnold, Candice McGahern, et al. (+3)
278 [GO] 2024―May―20 COVID-19 vaccine acceptance and uptake among caregivers of children aged 5-11 years in Ontario, Canada: A cross-sectional survey Elahe Karimi-Shahrbabak, Costanza Di Chiara, Daniel S. Farrar, Sarah M. Abu Fadaleh, Joelle Peresin, Brooke Low, et al. (+5)
279 [GO] 2024―May―19 Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern Ravendra Garg, Qiang Liu, Jill Van Kessel, Akarin Asavajaru, Eva-Maria Uhlemann, Morgane Joessel, et al. (+19)
280 [GO] 2024―May―17 Interchangeability of different COVID-19 vaccine platforms as booster doses: A phase 3 study mimicking real-world practice Sue Ann Costa Clemens, Lily Weckx, Eveline P. Milan, Igor Smolenov, Ralf Clemens
281 [GO] 2024―May―17 Effectiveness of mRNA booster doses in preventing infections and hospitalizations due to SARS-CoV-2 and its dominant variant over time in Valencian healthcare workers, Spain Natali Jiménez-Sepúlveda, Paula Gras-Valentí, Pablo Chico-Sánchez, José Miguel Castro-García, Elena Ronda-Pérez, Hermelinda Vanaclocha, et al. (+4)
282 [GO] 2024―May―15 Vaccine effectiveness in reducing COVID-19-related hospitalization after a risk-age-based mass vaccination program in a Chilean municipality: A comparison of observational study designs Cinthya Urquidi, Alejandro Sepúlveda-Peñaloza, María T. Valenzuela, Alexander Ponce, Verónica Menares, Claudia P. Cortes, et al. (+5)
283 [GO] 2024―May―13 Heterologous Ad26.COV2.S booster after primary BBIBP-CorV vaccination against SARS-CoV-2 infection: 1-year follow-up of a phase 1/2 open-label trial Sant Muangnoicharoen, Rakpong Wiangcharoen, Saranath Lawpoolsri, Sira Nanthapisal, Anan Jongkaewwattana, Chatnapa Duangdee, et al. (+11)
284 [GO] 2024―May―10 A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial Vu Dinh Thiem, Pham Thi Van Anh, Chu Van Men, Do Thai Hung, Andrew J. Pollard, Akari Kamitani, et al. (+5)
285 [GO] 2024―May―09 Effectiveness of COVID-19 booster vaccination, morbidity and absenteeism among healthcare personnel during the 2022-2023 season dominated by Omicron BA.5 and BA.2 subvariants Helena C. Maltezou, Maria N. Gamaletsou, Theodoros V. Giannouchos, Dimitra-Maria Koukou, Flora Sourri, Amalia Karapanou, et al. (+6)
286 [GO] 2024―May―09 Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection Keon Young Lee, Kyoung-Ho Song, Kyoung Hwa Lee, Jin Yang Baek, Eu Suk Kim, Young Goo Song, et al. (+13)
287 [GO] 2024―May―07 Strategies to strengthen COVID-19 vaccine uptake and improve vaccine equity in U.S. Territories and Freely Associated States during the first six months of vaccine rollout Ashley Tippins, Jeniffer Concepción Acevedo, Francisco S. Palomeque, Kelsey C. Coy, Phillippa Chadd, Daniel Stowell, et al. (+16)
288 [GO] 2024―May―06 mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network Phyumar Soe, Hubert Wong, Monika Naus, Matthew P. Muller, Otto G. Vanderkooi, James D. Kellner, et al. (+8)
289 [GO] 2024―May―06 Trust in governments, public health institutions, and other information sources as determinants of COVID-19 vaccine uptake behavior in Japan Alton Cao, Mami Ueta, Manae Uchibori, Michio Murakami, Hiroyuki Kunishima, Rauniyar Santosh Kumar, et al. (+10)
290 [GO] 2024―May―06 Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster Jianhua Li, Liming Gong, Jiaxuan Li, Zhenyu Gong, Xiaoxiao Wang, Hao Yan, et al. (+3)
291 [GO] 2024―May―06 Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development Tuksin Jearanaiwitayakul, Panya Sunintaboon, Anuwat Kittiayuwat, Jitra Limthongkul, Jidapar Wathanaphol, Yada Janhirun, et al. (+3)
292 [GO] 2024―May―03 The correlation between conspiracy mentality and vaccine intentions is moderated by social events: Evidence from longitudinal data during COVID-19 pandemic in the UK Indro Adinugroho, Tom Stafford, Richard P. Bentall
293 [GO] 2024―May―03 The impact of COVID-19 vaccination campaign on pediatric vaccine uptake based on parents’ attitudes towards mandatory and recommended vaccination in Southern Italy Francesco Baglivo, Luigi De Angelis, Mariano Magrì, Ingrid De Nicola, Erica De Vita, Pietro Luigi Lopalco, et al. (+2)
294 [GO] 2024―May―03 Immunogenicity and safety of a recombinant Omicron BA.4/5-Delta COVID-19 vaccine ZF2202-A in Chinese adults Hua Hu, Fangli Ma, Lihui Gong, Yaqin Wang, Maodi Xu, Hua Sun, et al. (+4)
295 [GO] 2024―Apr―30 Effects of parental childhood cultural health environment on children’s influenza and COVID-19 vaccination status Sasha A. Fleary, Zachary Shahn, Chloe A. Teasdale
296 [GO] 2024―Apr―29 Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands by medical risk condition: A test-negative case-control study F.A. Niessen, P.C.J.L. Bruijning-Verhagen, M.J.M. Bonten, V. Peters, H.S.M. Ammerlaan, C.E. Delsing, et al. (+14)
297 [GO] 2024―Apr―27 Collective good and individual choice: Perceptions on COVID-19 vaccine mandate among COVID-19 vaccinated individuals Kaivalya Gudooru, Kimberly Nguyen, Kathy Le, Vyas Sarabu, Meredith Hosek, Anna Phan, et al. (+5)
298 [GO] 2024―Apr―26 COVID-19 booster vaccine uptake and reduced risks for long-COVID: A cross-sectional study of a U.S. adult population Zhigang Xie, Sericea Stallings-Smith, Shraddha Patel, Stuart Case, Young-Rock Hong
299 [GO] 2024―Apr―25 Authors’ reply: Excess mortality in Cyprus during the COVID-19 vaccination campaign Theodore Lytras, Maria Athanasiadou, Anna Demetriou, Despina Stylianou, Alexandros Heraclides, Olga Kalakouta
300 [GO] 2024―Apr―25 A programmatic update on COVID-19 vaccination in rural communities in the United States Alexandra M. Piasecki, Diane M. Hall, Julie Zajac, Scott A. Miller, Jane R. Nilson
301 [GO] 2024―Apr―24 The role of religion and COVID-19 vaccine uptake in England Martin Ejnar Hansen, Steven David Pickering
302 [GO] 2024―Apr―23 Non-specific effects of the inactivated influenza vaccine. A test-negative study: The inactivated influenza vaccine and SARS-CoV-2 infections Anne Jasmijn Sellies, Mirjam J. Knol, Hester E. de Melker, Patricia C.J.L. Bruijning-Verhagen, Annemarijn R. de Boer
303 [GO] 2024―Apr―22 Who is getting COVID-19 boosters? A latent class analysis in a nationally representative sample of Mexican adults 60 years and over Martha Carnalla, Dalia Stern, M. Arantxa Colchero, Karla Rangel-Moreno, Ana Basto-Abreu, Celia M. Alpuche-Aranda, et al. (+2)
304 [GO] 2024―Apr―21 BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study Sanjin Musa, Lore Merdrignac, Sinisa Skocibusic, Rozalija Nedic, Seila Cilovic-Lagarija, Esther Kissling
305 [GO] 2024―Apr―19 Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France Gaëlle Lièvre, Jonathan Sicsic, Simon Galmiche, Tiffany Charmet, Arnaud Fontanet, Judith E. Mueller
306 [GO] 2024―Apr―18 Predictors of willingness to receive updated 2023-2024 COVID-19 booster vaccines among a convenience sample in Minnesota I.J. Ricke, A.B. Spaulding, N.N. Rajtar, E.M. Benton, I.G. Anderson, L. Lundberg, et al. (+2)
307 [GO] 2024―Apr―18 COVID-19 vaccine uptake among children and adolescents in Norway: A comprehensive registry-based cohort study of over 800,000 individuals Saima Orangzeb, Anteneh Desalegn, Nhung T.H. Trinh, Jing Zhao, Hedvig Nordeng, Angela Lupattelli
308 [GO] 2024―Apr―17 Exploring COVID-19 vaccine uptake and hesitancy among vulnerable populations in inner city Vancouver, Canada: Insights into characteristics and clinical outcomes Saina Beitari, Shana Yi, Shawn Sharma, Rossitta Yung, Brian Conway
309 [GO] 2024―Apr―17 Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2-derived RBD antigen Victor A. Ramos-Duarte, Alejandro Orlowski, Carolina Jaquenod de Giusti, Mariana G. Corigliano, Ariel Legarralde, Luisa F. Mendoza-Morales, et al. (+5)
310 [GO] 2024―Apr―16 COVID-19 vaccination communication: Effects of vaccine conspiracy beliefs and message framing among black and white participants Namyeon Lee, Yoorim Hong, Ciera E. Kirkpatrick, Sisi Hu, Sungkyoung Lee, Amanda Hinnant
311 [GO] 2024―Apr―16 Overview of U.S. COVID-19 vaccine safety surveillance systems Julianne Gee, Tom T. Shimabukuro, John R. Su, David Shay, Margaret Ryan, Sridhar V. Basavaraju, et al. (+25)
312 [GO] 2024―Apr―16 Analysis of causal relations between vaccine hesitancy for COVID-19 vaccines and ideological orientations in Brazil Eanes Torres Pereira, Sylvia Iasulaitis, Bruno Cardoso Greco
313 [GO] 2024―Apr―16 Avoidable COVID-19-related deaths and hospitalizations in Brazil, 2020-2023 Emil Kupek
314 [GO] 2024―Apr―16 Erratum to “Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model” [Vaccine 42(6) (2024) 1292-1299] Yuanyuan Ji, Xiuwen Sui, Wei Miao, Chang Wang, Qing Wang, Zhuojun Duan, et al. (+6)
315 [GO] 2024―Apr―15 Patient concerns and physician strategies for addressing COVID-19 vaccine hesitancy Joy Melnikow, Andrew Padovani, Jingwen Zhang, Marykate Miller, Melissa Gosdin, Sabrina Loureiro, Brock Daniels
316 [GO] 2024―Apr―15 Assessment of the impact of the vaccine pass policy on COVID-19 vaccine hesitancy and uptake among Chinese adults in Hong Kong Irene O.L. Wong, Cherry Wong, Nelly Mak, Alan Dai, Jingyi Xiao, Peng Wu, et al. (+3)
317 [GO] 2024―Apr―14 Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient Layan Sukik, Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, Patrick Tang, Hadi M. Yassine, et al. (+18)
318 [GO] 2024―Apr―11 Despite mandated primary series, health care personnel still hesitant about COVID-19 vaccine and immunizing children Mundeep K. Kainth, Grace N. Sembajwe, Heejoon Ahn, Min Qian, Maxine Carrington, Donna Armellino, Sophia Jan
319 [GO] 2024―Apr―11 Characterization of Brighton Collaboration criteria for myocarditis and pericarditis following COVID-19 vaccine in Korean adolescents Jue Seong Lee, HyoSug Choi, Seung Hwan Shin, Myung-Jae Hwang, Sara Na, Jong Hee Kim, et al. (+6)
320 [GO] 2024―Apr―11 COVID-19 vaccine uptake among non-US-born populations in the United States, 2020-2022 Margaret B. Nolan, Ella Chrenka, Patricia Walker, Abigail Steiner, Kristine Knuti Rodrigues, Jeremy J. Michel, et al. (+6)
321 [GO] 2024―Apr―10 Addressing vaccine hesitancy: Learning from the successes and failures of the COVID-19 pandemic Peter J. Pitts, Gregory A. Poland
322 [GO] 2024―Apr―09 A comparative analysis of knowledge, attitude, and practice (KAP) towards influenza and influenza vaccination among healthcare workers in Kyrgyzstan prior to and during the COVID-19 pandemic Rakhat Akmatova, Malembe S. Ebama, Sanjar Temirbekov, Venera Alymkulova, Dinara Otorbaeva
323 [GO] 2024―Apr―09 A survey of state and local practices encouraging pediatric COVID-19 vaccination of children ages 6 months through 11 years Alaya Koneru, Katelyn Wells, Catherine Amanda Carnes, Kathryn Drumhiller, Kevin Chatham-Stephens, Mackenzie Melton, et al. (+5)
324 [GO] 2024―Apr―09 Motivation for COVID-19 Vaccination: Applying a Self-Determination Theory Perspective to a Global Health Crisis Helen Thai, Élodie C. Audet, Richard Koestner
325 [GO] 2024―Apr―05 A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases Anna Schultze, Ivonne Martin, Davide Messina, Sophie Bots, Svetlana Belitser, Juan José Carreras-Martínez, et al. (+15)
326 [GO] 2024―Apr―04 Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial Holly E. Baum, Russell Thirard, Alice Halliday, Sarah Baos, Amy C. Thomas, Rosie A. Harris, et al. (+9)
327 [GO] 2024―Apr―04 Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trial Asrawati Nurdin, Yetty Movieta Nency, Martira Maddeppungeng, Rini Sekartini, Rini Mulia Sari, Fikrianti Surachman, et al. (+17)
328 [GO] 2024―Mar―30 Effectiveness of COVID-19 vaccination against school absenteeism in children and adolescents hospitalized with COVID-19 Helena C. Maltezou, Stavroula Kontogianni, Elisavet Michailidou, Eleni Vergadi, Theodoros V. Giannouchos, Evangelia Steletou, et al. (+4)
329 [GO] 2024―Mar―30 Self-reported determinants of COVID-19 vaccine acceptance among persons with and without autoimmune disease Jenny D. Gong, Emma Barnboym, Megan O'Mara, Natalie Gurevich, Maya Mattar, Donald D. Anthony, et al. (+2)
330 [GO] 2024―Mar―28 Testing the impact of differing behavioural science informed text message content in COVID-19 vaccination invitations on vaccine uptake: A randomised clinical trial Sarah W. Huf, Kate Grailey, Roberto Fernandez Crespo, Lena Woldmann, Matthew Chisambi, Helen Skirrow, et al. (+5)
331 [GO] 2024―Mar―25 Leveraging seasonal influenza health worker vaccination programmes for COVID-19 vaccine Introduction: A global qualitative analysis Anna-Maria Volkmann, Shoshanna Goldin, Britney McMurren, Claire Gapare, Beth Anne Pratt, Laura Frost, Shalini Desai
332 [GO] 2024―Mar―23 Global VAX: A U.S. contribution to global COVID-19 vaccination efforts, 2021-2023 Benjamin A. Dahl, Beth Tritter, Deena Butryn, Melissa Dahlke, Sean Browning, Richard Gelting, et al. (+18)
333 [GO] 2024―Mar―23 COVID-19 vaccine reactogenicity among participants enrolled in the GENCOV study Gregory Morgan, Selina Casalino, Sunakshi Chowdhary, Erika Frangione, Chun Yiu Jordan Fung, Elisa Lapadula, et al. (+17)
334 [GO] 2024―Mar―22 Exploring associations between the Big Five personality traits and cognitive ability with COVID-19 vaccination hesitancy and uptake among mothers and offspring in a UK prospective cohort study Jennifer Condie, Kate Northstone, Daniel Major-Smith, Isaac Halstead
335 [GO] 2024―Mar―22 High COVID-19 vaccine uptake following initial hesitancy among people in Australia who inject drugs Olivia Price, Paul Dietze, Lisa Maher, Gregory J. Dore, Rachel Sutherland, Caroline Salom, et al. (+5)
336 [GO] 2024―Mar―20 Differences in social media use by COVID-19 vaccination status Kenneth W. Moffett, Kate Seserman, Katherine A. Margolis, Elissa C. Kranzler, Michael C. Marshall, Heather Dahlen, et al. (+6)
337 [GO] 2024―Mar―20 Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge Lindsay Hill-Batorski, Richard Bowen, Helle Bielefeldt-Ohmann, Michael J. Moser, Sarah M. Matejka, David Marshall, et al. (+3)
338 [GO] 2024―Mar―20 Humoral and cellular immunity to SARS-CoV-2 following vaccination with non-mRNA vaccines in adolescent/young adults with cancer: A prospective cohort study Archana Sasi, Jyotsna Dandotiya, Jyotsana Kaushal, Shuvadeep Ganguly, Akshay Binayke, K.M. Ambika, et al. (+6)
339 [GO] 2024―Mar―19 Transformative vaccination: A pentavalent shield against COVID-19 and influenza with betulin-based adjuvant for enhanced immunity Igor Krasilnikov, Artur Isaev, Milana Djonovic, Alexander Ivanov, Ekaterina Romanovskaya-Romanko, Marina Stukova, Vitaly Zverev
340 [GO] 2024―Mar―17 COVID-19 vaccination in cancer patients: Immune responses one year after the third dose Roberta Campagna, Federica Dominelli, Maria Antonella Zingaropoli, Fabio Ciurluini, Giorgia Grilli, Alessandra Amoroso, et al. (+11)
341 [GO] 2024―Mar―16 Benefit-risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373) Jonathan Fix, T. Christopher Mast, Katherine Smith, Nicole Baker
342 [GO] 2024―Mar―14 The effect of SARS-COV-2 variant on non-respiratory features and mortality among vaccinated and non-fully vaccinated patients Shannon A. Cotton, Ajan Subramanian, Thomas D. Hughes, Yong Huang, Carmen Josefa Sierra, Alex K. Pearce, et al. (+4)
343 [GO] 2024―Mar―14 Identifying trusted local sources and predicting behavior change pathways according to COVID-19 vaccination status: Results of a 2022 statewide survey of Alaskan adults Drew B. Cameron, Laura Grage, Rebecca Van Wyck, Alexandra Edwards, Joy Chavez Mapaye, Ann Cheng, Gabriel Garcia
344 [GO] 2024―Mar―13 Predicting intention to vaccinate against COVID-19 in older Syrian refugees in Lebanon: Findings from a multi-wave study Noura El Salibi, Sawsan Abdulrahim, Maria El Haddad, Berthe Abi Zeid, Marwan F. Alawieh, Zeinab Ramadan, et al. (+2)
345 [GO] 2024―Mar―13 The effect of a financial incentive on COVID-19 vaccination uptake, and predictors of uptake, in people experiencing homelessness: A randomized controlled trial Laura K. McCosker, Robert S. Ware, Holly Seale, Dona Hooshmand, Ryan O'Leary, Martin J. Downes
346 [GO] 2024―Mar―12 Sociodemographic and Occupational Characteristics Associated with Early and Continued COVID-19 Vaccine Uptake Among Healthcare Personnel: Monroe County, NY Savanah Russ, Christopher Myers, Erin Licherdell, Acacia Bowden, Ellen Chinchilli, Runda Dahhan, et al. (+3)
347 [GO] 2024―Mar―11 Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the vaccine adverse event reporting System - United States, September 1, 2022 - March 31, 2023 Pedro L. Moro, Grace Carlock, Nimita Fifadara, Tei Habenicht, Bicheng Zhang, Penelope Strid, Paige Marquez
348 [GO] 2024―Mar―11 Partisan divide and Racial/Ethnic disparities in COVID-19 vaccine hesitancy among Parents/Guardians and vaccine uptake among children in the U.S. Alice Shijia Yan, Neil Jay Sehgal
349 [GO] 2024―Mar―11 Pandemic antecedents - Exploring predictivity and relationships between COVID-19 vaccine uptake and influenza, shingles, and HPV vaccination Monique Luisi, Mugur V. Geana, Jun Pei
350 [GO] 2024―Mar―08 Safety and immunogenicity of heterologous boosting with a bivalent SARS-CoV-2 mRNA vaccine (XBB.1.5/BQ.1) in Chinese participants aged 18 years or more: A randomised, double-blinded, active-controlled phase 1 trial Yu-Wen Su, Yuan-Zheng Qiu, Yuan-Hui Wang, Yan Xu, Chao-Chao Huang, Qing Zhang, et al. (+8)
351 [GO] 2024―Mar―07 Neutralization of SARS-CoV-2 Omicron subvariant BA.2.87.1 Ninaad Lasrado, Annika Rössler, Marjorie Rowe, Ai-ris Y. Collier, Dan H. Barouch
352 [GO] 2024―Mar―07 Effectiveness of inactivated COVID-19 vaccine CoronaVac in children aged less than 3 years old during Omicron wave in Hong Kong W.H.S. Wong, D.L. Leung, K.M. Yip, H.K. So, J.S. Rosa Duque, Y.L. Lau
353 [GO] 2024―Mar―07 Social and demographic factors associated with receipt of a COVID-19 vaccine initial booster dose and with interval between primary series completion and initial booster dose uptake among persons aged ≥ 12 years, United States, August 2021-October 2022 Lu Meng, LaTreace Harris, Lauren Shaw, Hoody Lymon, Hannah Reses, Jeneita Bell, et al. (+3)
354 [GO] 2024―Mar―06 “COVID is a huge jigsaw puzzle that I am trying to make sense of myself”: Exploring the perceptions towards the COVID-19 vaccine communication strategy in Australia amongst unvaccinated Australian adults Joshua Karras, Mia Harrison, Maryke Steffens, Ikram Abdi, Holly Seale
355 [GO] 2024―Mar―06 Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study Monika Raethke, Florence van Hunsel, Nicoletta Luxi, Thomas Lieber, Chiara Bellitto, Erik Mulder, et al. (+13)
356 [GO] 2024―Mar―05 Association of COVID-19 vaccination with duration of hospitalization in older adults in Hong Kong Dongxuan Chen, Benjamin J. Cowling, Kylie E.C. Ainslie, Yun Lin, Jessica Y. Wong, Eric H.Y. Lau, et al. (+2)
357 [GO] 2024―Mar―02 Developing a novel screening tool to address pediatric COVID-19 vaccine hesitancy at point of care Sarah G. Yashar-Gershman, Alix T. Rosenberg, Muskaan Sawhney, Maria Fernanda Machicao, Howard R. Moskowitz, Henry H. Bernstein
358 [GO] 2024―Feb―29 Projections of the incidence of COVID-19 in Japan and the potential impact of a Fall 2023 COVID-19 vaccine Michele Kohli, Michael Maschio, Amy Lee, Ataru Igarashi
359 [GO] 2024―Feb―29 An overview of the COVID-19 pediatric vaccine program - The U.S. experience vaccinating children ages 6 months through 17 years Kevin Chatham-Stephens, Rosalind J. Carter, Chris Duggar, Kate R. Woodworth, Catherine Amanda Carnes, Achal Bhatt, et al. (+4)
360 [GO] 2024―Feb―29 Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic Dana Meaney-Delman, Sarah Carroll, Kara Polen, Tara C. Jatlaoui, Sarah Meyer, Sara Oliver, et al. (+9)
361 [GO] 2024―Feb―29 Impact evaluation of a youth led intervention to increase COVID-19 vaccine uptake in Kwazulu-Natal, South Africa Edmore Marinda, Qaqambile Mathentamo, Nancy Coulson, Saahier Parker, Patrick DMC Katoto, Gregory Houston, et al. (+5)
362 [GO] 2024―Feb―28 Intensification of integrated immunization services to recover routine vaccination coverage and bring COVID-19 vaccine to the population of Iraq in 2022 Firas Jabbar, Kamal A Kadhim, Riyadh A Alhilfi, Abdulaal Chitheer, Alaa Rahi, David B Hipgrave
363 [GO] 2024―Feb―26 Socio-demographic determinants of COVID-19 vaccine uptake in Ontario: Exploring differences across the Health Region model Ariel Mundo Ortiz, Bouchra Nasri
364 [GO] 2024―Feb―22 Mortality risk after COVID-19 vaccination: A self-controlled case series study Stanley Xu, Lina S. Sy, Vennis Hong, Paddy Farrington, Sungching C. Glenn, Denison S. Ryan, et al. (+13)
365 [GO] 2024―Feb―22 Audiovestibular adverse events following COVID-19 vaccinations Aishwarya N. Shetty, Hannah J. Morgan, Linny K. Phuong, John Mallard, Diana Vlasenko, Christopher Pearce, et al. (+3)
366 [GO] 2024―Feb―16 Risk of SARS-CoV-2 breakthrough infection following NVX-CoV2373 and BNT162b2 vaccinations in Korean Adults: A population-based observational study Hee Kyoung Kim, Seon Kyeong Park, Seung Ah Choe, Eun Sun Gwak, Benjamin John Cowling, Young-Man Kim, et al. (+7)
367 [GO] 2024―Feb―15 U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 - May 2023 Christopher Duggar, Jeanne M. Santoli, Cameron Noblit, Lori B. Moore, Roua El Kalach, Carolyn B. Bridges
368 [GO] 2024―Feb―15 COVID-19 vaccine perspectives and uptake among university students three years into the pandemic Barbara J. Kuter, Kate Brien, Susannah Anderson, Sarah Bauerle Bass, Linda Gutierrez, Stella Winters, et al. (+3)
369 [GO] 2024―Feb―15 Vaccine effectiveness against COVID-19: A test negative case-control study in Tunisia, August 2021 Emna Mziou, Aicha Hchaichi, Hejer Letaief, Sonia Dhaouadi, Mouna Safer, Khouloud Talmoudi, et al. (+7)
370 [GO] 2024―Feb―15 Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trial Fei Jin, Yuanzheng Qiu, Zhiwei Wu, Yuan-Hui Wang, Chengye Cai, Liangcai Fu, et al. (+18)
371 [GO] 2024―Feb―14 Did the COVID-19 experience change U.S. parents’ attitudes towards HPV vaccination? Results from a national survey Ann C. Klassen, Giyoung Lee, Shawn Chiang, Regan Murray, Mengfei Guan, Wen-Juo Lo, et al. (+4)
372 [GO] 2024―Feb―14 The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection Francesco Donato, Andrea Pilotto, Emanuele Focà, Marco Tresoldi, Alessio Tonoli, Cristiano Perani, et al. (+13)
373 [GO] 2024―Feb―13 Food insecurity and COVID-19 vaccine hesitancy among adults in the United States (US) Elizabeth B. Hearn, Ganiat Kehinde, Usha Sambamoorthi
374 [GO] 2024―Feb―12 Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination - A self-controlled case series analysis Hannah J. Morgan, Hazel J. Clothier, Gonzalo Sepulveda Kattan, James H. Boyd, Jim P. Buttery
375 [GO] 2024―Feb―12 COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals K. Faksova, D. Walsh, Y. Jiang, J. Griffin, A. Phillips, A. Gentile, et al. (+30)
376 [GO] 2024―Feb―10 SARS-CoV-2 specific antibody response after an mRNA vaccine as the third dose: Homologous versus heterologous boost Olivera Lijeskić, Neda Bauman, Miloš Marković, Jelena Srbljanović, Branko Bobić, Đorđe Zlatković, Tijana Štajner
377 [GO] 2024―Feb―09 COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic Lauri E. Markowitz, Robert H. Hopkins, Karen R. Broder, Grace M. Lee, Kathryn M. Edwards, Matthew F. Daley, et al. (+22)
378 [GO] 2024―Feb―09 Safe in pregnancy: A global living systematic review and meta-analysis of COVID-19 vaccines in pregnancy Pierre Buekens, Mabel Berrueta, Agustín Ciapponi, Ariel Bardach, Agustina Mazzoni, Federico Rodriguez-Cairoli, et al. (+6)
379 [GO] 2024―Feb―09 Leveraging the immunoinformatics approach for designing the SARS-CoV-2 omicron-specific antigenic cassette of mRNA vaccine Rucha Wadapurkar, Sanjay Singh, Ajay Singh
380 [GO] 2024―Feb―06 Public opinion on global COVID-19 vaccine procurement and distribution policies: A nationally representative survey in Aotearoa New Zealand 2022 Komathi Kolandai, Barry Milne, Martin von Randow, Chris Bullen, Samantha Marsh, John A. Crump
381 [GO] 2024―Feb―05 The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study Megumi Maeda, Fumiko Murata, Haruhisa Fukuda
382 [GO] 2024―Feb―02 The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling study Samik Datta, Giorgia Vattiato, Oliver J. Maclaren, Ning Hua, Andrew Sporle, Michael J. Plank
383 [GO] 2024―Feb―02 Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine development Sho Miyamoto, Tadaki Suzuki
384 [GO] 2024―Feb―02 Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study Patrick Rivers, Cynthia Porter, Lindsay B. LeClair, Zuha Jeddy, Ashley L. Fowlkes, Julie Mayo Lamberte, et al. (+18)
385 [GO] 2024―Feb―02 Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRNA booster vaccine versus two-dose primary series against symptomatic SARS-CoV-2 infection Julia C. Bennett, Kyle G. Luiten, Jessica O'Hanlon, Peter D. Han, Devon McDonald, Tessa Wright, et al. (+17)
386 [GO] 2024―Feb―02 Advancing public health informatics during the COVID-19 pandemic: Lessons learned from a public-private partnership with pharmacies Nkenge Jones-Jack, Roua El Kalach, Diana Yassanye, Ruth Link-Gelles, Abdulhakeem Olorukooba, Amee Khamar deMartino, et al. (+10)
387 [GO] 2024―Feb―01 Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine formulated with a functional polymer Subeena Sood, Majed M. Matar, Jessica Kim, Meredyth Kinsella, Kempaiah Rayavara, Olivia Signer, et al. (+14)
388 [GO] 2024―Jan―30 Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection Ying Huang, Hua Shi, David Forgacs, Ted M. Ross
389 [GO] 2024―Jan―30 Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model Yuanyuan Ji, Xiuwen Sui, Wei Miao, Chang Wang, Qing Wang, Zhuojun Duan, et al. (+6)
390 [GO] 2024―Jan―28 Impact of the 'Health on Wheels' (HoW) strategy on COVID-19 vaccination coverage in hard-to-reach communities in Alta Verapaz, Guatemala, 2022 Evelyn Balsells, Manolo Vicente, Sharon Reyes, Marlon Figueroa, Keyla Sum, Maria Antonieta López Lacán, et al. (+8)
391 [GO] 2024―Jan―27 Are COVID-19 vaccination mandates for healthcare workers effective? A systematic review of the impact of mandates on increasing vaccination, alleviating staff shortages and decreasing staff illness Arnold I. Okpani, Prince Adu, Tyler Paetkau, Karen Lockhart, Annalee Yassi
392 [GO] 2024―Jan―27 Antibodies against SARS-CoV-2 non-structural protein 3 cross-react with human muscle cells and neuroglial cells Xin-Yue Yang, Ting Liu, Si-Cong Jiang, Zhong-Wei Zhang, Yu-Fan Fu, Zi-Lin Li, et al. (+2)
393 [GO] 2024―Jan―27 Short term safety of BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine among children aged 5-11 years, a nationwide parental survey Shirley Shapiro Ben David, Sharon Baruch Gez, Limor Adler, Rada Kovatch, Daniella Rahamim-Cohen, Na'ama Shamir-Stein, et al. (+2)
394 [GO] 2024―Jan―26 The U.S. COVID-19 vaccination program: A look back and future directions Elisha Hall, Barbara E. Mahon, Georgina Peacock
395 [GO] 2024―Jan―25 Determinants of SARS-CoV-2 IgG response and decay in Canadian healthcare workers: A prospective cohort study Nicola Cherry, Anil Adisesh, Igor Burstyn, Carmen Charlton, Yan Chen, Quentin Durand-Moreau, et al. (+5)
396 [GO] 2024―Jan―24 Influence of Community Determinants on Barriers and Facilitators to COVID-19 Vaccine Uptake: Regional Stakeholders’ Perspectives Savanah Russ, Nancy Bennett, Edwin van Wijngaarden, Elaine Hill, Yu Liu
397 [GO] 2024―Jan―23 Strengthening COVID-19 vaccine confidence & demand during the US COVID-19 emergency response Neetu Abad, Kimberly E. Bonner, Jessica Kolis, Kathryn A. Brookmeyer, Chris Voegeli, James T. Lee, et al. (+16)
398 [GO] 2024―Jan―23 Lessons learned: COVID-19 vaccinations and people with disabilities Karyl Rattay, JoAnn M. Thierry, Marshalyn Yeargin-Allsopp, Shannon Griffin-Blake, Catherine E. Rice, Kevin Chatham-Stephens, Karen Remley
399 [GO] 2024―Jan―22 Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study Mohamad Hamad Saied, Joeri W. van Straalen, Sytze de Roock, Frans M. Verduyn Lunel, Jelle de Wit, Lia G.H. de Rond, et al. (+8)
400 [GO] 2024―Jan―22 Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates Ranajit Pal, Maria Grazia Ferrari, Yoshikazu Honda-Okubo, Lauren Wattay, Jesica Caple, Jennifer Navarrete, et al. (+2)
401 [GO] 2024―Jan―21 Influence of the COVID-19 pandemic on caregiver beliefs and experiences of routine childhood immunisation in Indonesia Madeleine Randell, Meru Sheel, Michelle Dynes, Mu Li, Margie Danchin, Fitriyani Sukesmi, et al. (+8)
402 [GO] 2024―Jan―21 The role of funded partnerships in working towards decreasing COVID-19 vaccination disparities, United States, March 2021-December 2022 Amy Parker Fiebelkorn, Sara Adelsberg, Rishelle Anthony, Samrawit Ashenafi, Amimah F. Asif, Maria Azzarelli, et al. (+50)
403 [GO] 2024―Jan―21 Social network risk factors and COVID-19 vaccination: A cross-sectional survey study Ally Memedovich, Taylor Orr, Aidan Hollis, Charleen Salmon, Jia Hu, Kate Zinszer, et al. (+2)
404 [GO] 2024―Jan―21 SARS-CoV-2 vaccination willingness and humoral vaccination response in radiation oncology patients Hans Geinitz, Elisabeth Silberberger, Kurt Spiegl, Johann Feichtinger, Helga Wagner, Philipp Hermann, et al. (+14)
405 [GO] 2024―Jan―20 Examining changes in sense of purpose before, during, and after COVID-19 vaccination Patrick L. Hill, Talia Morstead, Gabrielle N. Pfund, Anthony L. Burrow, Anita DeLongis, Nancy L. Sin
406 [GO] 2024―Jan―20 Mixed-methods examination of attitudes and behaviors related to COVID-19 vaccines among parents of children with autism and autistic adults Melissa M. Mitchell, Adriana Klott, Jared Scholtes, B. Blair Braden, Christopher J. Smith, Nicole L. Matthews
407 [GO] 2024―Jan―17 Restricted Omicron-specific cross-variant memory B-cell immunity after a 3rd dose/booster of monovalent Wuhan-Hu-1-containing COVID-19 mRNA vaccine Iana H. Haralambieva, Jonathon M. Monroe, Inna G. Ovsyannikova, Nathaniel D. Warner, Diane E. Grill, Gregory A. Poland, Richard B. Kennedy
408 [GO] 2024―Jan―15 How manufacturing won or lost the COVID-19 vaccine race Michael L. King
409 [GO] 2024―Jan―14 COVID-19 vaccination among young people who use drugs in Vancouver, Canada Erica McAdam, Kanna Hayashi, Brittany Barker, Hudson Reddon, JinCheol Choi, Thomas Kerr, Kora DeBeck
410 [GO] 2024―Jan―11 Assessing the relationship between existing childhood, adolescent and adult immunization programmes and national COVID-19 vaccination capacities in 2021 Shoshanna Goldin, Ann Moen, William J. Moss, Jennifer Nuzzo
411 [GO] 2024―Jan―09 Mixed methods approach to understanding COVID-19 vaccine hesitancy among immigrants in the Chicago MaryGrace Sharp, Paula Lozano, Alia Southworth, Aven Peters, Helen Lam, Fornessa T. Randal, et al. (+2)
412 [GO] 2024―Jan―09 The mental health symptoms of individuals with sensory disabilities and the reasons that lead to COVID-19 vaccine refusal and hesitancy Amanda M. Hinson-Enslin, Luis Enrique Espinoza
413 [GO] 2024―Jan―09 Characterizing predictors of COVID-19 vaccine refusal in an urban southern California jail population Nazia S. Qureshi, Loren G. Miller, Stephen P. Judge, Ngoc Dung T. Tran, Sean O. Henderson
414 [GO] 2024―Jan―06 Exploring preventive care practices among unvaccinated individuals in the United States during the COVID-19 pandemic Dejan K. Filipas, Muhieddien Labban, Edoardo Beatrici, Benjamin V. Stone, Zhiyu Qian, Vincent D́Andrea, et al. (+4)
415 [GO] 2024―Jan―06 Parental concerns and vaccine hesitancy against COVID-19 vaccination for children in Greece: A cross-sectional survey E. Steletou, T. Giannouchos, G. Dimitriou, A. Karatza, X. Sinopidis, H.C. Maltezou, et al. (+2)
416 [GO] 2024―Jan―05 Challenges and opportunities during the COVID-19 vaccination efforts in long-term care Nimalie D. Stone, Amy Parker Fiebelkorn, Angela Guo, Elizabeth Mothershed, Lauren Moccia, Jeneita Bell, et al. (+6)
417 [GO] 2024―Jan―05 Racial and ethnic differences in COVID-19 vaccine readiness among adults in the United States, January 2021-April 2023 Elissa C. Kranzler, Timothy O. Ihongbe, Michael C. Marshall, Benjamin Denison, Heather Dahlen, Blake Hoffman, et al. (+3)
418 [GO] 2024―Jan―04 Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions - A cross-sectional study in six EU member states Caroline Buhl, Ramune Jacobsen, Anna Birna Almarsdóttir, Shahab Abtahi, Armin Andersen, Elena Deligianni, et al. (+14)
419 [GO] 2024―Jan―04 Massachusetts companion program bolsters COVID-19 vaccine rates among seniors Marie-Laure Charpignon, Shagun Gupta, Maimuna Shahnaz Majumder
420 [GO] 2023―Dec―29 Development of COVID-19 vaccine policy - United States, 2020-2023 Sara E. Oliver, Megan Wallace, Evelyn Twentyman, Danielle L. Moulia, Monica Godfrey, Ruth Link-Gelles, et al. (+10)
421 [GO] 2023―Dec―28 mRNA vaccines for COVID-19 are safe and clinically effective in patients with cardiac amyloidosis Gina Barzen, Finn Rieber, Karl Stangl, Katrin Hahn, Sebastian Spethmann
422 [GO] 2023―Dec―27 CDC COVID-19 vaccination program: Healthcare provider compliance with COVID-19 vaccine requirements and recommendations Tamara C. Surtees, Charleigh J. Granade, Christopher Wells, Michelle Banks, Paul Lucas, Samuel B. Graitcer
423 [GO] 2023―Dec―27 Long term follow up and outcomes of Covid-19 vaccine associated myocarditis in Victoria, Australia: A clinical surveillance study Priya Shenton, Silja Schrader, Julia Smith, Annette Alafaci, Nicholas Cox, Andrew Taylor, et al. (+5)
424 [GO] 2023―Dec―23 Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023 Elina Seppälä, Jesper Dahl, Lamprini Veneti, Kjersti Margrethe Rydland, Birgitte Klüwer, Andreas Rohringer, Hinta Meijerink
425 [GO] 2023―Dec―23 Comparison of adult hesitancy towards COVID-19 vaccines and vaccines in general in the USA Kimberly H. Nguyen, Kelsey C. Coy, Carla L. Black, Paul Scanlon, James A. Singleton
426 [GO] 2023―Dec―23 Vaccine-associated respiratory pathology correlates with viral clearance and protective immunity after immunization with self-amplifying RNA expressing the spike (S) protein of SARS-CoV-2 in mouse models Alla Kachko, Prabhuanand Selvaraj, Shufeng Liu, Jaekwan Kim, David Rotstein, Charles B. Stauft, et al. (+5)
427 [GO] 2023―Dec―22 Neighborhood-level vaccine impact on COVID-19 infection and hospital admission in Q, Canada, during the Delta and early Omicron periods Ernest Lo, Nicholas Brousseau, Fannie Defay, Élise Fortin, Marilou Kiely
428 [GO] 2023―Dec―21 Immunogenicity and safety of a second heterologous booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Interim analysis report of a phase 3 open-label trial Kenji Kuriyama, Kyoko Murakami, Kenkichi Sugiura, Sho Sakui, Ron P. Schuring, Mitsuhiro Mori
429 [GO] 2023―Dec―20 Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions Ruth Link-Gelles, Amadea Britton, Katherine E. Fleming-Dutra
430 [GO] 2023―Dec―20 Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study Marcelo Wolff, Paulo Charpentier, Andrea Canals, Cecilia Vial, Juan Hormazábal, Jimena Cortés, Macarena Silva
431 [GO] 2023―Dec―19 COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study) Takeshi Arashiro, Maki Miwa, Hidenori Nakagawa, Junpei Takamatsu, Kunihiro Oba, Satoshi Fujimi, et al. (+55)
432 [GO] 2023―Dec―18 9-Month observational Dia-Vacc study of vaccine type influence on SARS-CoV-2 immunity in dialysis and kidney transplant patients Julian Stumpf, Leona Anders, Torsten Siepmann, Jörg Schwöbel, Claudia Karger, Tom Lindner, et al. (+29)
433 [GO] 2023―Dec―16 A multifaceted approach for identification, validation, and immunogenicity of naturally processed and in silico-predicted highly conserved SARS-CoV-2 peptides Tamar Ratishvili, Huy Quang Quach, Iana H. Haralambieva, Yogesh R. Suryawanshi, Inna G. Ovsyannikova, Richard B. Kennedy, Gregory A. Poland
434 [GO] 2023―Dec―15 Observations of COVID-19 vaccine coverage and vaccine hesitancy on COVID-19 outbreak: An American ecological study Deewan Bajracharya, Rick J. Jansen
435 [GO] 2023―Dec―15 Characterization of SARS-CoV-2-specific humoral immunity and associated factors in the healthy population post-vaccination Xiao-Yong Zhan, Yun Chen, Xiaoying Zhang, Qipeng Shi, Kaiyin Chen, Changchun Zeng, et al. (+20)
436 [GO] 2023―Dec―14 Factors associated with COVID-19 autumn 2022 booster uptake in the Netherlands among older adults aged ≥ 60 years and younger adults with chronic conditions Caren van Roekel, Lisanne Labuschagne, Joyce Pijpers, Annika van Roon, Bente Smagge, José A. Ferreira, et al. (+2)
437 [GO] 2023―Dec―14 Intranasal immunization with the recombinant measles virus encoding the spike protein of SARS-CoV-2 confers protective immunity against COVID-19 in hamsters Sang-In Park, Sohyun Park, Kunse Lee, Hye Won Kwak, Yong Kwan Kim, Hyeong-Jun Park, et al. (+16)
438 [GO] 2023―Dec―14 Impact of the COVID-19 pandemic on routine vaccination coverage under varying prevalence Conditions: A cohort study in Beijing, China Zhiqiang Cao, Rui Yu, Qianli Yuan, Wenyan Ji, Xiaomei Li, Pei Gao, et al. (+3)
439 [GO] 2023―Dec―14 Monitoring and reporting the US COVID-19 vaccination effort Lynn Gibbs Scharf, Kafayat Adeniyi, Emily Augustini, Deborah Boyd, Laura Corvin, Roua El Kalach, et al. (+26)
440 [GO] 2023―Dec―13 Access to SARS-CoV-2 vaccination in immigrants in Italy, by geographical area of origin Eliana Ferroni, Nicola Gennaro, Giovanni Maifredi, Olivia Leoni, Francesco Profili, Cristina Stasi, et al. (+5)
441 [GO] 2023―Dec―12 The importance of community-specific survey data in understanding behavioral and social drivers of COVID-19 vaccination: Lessons learned from urban neighborhoods in four United States cities Sasigant So O'Neil, Emma L. Pendl-Robinson, Elizabeth A. Carosella, Brianna D. Sullivan, Anitha Sivasankaran
442 [GO] 2023―Dec―11 Effectiveness of COVID-19 vaccine mandates in raising vaccination rates among the elderly and general population in Europe: Controlled interrupted time series analysis Theodore Lytras, Abba Adema Alumasa Di Gregorio, Dimitrios Apostolopoulos, Demetris Naziris, Christina Zingerle, Alexandros Heraclides
443 [GO] 2023―Dec―09 Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review Miceline Mésidor, Yan Liu, Denis Talbot, Danuta M. Skowronski, Gaston De Serres, Joanna Merckx, et al. (+5)
444 [GO] 2023―Dec―08 Stronger and durable SARS-CoV-2 immune response to mRNA vaccines in 5-11 years old children with prior COVID-19 Costanza Di Chiara, Anna Cantarutti, Maria Raffaella Petrara, Francesco Bonfante, Elisa Benetti, Riccardo Boracchini, et al. (+15)
445 [GO] 2023―Dec―08 SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacy Yongjun Sui, Hanne Andersen, Jianping Li, Tanya Hoang, Mahnaz Minai, Bianca M. Nagata, et al. (+4)
446 [GO] 2023―Dec―07 The intention to get COVID-19 booster vaccination and its association with cognitive and emotional factors: A survey of Chinese COVID-19 infected people in Hong Kong Yanqiu Yu, Xiaoying Zhang, Mason M.C. Lau, Joseph T.F. Lau
447 [GO] 2023―Dec―07 Why did Brazil fail to vaccinate children against COVID-19 during the pandemic? An assessment of attitudinal and behavioral determinants Wladimir Gramacho, Mathieu Turgeon, Pedro Santos Mundim, Isadora Pereira
448 [GO] 2023―Dec―06 CDC COVID-19 Vaccine Pregnancy Registry: Design, data collection, response rates, and cohort description Sabrina A. Madni, Andrea J. Sharma, Lauren Head Zauche, Ansley V. Waters, John F. Nahabedian, Tara Johnson, Christine K. Olson
449 [GO] 2023―Dec―05 The relative effectiveness of three and four doses of COVID-19 vaccine in Victoria, Australia: A data linkage study Jose T. Canevari, Allen C. Cheng, Logan Wu, Stacey L. Rowe, Dennis E. Wollersheim, Daniel West, et al. (+2)
450 [GO] 2023―Dec―01 Production, purification and immunogenicity of Gag virus-like particles carrying SARS-CoV-2 components Anahita Bakhshizadeh Gashti, Gerard Agbayani, Sabahudin Hrapovic, Nasha Nassoury, Nathalie Coulombe, Renu Dudani, et al. (+4)
451 [GO] 2023―Nov―27 RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccine Yuanyuan Wang, Yunqi Hu, Yong Ma, Pengbin Li, Siwei Zhou, Mengxin Xu, et al. (+9)
452 [GO] 2023―Nov―25 Resilience of routine childhood immunization services in two counties in Kenya in the face of the COVID-19 pandemic Harriet Mirieri, Carolyne Nasimiyu, Jeanette Dawa, Caroline Mburu, Rose Jalang'o, Peter Kamau, et al. (+18)
453 [GO] 2023―Nov―25 Modeling COVID-19 vaccine booster-elicited antibody response and impact of infection history Takara Nishiyama, Yuichiro Miyamatsu, Hyeongki Park, Naotoshi Nakamura, Risa Yokokawa Shibata, Shingo Iwami, Yoji Nagasaki
454 [GO] 2023―Nov―25 Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients Nicolás Ducasa, Paula Benencio, Ezequiel Mauro, Margarita Anders, Bianca Mazzitelli, Lucía Bleichmar, et al. (+9)
455 [GO] 2023―Nov―23 Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design Amanda B. Payne, Allison Avrich Ciesla, Elizabeth A.K. Rowley, Zachary A. Weber, Sarah E. Reese, Toan C. Ong, et al. (+9)
456 [GO] 2023―Nov―22 Breakthrough COVID-19 infections and perceived vaccine effectiveness Stephen R. Neely, Feng Hao
457 [GO] 2023―Nov―22 Sociodemographic factors and attitudes associated with Australian parental acceptance of paediatric COVID-19 vaccination Bing Wang, Joshua McDonough, Gang Chen, Jason J. Ong, Helen Marshall
458 [GO] 2023―Nov―22 Excess mortality in Cyprus during the COVID-19 vaccination campaign Eleftheria C. Economidou, Elpidoforos S. Soteriades
459 [GO] 2023―Nov―19 “I’d do it for my baby”: Lessons learned from qualitative research on COVID-19 vaccination among pregnant women in Côte d’Ivoire Danielle Naugle, Natalie Tibbels, Abdul Dosso, William Benie, Marjorie Nana
460 [GO] 2023―Nov―17 Assessing parental intention to vaccinate against COVID-19, influenza, and RSV in the United States in late 2023 Simon F. Haeder
461 [GO] 2023―Nov―17 Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic Nofar Amitai, Reut Wertheimer, Dario Prais, Keren-Or Wertheimer, Gilat Livni
462 [GO] 2023―Nov―16 Who gets COVID-19 booster vaccination? Trust in public health institutions and promotion strategies post-pandemic in the Republic of Korea Yongjin Choi, Soohyun Park, Jinwoo Lee, Youngsung Kim, Byoung Joon Kim, Leesa Lin, Ashley M. Fox
463 [GO] 2023―Nov―14 Impact of a hypothetical COVID-19 vaccine mandate on parental likelihood to vaccinate children: Exploring school-related concerns and vaccination decision-making Joshua T. Sarafian, Stephanie A. Eucker, Michael Gillman, Amy M. DeLaroche, Robert M. Rodriguez, David Rayburn, et al. (+7)
464 [GO] 2023―Nov―14 Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023 Ian D. Plumb, Melissa Briggs Hagen, Ryan Wiegand, Ghinwa Dumyati, Christopher Myers, Karisa K. Harland, et al. (+64)
465 [GO] 2023―Nov―11 Impact of the surge of COVID-19 Omicron outbreak on the intention of seasonal influenza vaccination in Hong Kong: A cross-sectional study Xiaoting Jiang, Jingxuan Wang, Conglu Li, Eng Kiong Yeoh, Zihao Guo, Yuchen Wei, Ka Chun Chong
466 [GO] 2023―Nov―11 “Who is Anders Tegnell?” Unanswered questions hamper COVID-19 vaccine uptake: A qualitative study among ethnic minorities in Sweden Sibylle Herzig van Wees, Maria Stålgren, Nina Viberg, Bi Puranen, Anna Mia Ekström, Elin C. Larsson
467 [GO] 2023―Nov―11 Factors associated with uptake of bivalent mRNA COVID-19 vaccines in a large US health care system Katia J. Bruxvoort, Lina S. Sy, Vennis Hong, Bruno Lewin, Lei Qian, Xuan Huang, et al. (+3)
468 [GO] 2023―Nov―10 COVID-19 vaccination attitudes, values, intentions: US parents for their children, September 2021 Matthew Z. Dudley, Benjamin Schwartz, Janesse Brewer, Lilly Kan, Roger Bernier, Jennifer E. Gerber, et al. (+4)
469 [GO] 2023―Nov―10 Inactivated COVID-19 vaccines in peri-pregnancy period: Evaluation of safety for both pregnant women and neonates Caihua Yang, Zengyue Zheng, Ping Zheng, Juan Chen, Qianyun Huang, Yue Chen, et al. (+4)
470 [GO] 2023―Nov―07 The association between antipyretic analgesics use and SARS-CoV-2 antibody titers following the second dose of the BNT162b2 mRNA vaccine: An observational study Yosuke Inoue, Yunfei Li, Shohei Yamamoto, Ami Fukunaga, Hironori Ishiwari, Masamichi Ishii, et al. (+5)
471 [GO] 2023―Nov―04 Dimensions of equality in uptake of COVID-19 vaccination in Wales, UK: A multivariable linked data population analysis Gethin Jones, Malorie Perry, Rowena Bailey, Sudha Arumugam, Adrian Edwards, Alex Lench, et al. (+10)
472 [GO] 2023―Nov―04 Investigation of the SARS-CoV-2 post-vaccination antibody response in Canadian farmed mink Line Gram Hansen, Lars Erik Larsen, Thomas Bruun Rasmussen, Younes Miar, Ria Lassuniére, Charlotte Sværke Jørgensen, Pia Ryt-Hansen
473 [GO] 2023―Nov―03 Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults Gui-Ling Chen, Xu-Ya Yu, Li-Ping Luo, Fan Zhang, Xia-Hong Dai, Nan Li, et al. (+21)
474 [GO] 2023―Nov―01 Vaccines and global health: COVID-19 vaccine development, strategy, and implementation symposium - Summary of the meeting at Vagelos College of Physicians and Surgeons (February 22-26, 2021, New York) Wilmot G. James, Lawrence R. Stanberry, Phillip S. LaRussa, Marc D. Grodman
475 [GO] 2023―Oct―29 A single blinded, phase IV, adaptive randomised control trial to evaluate the safety of coadministration of seasonal influenza and COVID-19 vaccines (The FluVID study) J.A. Ramsay, M. Jones, A.M. Vande More, S.L. Hunt, P.C.M. Williams, M. Messer, et al. (+6)
476 [GO] 2023―Oct―28 Understanding COVID-19 vaccine hesitancy in Canada Claire Corsten, Zoua M. Vang, Ian Gold, Maya J. Goldenberg, Fernanda Pérez-Gay Juarez, Daniel Weinstock, et al. (+3)
477 [GO] 2023―Oct―28 Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines Yi Liu, Stephany Sánchez-Ovando, Louise Carolan, Leslie Dowson, Arseniy Khvorov, A. Jessica Hadiprodjo, et al. (+24)
478 [GO] 2023―Oct―26 Adverse events of acute nephrotoxicity reported to EudraVigilance and VAERS after COVID-19 vaccination Cleo Anastassopoulou, Fotini Boufidou, Sophia Hatziantoniou, Konstantinos Vasileiou, Nikolaos Spanakis, Athanasios Tsakris
479 [GO] 2023―Oct―25 The state of COVID-19 vaccine confidence and need in Black individuals in Canada: Understanding the role of sociodemographic factors, health literacy, conspiracy theories, traumatic stressors and racial discrimination Jude Mary Cénat, Seyed Mohammad Mahdi Moshirian Farahi, Cathy Broussard, Rose Darly Dalexis
480 [GO] 2023―Oct―25 Background rates for severe cutaneous reactions in the US: Contextual support for safety assessment of COVID-19 vaccines and novel biologics Diane Gubernot, Mikhail Menis, Barbee Whitaker
481 [GO] 2023―Oct―25 “Fighting the pandemic!” Western Australian pharmacists’ perspectives on COVID-19 vaccines: A qualitative study Taaiba Walliar, Basil Khan, Sophie Newstead, Ghoufran Al-Assadi, Sandra M Salter, Liza Seubert, et al. (+2)
482 [GO] 2023―Oct―24 Antibodies to SARS-CoV2 induced by vaccination and infection correlate with protection against the infection Noelia Flor, María Inés García, Ana Molineri, Oscar Bottasso, Cristina Diez, Carolina Veaute
483 [GO] 2023―Oct―21 Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86 Ninaad Lasrado, Ai-ris Y. Collier, Nicole P. Hachmann, Jessica Miller, Marjorie Rowe, Eleanor D. Schonberg, et al. (+11)
484 [GO] 2023―Oct―20 Innovative method for rapid detection of falsified COVID-19 vaccines through unopened vials using handheld Spatially Offset Raman Spectroscopy (SORS) Sara Mosca, Qianqi Lin, Robert Stokes, Tehmina Bharucha, Bevin Gangadharan, Rebecca Clarke, et al. (+17)
485 [GO] 2023―Oct―19 Corrigendum to “Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants” [Vaccine 41(11) (2023) 1892-1901] Hye Won Kwak, Hyo-Jung Park, Seo-Yeon Jung, Eun Young Oh, Sang-In Park, Yeonhwa Kim, et al. (+21)
486 [GO] 2023―Oct―19 Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants Yoshikazu Honda-Okubo, Richard Bowen, Mckinzee Barker, Helle Bielefeldt-Ohmann, Nikolai Petrovsky
487 [GO] 2023―Oct―19 Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study E. McClymont, A. Atkinson, A. Albert, G. Av-Gay, J. Andrade, J. Barrett, et al. (+16)
488 [GO] 2023―Oct―17 Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries Fabio Riefolo, Belén Castillo-Cano, Mar Martín-Pérez, Davide Messina, Roel Elbers, Dorieke Brink-Kwakkel, et al. (+15)
489 [GO] 2023―Oct―17 U.S. public support and opposition to vaccination mandates in K-12 education in light of the COVID-19 pandemic Simon F. Haeder
490 [GO] 2023―Oct―17 Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 Omicron subvariant BF.7 among outpatients in Beijing, China Hui Yang, Zhaojian Wang, Ying Zhang, Man Xu, Yushu Wang, Yi Zhang, et al. (+2)
491 [GO] 2023―Oct―17 Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection Takeyuki Goto, Yong Chong, Naoki Tani, Natsumi Susai, Tomoyo Yoshinaga, Tomoki Sasaki, et al. (+5)
492 [GO] 2023―Oct―13 Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan Takeshi Arashiro, Yuzo Arima, Jin Kuramochi, Hirokazu Muraoka, Akihiro Sato, Kumi Chubachi, et al. (+31)
493 [GO] 2023―Oct―09 Nonclinical safety assessment and immunogenicity of rVSVInd(GML)-mspSGtc vaccine for SARS-CoV-2 in rabbits Heeseon Park, Min Seong Jang, Jung-Ah Choi, Woojin Kim, Yong-Bum Kim, Na Hyung Kim, et al. (+3)
494 [GO] 2023―Oct―09 SARS-CoV-2 mRNA vaccine requires signal peptide to induce antibody responses Chuncong Mo, Xiao Li, Qianying Wu, Ye Fan, Donglan Liu, Yuhui Zhu, et al. (+9)
495 [GO] 2023―Oct―09 Safety, immunogenicity and efficacy of Relcovax®, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus Nikhil Sathe, Sameer Shaikh, Mahesh Bhavsar, Leena Parte, Anjaneyulu Gadiparthi, Satish Kad, et al. (+16)
496 [GO] 2023―Oct―07 Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada T.D. Procter, H. Ogasawara, S. Spruin, S. Wijayasri, N. Abraham, C. Blaser, et al. (+3)
497 [GO] 2023―Sep―27 Approaches to evaluate the specific immune responses to SARS-CoV-2 Ana Lopez-Gomez, Hector F. Pelaez-Prestel, Ignacio Juarez
498 [GO] 2023―Sep―27 25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinations A.H.A. Lavell, A.E. Schramade, J.J. Sikkens, K. van der Straten, K.A. van Dort, M.A. Slim, et al. (+31)
499 [GO] 2023―Sep―26 Sequential heterologous immunization with COVID-19 vaccines induces broader neutralizing responses against SARS-CoV-2 variants in comparison with homologous boosters Xiuli Shen, Yanling Hao, Shuhui Wang, Dan Li, Li Ren, Meiling Zhu, et al. (+7)
500 [GO] 2023―Sep―25 Trends in COVID-19 and influenza vaccine ordering and distribution in Massachusetts jails Nicole Cassarino, Kathryn K. Ahnger-Pier, Alysse Wurcel
501 [GO] 2023―Sep―23 Insights to COVID-19 vaccine delivery: Results from a survey of 27 countries Ishani Mathur, Rachael Church, Anika Ruisch, Karina Noyes, Anna McCaffrey, Ulla Griffiths, et al. (+4)
502 [GO] 2023―Sep―22 Acceptance of COVID-19 vaccination and vaccine confidence levels in Thailand: A cross-sectional study P. Ngamchaliew, N. Kaewkuea, N. Nonthasorn, T. Vonnasrichan, N. Rongsawat, L. Rattanachai, et al. (+3)
503 [GO] 2023―Sep―22 Effectiveness of various COVID-19 vaccine regimens among 10.4 million patients from the National COVID Cohort Collaborative during Pre-Delta to Omicron periods - United States, 11 December 2020 to 30 June 2022 Yuanyuan Fu, Kaipeng Wu, Zhanwei Wang, Hua Yang, Yu Chen, Lang Wu, et al. (+4)
504 [GO] 2023―Sep―20 A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Novavax COVID-19 Vaccine (NVX-CoV2373), a recombinant spike protein vaccine with Matrix-M adjuvant to prevent disease caused by SARS-CoV-2 viruses Bethanie Wilkinson, Kinjal S. Patel, Katherine Smith, Robert Walker, Chengbin Wang, Ann M. Greene, et al. (+4)
505 [GO] 2023―Sep―19 Review: Factors influencing parents’ decisions to vaccinate children against COVID-19 Haifa S. Alharbi
506 [GO] 2023―Sep―17 A large survey on COVID-19 vaccination in patients with Parkinson’s disease and healthy population Chao Han, Zhen Zhen Zhao, Piu Chan, Fang Li, Chun Ling Chi, Xin Zhang, et al. (+3)
507 [GO] 2023―Sep―17 Preclinical evaluation of a SARS-CoV-2 variant B.1.351-based candidate DNA vaccine Ria Lassaunière, Charlotta Polacek, Jeanette Linnea Tingstedt, Anders Fomsgaard
508 [GO] 2023―Sep―16 Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness Nicole Shaver, Melanie Katz, Gideon Darko Asamoah, Lori-Ann Linkins, Wael Abdelkader, Andrew Beck, et al. (+38)
509 [GO] 2023―Sep―15 COVID-19 vaccine effectiveness against hospitalizations in Paraguay, May 2021-April 2022: A test-negative design Sandra Irala, Sarah Hamid, Elena Penayo, Fabiana Michel, Paula Couto, Cynthia Vazquez, et al. (+7)
510 [GO] 2023―Sep―15 Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate Megha Katare Pandey, Katherukamem Rajukumar, Dhanapal Senthilkumar, Subbiah Kombiah, Fateh Singh, Govindarajulu Venkatesh, et al. (+5)
511 [GO] 2023―Sep―12 COVID-19 vaccine booster doses provide increased protection against COVID-19 hospitalization compared with previously vaccinated individuals: Interim findings from the REFORCO-Brazil real-world effectiveness study during Delta and Omicron Wilhelmine Meeraus, Anke L. Stuurman, Ilgaz Durukal, Eduardo Conde-Sousa, Andrew Lee, André Santa Maria, et al. (+6)
512 [GO] 2023―Sep―10 An overview of protein-based SARS-CoV-2 vaccines Yogesh R. Suryawanshi
513 [GO] 2023―Sep―09 When to be vaccinated? What to consider? Modelling decision-making and time preference for COVID-19 vaccine through a conjoint experiment Pak Hong Ricci Yue, Hi Po Bobo Lau, Siu Man Ng, Lai Wan Cecilia Chan, Samson Yuen
514 [GO] 2023―Sep―09 Comparative effectiveness and duration of protection of ChAdOx1, CoronaVac, BNT162b2, mRNA-1273, and Ad26.COV2.S COVID-19 vaccines for symptomatic and hospitalized Mu, Delta, and Omicron: A test-negative case-control study Angel Paternina-Caicedo, David Santiago Quevedo, Diana Sofía Ríos, Diane Moyano, Nelson Alvis-Guzmán, Nelson Rafael Alviz-Zakzuk, et al. (+5)
515 [GO] 2023―Sep―05 Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis A. Phillips, Y. Jiang, D. Walsh, N. Andrews, M. Artama, H. Clothier, et al. (+21)
516 [GO] 2023―Sep―04 Understanding low COVID-19 booster uptake among US adults Elizabeth T. Jacobs, Felina M. Cordova-Marks, Leslie V. Farland, Kacey C. Ernst, Jennifer G. Andrews, Sage Vu, et al. (+4)
517 [GO] 2023―Sep―04 Characteristics of epitope dominance pattern and cross-variant neutralisation in 16 SARS-CoV-2 mRNA vaccine sera Mayo Yasugi, Yu Nakagama, Natsuko Kaku, Yuko Nitahara, Noritoshi Hatanaka, Shinji Yamasaki, Yasutoshi Kido
518 [GO] 2023―Sep―01 Confirmed cases of COVID-19 after vaccination against COVID in health personnel in Bogotá, Colombia Alexandra Porras-Ramírez, Rafael Sánchez-París, Walter López-Devia, Zuly Moreno-Perilla, Roberto Jurado-Zambrano, Carlos Luna-Jaspe Caina, et al. (+4)
519 [GO] 2023―Sep―01 Correlates of COVID-19 vaccine coverage in Arkansas: Results from a weighted random sample survey Don E. Willis, Ramey Moore, Jennifer A. Andersen, Ji Li, James P. Selig, Joshua C. McKinnon, et al. (+3)
520 [GO] 2023―Sep―01 Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose Maria da Penha Gomes Gouvea, Ketty Lysie Libardi Lira Machado, Yasmin Gurtler Pinheiro de Oliveira, Isac Ribeiro Moulaz, Allan Gonçalves Henriques, Thayná Martins Gouveia, et al. (+33)
521 [GO] 2023―Aug―31 Developmental and reproductive safety of Advax-CpG55.2™ adjuvanted COVID-19 and influenza vaccines in mice Isaac G. Sakala, Yoshikazu Honda-Okubo, Nikolai Petrovsky
522 [GO] 2023―Aug―31 Rheumatoid arthritis and older age are associated with lower humoral and cellular immune response to primary series COVID-19 mRNA vaccine Holly M. Dudley, Megan O'Mara, Ann Auma, Jenny Gong, Yael Ross, Natalie Gurevich, et al. (+17)
523 [GO] 2023―Aug―31 The impact of the COVID-19 pandemic on parental vaccine hesitancy: A cross-sectional survey Lily A. Grills, Abram L. Wagner
524 [GO] 2023―Aug―31 Challenges & opportunities for the epidemiological evaluation of the effects of COVID-19 vaccination on reproduction and pregnancy Annette K. Regan, Deshayne B. Fell, Lauren A. Wise, Gabriela Vazquez-Benitez, Siri E. Håberg, Comfort Ogar, et al. (+3)
525 [GO] 2023―Aug―30 Canada’s National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemic Matthew Tunis, Shelley Deeks, Robyn Harrison, Caroline Quach, Shainoor Ismail, Marina Salvadori, et al. (+4)
526 [GO] 2023―Aug―29 Social network, political climate, income inequality, and Americans uptake of monovalent COVID-19 booster Feng Hao, Wanyun Shao
527 [GO] 2023―Aug―29 Parental attitudes, beliefs and behaviors toward childhood and COVID-19 vaccines: A countrywide survey conducted in Kazakhstan examining vaccine refusal and hesitancy Alua Yeskendir, Arnur Gusmanov, Baurzhan Zhussupov
528 [GO] 2023―Aug―27 COVID-19 vaccine hesitancy among older adult Thai Muslim people: A case-control study Farooq Phiriyasart, Natnaree Aimyong, Ann Jirapongsuwan, Norisan Roseh
529 [GO] 2023―Aug―27 Vaccine microarray patch self-administration: An innovative approach to improve pandemic and routine vaccination rates E. Hacker, B. Baker, T. Lake, C. Ross, M. Cox, C. Davies, et al. (+3)
530 [GO] 2023―Aug―26 The immunogenicity of Alum+CpG adjuvant SARS-CoV-2 inactivated vaccine in mice Jie Yang, Boran Li, Dongsheng Yang, Jie Wu, Anna Yang, Wenhui Wang, et al. (+12)
531 [GO] 2023―Aug―25 Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan I.-Ru Chen, Guei-Jane Wang, Po-Ren Hsueh, Chia-Hui Chou, Long-Bin Jeng, Hui-Ju Lin, et al. (+4)
532 [GO] 2023―Aug―25 The prevalence and clinical course of shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccines in Dutch hospital workers Esther R.C. Janssen, Astrid Z. van Montfoort, Freek Hollman, Frederik O. Lambers Heerspink
533 [GO] 2023―Aug―25 Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2 Shiho Chiba, Peter J. Halfmann, Shun Iida, Yuichiro Hirata, Yuko Sato, Makoto Kuroda, et al. (+4)
534 [GO] 2023―Aug―25 COVID-19 vaccine decision-making among Black women: A qualitative study Inari S. Mohammed, Rachel Widome, Kelly M. Searle
535 [GO] 2023―Aug―24 Use of adrenaline to manage suspected anaphylaxis following COVID-19 vaccination: An Australian retrospective cohort study Lucy Deng, Kathryn Tapper, Deepali Thosar, Emma Goeman, Louise Baker, Stephen Adelstein, et al. (+10)
536 [GO] 2023―Aug―22 Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell lines Ozan S. Kumru, Mrinmoy Sanyal, Natalia Friedland, John M. Hickey, Richa Joshi, Payton Weidenbacher, et al. (+5)
537 [GO] 2023―Aug―19 Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines Tat'Yana A. Kenigsberg, Kristin Goddard, Kayla E. Hanson, Ned Lewis, Nicola Klein, Stephanie A. Irving, et al. (+10)
538 [GO] 2023―Aug―18 Neutralizing antibody and T-cell responses against SARS-CoV-2 variants by heterologous CoronaVac/ChAdOx-1 vaccination in elderly subjects with chronic obstructive pulmonary disease Warawut Chaiwong, Nuchjira Takheaw, Supansa Pata, Witida Laopajon, Pilaiporn Duangjit, Juthamas Inchai, et al. (+12)
539 [GO] 2023―Aug―17 Lessons learned from the COVID-19 pandemic for improved influenza control Abraham Palache, John-Kenneth Billingsley, Kristin MacLaren, Lyn Morgan, Steven Rockman, Paula Barbosa
540 [GO] 2023―Aug―17 Predictors of incomplete COVID-19 vaccine schedule among adults in Scotland: Two retrospective cohort analyses of the primary schedule and third dose Kirsty Morrison, Lucy Cullen, Allan B. James, Vera Chua, Christopher Sullivan, Chris Robertson, et al. (+12)
541 [GO] 2023―Aug―15 Are intelligent people more likely to get vaccinated? The association between COVID-19 vaccine adherence and cognitive profiles Meital Zur, Leah Shelef, Elon Glassberg, Noam Fink, Ilan Matok, Limor Friedensohn
542 [GO] 2023―Aug―14 Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial Orasri Wittawatmongkol, Pornumpa Bunjoungmanee, Pope Kosalaraksa, Kamolwish Laoprasopwattana, Sophida Boonsathorn, Napaporn Chantasrisawad, et al. (+13)
543 [GO] 2023―Aug―14 DS-5670a, a novel mRNA-encapsulated lipid nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2: Results from a phase 2 clinical study Kaoru Toyama, Takashi Eto, Kenji Takazawa, Shinji Shimizu, Tetsuo Nakayama, Kei Furihata, et al. (+7)
544 [GO] 2023―Aug―12 Parental acceptability of vaccinating young children against influenza and COVID-19 Céline Berthélémy, Pascal Bouché, Zohra Lamiral, Jean-Marc Boivin
545 [GO] 2023―Aug―10 Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study Higor S. Monteiro, Antonio S. Lima Neto, Rebecca Kahn, Geziel S. Sousa, Humberto A. Carmona, José S. Andrade, Marcia C. Castro
546 [GO] 2023―Aug―06 COVID-19 vaccine behaviour among citizens of the Métis Nation of Ontario: A qualitative study Abigail J. Simms, Keith D. King, Noel Tsui, Sarah A. Edwards, Graham Mecredy
547 [GO] 2023―Aug―06 Individual and structural determinants of COVID-19 vaccine uptake in a marginalized community in the United States Jeanna Campbell, Amandeep Kaur, Danilo Gamino, Ellen Benoit, Brianna Amos, Liliane Windsor
548 [GO] 2023―Aug―04 Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study L. Moscara, V. Venerito, A. Martinelli, A. Di Lorenzo, F. Toro, F. Violante, et al. (+2)
549 [GO] 2023―Aug―04 Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves’ disease: An observational cohort study Shichen Xu, Huixin Yu, Xian Cheng, Jing Wu, Jiandong Bao, Li Zhang
550 [GO] 2023―Aug―03 Protection against symptomatic SARS-CoV-2 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original monovalent vaccines - A matched cohort study in France Vincent Auvigne, Cynthia Raissa Tamandjou Tchuem, Justine Schaeffer, Sophie Vaux, Isabelle Parent Du Chatelet
551 [GO] 2023―Jul―30 A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States Megan Wallace, Hannah G. Rosenblum, Danielle L. Moulia, Karen R. Broder, Tom T. Shimabukuro, Christopher A. Taylor, et al. (+6)
552 [GO] 2023―Jul―29 Beyond the numbers: An in-depth look at Cameroon's fifth national COVID-19 vaccination campaign through geographical and gender lenses Adidja Amani, Andreas Ateke Njoh, Phionah Atuhebwe, Shalom Ndoula, Raoul Nembot, Franck Mbossou, et al. (+13)
553 [GO] 2023―Jul―29 Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection Bette Liu, Sandrine Stepien, Jiahui Qian, Heather Gidding, Katrina Nicolopoulos, Janaki Amin, et al. (+2)
554 [GO] 2023―Jul―28 COVID-19 vaccine uptake before and after a vaccine mandate at a major academic hospital: Trends by race/ethnicity and level of patient contact Judith Green-McKenzie, Frances S. Shofer, Gregory Kruse, Florence Momplaisir, Patrick J. Brennan, Barbara J. Kuter
555 [GO] 2023―Jul―27 Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naïve New Zealand cohort Brittany Lavender, Caitlin Hooker, Chris Frampton, Michael Williams, Simon Carson, Aimee Paterson, et al. (+8)
556 [GO] 2023―Jul―26 BNT162b2 mRNA COVID-19 against symptomatic Omicron infection following a mass vaccination campaign in southern Brazil: A prospective test-negative design study Regis Goulart Rosa, Maicon Falavigna, Josélia Larger Manfio, Cintia Laura Pereira de Araujo, Mírian Cohen, Gynara Rezende Gonzalez do Valle Barbosa, et al. (+23)
557 [GO] 2023―Jul―22 Effectiveness of COVID-19 vaccines against infection in Japan: A test-negative study from the VENUS study Yudai Tamada, Kenji Takeuchi, Taro Kusama, Megumi Maeda, Fumiko Murata, Ken Osaka, Haruhisa Fukuda
558 [GO] 2023―Jul―20 Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink W. Katherine Yih, Matthew F. Daley, Jonathan Duffy, Bruce Fireman, David L. McClure, Jennifer C. Nelson, et al. (+7)
559 [GO] 2023―Jul―20 Impact of a COVID-19 certificate requirement on vaccine uptake pattern and intention for future vaccination. A cross-sectional study among French adults Lucia Araujo-Chaveron, Jonathan Sicsic, Hadrien Moffroid, Carolina Díaz Luévano, Serge Blondel, François Langot, Judith E. Mueller
560 [GO] 2023―Jul―20 COVID-19 vaccine uptake in mental healthcare users: Czech nationwide register study Vojtech Pisl, Jan Vevera
561 [GO] 2023―Jul―16 Vaccine hesitancy comes in waves: Longitudinal evidence on willingness to vaccinate against COVID-19 from seven European countries Iryna Sabat, Sebastian Neumann-Böhme, Pedro Pita Barros, Aleksandra Torbica, Job van Exel, Werner Brouwer, et al. (+2)
562 [GO] 2023―Jul―16 Social inequalities and the early provision and dispersal of COVID-19 vaccinations in the United States: A population trends study Sean A.P. Clouston, Douglas W. Hanes, Bruce G. Link
563 [GO] 2023―Jul―16 Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate Alexandra Moros, Antoni Prenafeta, Antonio Barreiro, Eva Perozo, Alex Fernández, Manuel Cañete, et al. (+11)
564 [GO] 2023―Jul―13 COVID-19 mRNA vaccines as hypothetical epigenetic players: Results from an in silico analysis, considerations and perspectives Rossella Talotta
565 [GO] 2023―Jul―13 Impact of COVID vaccine and comorbidities in patients receiving casirivimab-imdevimab monoclonal antibody during SARS-CoV-2 B.1.617.2 (Delta) surge: A real-world study Pankaj Agrawal, Dushyant Damania, Attila Cseh, John Grab, Laura Strom, Brianna Frank, et al. (+2)
566 [GO] 2023―Jul―07 Social processes, practical issues, and COVID-19 vaccination among hesitant adults Don E. Willis, Sharon Reece, Morgan Gurel-Headley, James P. Selig, Ji Li, Stacy Zimmerman, et al. (+2)
567 [GO] 2023―Jul―05 Let's talk about COVID-19 vaccination: relevance of conversations about COVID-19 vaccination and information sources on vaccination intention in Switzerland Aylin Wagner, Sibylle Juvalta, Camilla Speranza, L. Suzanne Suggs, Julia Drava
568 [GO] 2023―Jul―03 Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination Lill Trogstad, Ida Laake, Anna H Robertson, Siri Mjaaland, Ida H Caspersen, Lene K Juvet, et al. (+3)
569 [GO] 2023―Jul―03 Barriers to COVID-19 vaccination of migrant populations: a qualitative interview study of immunisation providers in Victoria, Australia Jane Tuckerman, Jessica Kaufman, Isabella Overmars, Philippa Holland, Margie Danchin
570 [GO] 2023―Jul―03 Between nudges and mandates: The drivers of COVID-19 vaccination intentions and subsequent uptake in Russia Yana Roshchina, Ksenia Rozhkova, Sergey Roshchin
571 [GO] 2023―Jul―03 Veteran influenza vaccination acceptance rates after completion of the COVID-19 vaccination series among historical influenza vaccine refusers Ursula C. Patel, Thomas Schultz, Justin Schmidt
572 [GO] 2023―Jun―30 Immunogenicity and protective effects of recombinant bivalent COVID-19 vaccine in mice and rhesus macaques Yuying Liu, Aijing Zhang, Yan Wang, Jianguo Yang, Fei Yin, Shuming Wu, et al. (+20)
573 [GO] 2023―Jun―30 Effectiveness of inactivated influenza and COVID-19 vaccines in hospitalized children in 2022/23 season in Japan - The first season of co-circulation of influenza and COVID-19 Masayoshi Shinjoh, Munehiro Furuichi, Shinya Tsuzuki, Asef Iqbal, Naoya Fukushima, Sachiko Soen, et al. (+15)
574 [GO] 2023―Jun―28 Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice Katherine S Lee, Nathaniel A Rader, Olivia A Miller, Melissa Cooper, Ting Y Wong, Md. Shahrier Amin, et al. (+4)
575 [GO] 2023―Jun―27 Safety surveillance of the NVX-CoV2373 COVID-19 vaccine among Koreans aged 18 years and over Seontae Kim, Mijeong Ko, Yesul Heo, Yeon-Kyeng Lee, Yunhyung Kwon, Seok-Kyoung Choi, Eunok Bahng
576 [GO] 2023―Jun―24 Characterization of immune responses to two and three doses of the adenoviral vectored vaccine ChAdOx1 nCov-19 and the whole virion inactivated vaccine BBV152 in a mix-and-match study in India Anita Chaudhary, Ramya Madhavan, Sudhir Babji, Reshma Raju, Chanduni Syed, Ajith Kumar, et al. (+8)
577 [GO] 2023―Jun―23 Immediate adverse reactions following COVID-19 vaccination among 16-65-year-old Danish citizens K. Torp Hansen, F. Kusk Povlsen, B. Hammer Bech, S. Nygaard Hansen, C. Ulrikka Rask, P. Fink, et al. (+5)
578 [GO] 2023―Jun―23 Public Perception of COVID-19 Vaccines through Analysis of Twitter Content and Users Sameh N. Saleh, Samuel A. McDonald, Mujeeb A. Basit, Sanat Kumar, Reuben J. Arasaratnam, Trish M. Perl, et al. (+2)
579 [GO] 2023―Jun―23 Modifiers of COVID-19 Vaccine Efficacy: Results from Four COVID-19 Prevention Network Efficacy Trials Christine B. Turley, LaKesha Tables, Trevon Fuller, Lisa J. Sanders, Hyman Scott, Amaran Moodley, et al. (+29)
580 [GO] 2023―Jun―21 A cohort study reveals different dynamics of SARS-CoV-2-specific antibody formation after Comirnaty and Vaxzevria vaccination Adam Augustyniak, Tomasz Szymanski, Filip Porzucek, Adam Aron Mieloch, Julia Anna Semba, Katarzyna Anna Hubert, et al. (+8)
581 [GO] 2023―Jun―20 How to Model the Impact of Vaccines for Policymaking When the Characteristics are Uncertain: A Case Study in Thailand Prior to the Vaccine Rollout During the COVID-19 Pandemic Nantasit Luangasanatip, Chris Painter, Wirichada Pan-ngum, Sompob Saralamba, Tanaphum Wichaita, Lisa White, et al. (+5)
582 [GO] 2023―Jun―20 PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness Xiangyu Chen, Yao Lin, Shuai Yue, Yang Yang, Xiaofan Yang, Junjian He, et al. (+11)
583 [GO] 2023―Jun―19 Impacts of routine varicella vaccination program and COVID-19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan Kazuhiro Ud, Yusuke Okubo, Mitsuru Tsuge, Hirokazu Tsukahara, Isao Miyairi
584 [GO] 2023―Jun―19 Compliance, procrastination and refusal: American COVID-19 vaccination trust and value orientation Rueyling Tzeng, Fang-Yi Huang, Jaein Lee
585 [GO] 2023―Jun―19 An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects Cynomolgus macaques from a homologous SARS-CoV-2 virus challenge Yoshikazu Honda-Okubo, Lei Li, Greiciely André, King Ho Leong, Elizabeth W. Howerth, Anne G. Bebin-Blackwell, et al. (+2)
586 [GO] 2023―Jun―16 Public opinion on COVID-19 vaccine prioritization in Bangladesh: Who gets the vaccine and whom do you leave out? Raaj Kishore Biswas, Awan Afiaz, Samin Huq, Maysha Farzana, Enamul Kabir
587 [GO] 2023―Jun―16 Licenced doses of approved COVID-19 vaccines may not be optimal: a review of the early-phase, dose-finding trials David T Dunn, Richard Gilson, Sheena McCormack, Laura E McCoy
588 [GO] 2023―Jun―15 Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink Tat'Yana A. Kenigsberg, Kayla E. Hanson, Nicola P. Klein, Ousseny Zerbo, Kristin Goddard, Stanley Xu, et al. (+7)
589 [GO] 2023―Jun―15 Evaluation of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Adults Aged 65 Years and Older: Two Self-Controlled Studies in the U.S Azadeh Shoaibi, Patricia C. Lloyd, Hui-Lee Wong, Tainya C. Clarke, Yoganand Chillarige, Rose Do, et al. (+16)
590 [GO] 2023―Jun―15 Intramuscular administration of recombinant Newcastle disease virus expressing SARS-CoV-2 spike protein protects hACE-2 TG mice against SARS-CoV-2 infection Deok-Hwan Kim, Jiho Lee, Sungsu Youk, Jei-hyun Jeong, Da-ye Lee, Hyo-seon Ju, et al. (+13)
591 [GO] 2023―Jun―15 Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: day 28 results of a phase 1/2 open-label trial Sant Muangnoicharoen, Rakpong Wiangcharoen, Sira Nanthapisal, Supitcha Kamolratakul, Saranath Lawpoolsri, Anan Jongkaewwattana, et al. (+12)
592 [GO] 2023―Jun―13 COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn Flor M. Munoz, Christine M. Posavad, Barbra A. Richardson, Martina L. Badell, Katherine E. Bunge, Mark J. Mulligan, et al. (+18)
593 [GO] 2023―Jun―09 Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study Bahar Madran, İlker Kayi, Ayşe Beşer, Önder Ergönül
594 [GO] 2023―Jun―09 Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan Masahiro Ui, Takashi Hirama, Miki Akiba, Masako Honda, Toshiaki Kikuchi, Yoshinori Okada
595 [GO] 2023―Jun―08 Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021- January 2022 Brechje de Gier, Liselotte van Asten, Tjarda M. Boere, Annika van Roon, Caren van Roekel, Joyce Pijpers, et al. (+6)
596 [GO] 2023―Jun―08 Seasonal influenza vaccination in the Americas: Progress and challenges during the COVID-19 pandemic Francisco Nogareda, Radhika Gharpure, Marcela Contreras, Martha Velandia, Carmelita Lucia Pacis, Ana Elena Chevez, et al. (+2)
597 [GO] 2023―Jun―07 Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteria Rebecca J Shaw, Andrew J Doyle, Emily A Millen, Julia Stowe, Elise Tessier, Nick Andrews, Elizabeth Miller
598 [GO] 2023―Jun―06 From High Hopes to Disenchantment: A Qualitative Analysis of Editorial Cartoons on COVID-19 Vaccines in Canadian Newspapers Catherine Pelletier, Fabienne Labbé, Julie A. Bettinger, Janet Curran, Janice E. Graham, Devon Greyson, et al. (+5)
599 [GO] 2023―Jun―06 Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost Woo Joo Kim, Christine C. Roberts, Joon Young Song, Jin Gu Yoon, Hye Seong, Hak-Jun Hyun, et al. (+13)
600 [GO] 2023―Jun―06 Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine Elizabeth Elder, Chandrashekar Bangalore Revanna, Catharina Johansson, Robert P.A. Wallin, Johan Sjödahl, Ola Winqvist, Ali Mirazimi
601 [GO] 2023―Jun―05 COVID-19 vaccination and menstrual cycle characteristics: A prospective cohort study Amelia K. Wesselink, Sharonda M. Lovett, Janice Weinberg, Ruth J. Geller, Tanran R. Wang, Annette K. Regan, et al. (+7)
602 [GO] 2023―Jun―05 Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG Gergely Tibor Kozma, Tamás Mészáros, Petra Berényi, Réka Facskó, Zsófia Patkó, Csaba Zs. Oláh, et al. (+6)
603 [GO] 2023―Jun―05 Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study Jennifer H. Ku, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Julia E. Tubert, et al. (+8)
604 [GO] 2023―Jun―05 Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University Supawadee Makanut, Apirath Wangteeraprasert, Wittawat Jitpewngam, Jatuporn Ngoenkam, Sutatip Pongcharoen
605 [GO] 2023―Jun―02 One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis of a randomized, placebo-controlled phase 1/2 trial in Japan Kensuke Ishikawa, Maria-Claudia Nascimento, Michiko Asano, Hajime Hirata, Yohji Itoh, Elizabeth J. Kelly, et al. (+4)
606 [GO] 2023―May―29 Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: a nationwide cohort study A. Arrospide, MG. Sagardui, I. Larizgoitia, A. Iturralde, A. Moreda, J. Mar J
607 [GO] 2023―May―29 Vaccination, Human Mobility, and COVID-19 Health Outcomes: Empirical Comparison Before and During the Outbreak of SARS-Cov-2 B.1.1.529 (Omicron) Variant Songhua Hu, Chenfeng Xiong, Yingrui Zhao, Xin Yuan, Xuqiu Wang
608 [GO] 2023―May―29 Medical outcomes of children with neurodevelopmental disorders after SARS-CoV-2 vaccination: A six-month follow-up study Liang-Jen Wang, Ching-Shu Tsai, Wen-Jiun Chou, Chia-Jung Lee, Sheng-Yu Lee, Yi-Jun Chen, I-Chun Lin
609 [GO] 2023―May―24 Spontaneously reported adverse events following COVID-19 basic and booster immunizations in The Netherlands Saskia C. van der Boor, Else T.J. Schmitz-de Vries, Dennis Smits, Joep H.G. Scholl, Leàn Rolfes, Florence van Hunsel
610 [GO] 2023―May―24 COVID-19 Vaccine Safety Inquiries to the Centers for Disease Control and Prevention Immunization Safety Office Elaine R. Miller, Pedro L. Moro, Tom T. Shimabukuro, Grace Carlock, Shaeyla Davis, Emma Freeborn, et al. (+6)
611 [GO] 2023―May―22 Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review Anwar I. Joudeh, Abdu Qaid Lutf, Salah Mahdi, Gui Tran
612 [GO] 2023―May―22 Incidence of myopericarditis after mRNA COVID-19 vaccination: a meta-analysis with focus on adolescents aged 12-17 years Bao-Qiang Guo, Hong-Bin Li, Li-Qiang Yang
613 [GO] 2023―May―22 Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021 Peter J. Embi, Matthew E. Levy, Palak Patel, Malini B. DeSilva, Manjusha Gaglani, Kristin Dascomb, et al. (+33)
614 [GO] 2023―May―22 Estimating global changes in routine childhood vaccination coverage during the COVID-19 pandemic, 2020-2021 Cyrus Ghaznavi, Akifumi Eguchi, Kaung Suu Lwin, Daisuke Yoneoka, Yuta Tanoue, Rauniyar Santosh Kumar, et al. (+3)
615 [GO] 2023―May―22 Title: A qualitative study on COVID-19 pandemic impacts on parental attitudes and intentions for routine adolescent vaccinations: the role of trust Katarzyna T Bolsewicz, Maryke S Steffens, Catherine King, Ikram Abdi, Bianca Bullivant, Frank Beard
616 [GO] 2023―May―22 Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis Alicandro G, Orena BS, Rosazza C, Cariani L, Russo M, Zatelli M, et al. (+4)
617 [GO] 2023―May―17 Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination Zhao-Hua Zhou, Margaret M. Cortese, Jia-Long Fang, Robert Wood, Donna S. Hummell, Kimberly A. Risma, et al. (+20)
618 [GO] 2023―May―17 Uncovering inequities in Covid-19 vaccine coverage for adults and elderly in Brazil: A multilevel study of 2021-2022 data Antonio Fernando Boing, Alexandra Crispim Boing, Lorena Barberia, Marcelo Eduardo Borges, SV Subramanian
619 [GO] 2023―May―15 Comparison of mRNA Vaccine Effectiveness against COVID-19-associated Hospitalization by Vaccination Source: Immunization Information Systems, Electronic Medical Records, and Self-Report - IVY Network, February 1*August 31, 2022 Diya Surie, Levi Bonnell, Jennifer DeCuir, Manjusha Gaglani, Tresa McNeal, Shekhar Ghamande, et al. (+37)
620 [GO] 2023―May―15 COVID-19 Vaccine Decision-making among Pregnant and Lactating Women in Bangladesh Rupali J. Limaye, Prachi Singh, Alicia Paul, Berhaun Fesshaye, Clarice Lee, Eleonor Zavala, et al. (+6)
621 [GO] 2023―May―15 Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future Steven B. Black, Rebecca E Chandler, Kathryn M. Edwards, Miriam C.J.M. Sturkenboom
622 [GO] 2023―May―11 Factors Associated with Receipt of mRNA-1273 Vaccine at a United States National Retail Pharmacy During the COVID-19 Pandemic Erin Roberts, Philip O. Buck, Renae L. Smith-Ray, Nicolas Van de Velde, Tanya Singh, James Mansi, et al. (+2)
623 [GO] 2023―May―10 Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022 Senna C.J.L. van Iersel, Scott A. McDonald, Brechje de Gier, Mirjam J. Knol, Hester E. de Melker, C.H. Henri van Werkhovena, Susan J.M. Hahné
624 [GO] 2023―May―10 The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs Álvaro Roy, Stéphanie Polazzi, Dominique Ploin, Yves Gillet, Etienne Javouhey, Bruno Lina, et al. (+5)
625 [GO] 2023―May―10 Safety of the NVX-CoV2373 COVID-19 Vaccine in Randomized Placebo-Controlled Clinical Trials Katherine Smith, Karim Hegazy, Miranda R. Cai, Irene McKnight, Matthew D. Rousculp, Katia Alves
626 [GO] 2023―May―10 Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 - January 2022 Petter Langlete, Martin Tesli, Lamprini Veneti, Jostein Starrfelt, Petter Elstrøm, Hinta Meijerink
627 [GO] 2023―May―09 Personal risk or societal benefit? Investigating adults’ support for COVID-19 childhood vaccination Chiara Chiavenna, Laura P. Leone, Alessia Melegaro, Tiziano Rotesi, Scott E. Bokemper, Elliott E. Paintsil, et al. (+5)
628 [GO] 2023―May―08 Randomized Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Booster (Third Dose) of BNT162b2 COVID-19 Vaccine Coadministered With 20-Valent Pneumococcal Conjugate Vaccine in Adults ≥65 Years Old David Fitz-Patrick, Mariano Young, Kari Yacisin, Kathleen McElwee, Todd Belanger, Kelly Belanger, et al. (+5)
629 [GO] 2023―May―08 Quantification of Sars-CoV-2 Spike Protein Expression from mRNA Vaccines Using Isotope Dilution Mass Spectrometry William J.H. Sutton, Paul J. Branham, Yulanda M. Williamson, Hans C. Cooper, Fabio N. Najjar, Carrie L. Pierce-Ruiz, et al. (+2)
630 [GO] 2023―May―08 Anti-tumor necrosis factor therapy is associated with attenuated humoral response to SARS-COV-2 vaccines in patients with inflammatory bowel disease Filipa Bordalo Ferreira, Maria Ana Rafael, Lúcia Coimbra, Nazaré Boavida, Fernando Arrobas, Fábio Pereira Correia, et al. (+5)
631 [GO] 2023―May―08 Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: primary analysis report of a phase 3 open-label trial Kenji Kuriyama, Kyoko Murakami, Taisei Masuda, Kenkichi Sugiura, Sho Sakui, Ron P. Schuring, Mitsuhiro Mori
632 [GO] 2023―May―05 Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico Dania M. Rodriguez, Chelsea G. Major, Liliana Sánchez-González, Emma Jones, Mark J. Delorey, Claudia Alonso, et al. (+3)
633 [GO] 2023―May―03 Vaccine Effectiveness of the mRNA-1273 3-dose Primary Series Against COVID-19 in an Immunocompromised Population: A Prospective Observational Cohort Study Jennifer H. Ku, Lina S. Sy, Lei Qian, PBradley K. Ackerson, Yi Luo, Julia E. Tubert, et al. (+7)
634 [GO] 2023―May―02 Attitudes towards COVID-19 Vaccination among Incarcerated Persons in the Federal Bureau of Prisons, June-July 2021 Rena Fukunaga, Zoe E. Kaplan, Tami Rodriguez, Liesl Hagan, Kathleen Aarvig, Charles Dusseau, et al. (+2)
635 [GO] 2023―May―01 COVID-19 vaccination decisions among Gypsy, Roma and Traveller communities: a qualitative study moving beyond “vaccine hesitancy” Charlotte Kühlbrandt, Catherine R. McGowan, Rachel Stuart, Pippa Grenfell, Sam Miles, Alicia Renedo, Cicely Marston
636 [GO] 2023―May―01 COVID-19 vaccination rates among adolescents (12-17 years) by immigrant background and sociodemographic factors: a nationwide registry study in Norway Lema Hussaini, Angela S. Labberton, Brita A. Winje, Kristian B. Kraft, Marte Karoline R. Kjøllesdal, Rebecca N. Gleditsch, Anna A. Godøy
637 [GO] 2023―May―01 Hematologic Adverse Events Reported After COVID-19 Vaccination in the Philippines: A National Database Study Flordeluna Z. Mesina, Frances Alexandra D. Sapinoso, Joy Ann V. de Castro, Preeti Prerna M. Vaswani, Charles Eryll S. Sy, Rizza Ann A. Oquendo, Mark Ryann A. Lirasan
638 [GO] 2023―May―01 Effectiveness of the COVID-19 Vaccines on Preventing Symptomatic SARS-CoV-2 Infections and Hospitalizations in Southwestern Alaska, January-December, 2021 Brian Lefferts, Dana Bruden, Ian D. Plumb, Ellen Hodges, Elizabeth Bates, Gerald January, Michael G. Bruce
639 [GO] 2023―Apr―27 Efficacy of Primary Series AZD1222 (ChAdOx1 nCoV-19) Vaccination Against SARS-CoV-2 Variants of Concern: Final Analysis of a Randomized, Placebo-controlled, Phase 1b/2 Study in South African Adults (COV005) Anthonet L. Koen, Alane Izu, Vicky Baillie, Gaurav Kwatra, Clare L. Cutland, Lee Fairlie, et al. (+30)
640 [GO] 2023―Apr―26 Identifying Gaps in Vaccination Perception After Mandating the COVID-19 Vaccine in Saudi Arabia Nada Alsuhebany, Shuroug A. Alowais, Atheer Aldairem, Sumaya N. Almohareb, Khalid Bin Saleh, Khawla M. Kahtani, et al. (+5)
641 [GO] 2023―Apr―26 COVID-19 Vaccine Deliberation in Individuals Directly Impacted by Incarceration Charlotte Kim, Jenerius A. Aminawung, Lauren Brinkley-Rubinstein, Emily A. Wang, Lisa B. Puglisi
642 [GO] 2023―Apr―26 Safety and adverse effects of the coronavirus disease 2019 vaccine among the general Japanese adult population Xi Lu, Shota Masuda, Hasita Horlad, Takahiko Katoh
643 [GO] 2023―Apr―25 COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs Miao Jiang, Elina Väisänen, Pekka Kolehmainen, Moona Huttunen, Seppo Ylä-Herttuala, Seppo Meri, et al. (+2)
644 [GO] 2023―Apr―24 Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers Clare Nugent, Yasin Abul, Elizabeth M. White, Fadi Shehadeh, Matthew Kaczynski, Lewis Oscar Felix, et al. (+16)
645 [GO] 2023―Apr―19 Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem Lisa Clarke, Timothy Brighton, Sanjeev D. Chunilal, Christine S.M. Lee, Freda Passam, Jennifer Curnow, et al. (+2)
646 [GO] 2023―Apr―18 Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines Alexis Pillsbury, Anastasia Phillips, Lucy Deng, Helen Quinn, Kristine Macartney, Heather Gidding
647 [GO] 2023―Apr―17 A tailored COVID-19 vaccination pathway for children 5 to 11 years in Victoria, Australia SF Gordon, J Lam, JT Vasquez, R Cercone, N Tenneti, J Hart, et al. (+5)
648 [GO] 2023―Apr―17 COVID-19 vaccine distribution: A high reliability organization approach Claire Houtsma, Amanda M. Raines, Amy Reggio, La-Kenya Rushing, Ebony Harding, Edward Payton, Caitlin Martin-Klinger
649 [GO] 2023―Apr―14 COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) Kamila M Ludwikowska, Aneta Popiel, Agnieszka Matkowska-Kocjan, Mateusz Biela, Marta Wójcik, Filip Szenborn, et al. (+5)
650 [GO] 2023―Apr―14 Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models Tobias L. Freitag, Riku Fagerlund, Nihay Laham Karam, Veli-Matti Leppänen, Hasan Ugurlu, Ravi Kant, et al. (+21)
651 [GO] 2023―Apr―12 Safety and Immunogenicity of Homologous versus Heterologous Booster Dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 Vaccines in Adults: An Observer-blinded, Multi-center, Phase 2 Randomized Trial Lila Estephan, Ying-Chin Lin, Yi-Tsung Lin, Yen-Hsu Chen, Sung-Ching Pan, Szu-Min Hsieh, et al. (+7)
652 [GO] 2023―Apr―10 Promises and challenges of mucosal COVID-19 vaccines Abhay P.S. Rathore, Ashley L. St. John
653 [GO] 2023―Apr―10 Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus Chi-Chieh Chang, Abdullah Algaissi, Chia-Chun Lai, Chun-Kai Chang, Jr-Shiuan Lin, Yi-Shiang Wang, et al. (+12)
654 [GO] 2023―Apr―07 Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontario, Canada J. Leigh Hobbs, Lauren A. Paul, Sarah A. Buchan, Tara Harris, Sarah E. Wilson
655 [GO] 2023―Apr―07 Factors Impacting Parental Uptake of COVID-19 Vaccination for U.S. Children ages 5-17 Julen N. Harris, Christine M. Mauro, Tucker L. Morgan, Ariel de Roche, Gregory D. Zimet, Susan L. Rosenthal
656 [GO] 2023―Apr―05 Evaluation of mortality risk after COVID-19 vaccination, Utah 2021 Jessica R. Payne, Srimoyee Bose, Rachel W. Kubiak, Leisha D. Nolen
657 [GO] 2023―Apr―05 VACCINE EFFECTIVENESS AGAINST TRANSMISSION OF ALPHA, DELTA AND OMICRON SARS-COV-2-INFECTION, BELGIAN CONTACT TRACING, 2021-2022 Toon Braeye, Lucy Catteau, Ruben Brondeel, Joris van Loenhout, Kristiaan Proesmans, Laura Cornelissen, et al. (+9)
658 [GO] 2023―Apr―04 The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA) Martina Frodlund, Per Nived, Aikaterina Chatzidionysiou, Anna Södergren, Eva Klingberg, Anders Bengtsson, et al. (+5)
659 [GO] 2023―Apr―04 Public discourse and debate about vaccines in the midst of the covid-19 pandemic: a qualitative content analysis of Twitter Enrique Prada-Gonzalez, Andrea Langbecker, Daniel Catalan-Matamoros
660 [GO] 2023―Apr―04 What Accounts for the Variation in COVID-19 Vaccine Hesitancy in Eastern, Southern and Western Europe? Dimiter Toshkov
661 [GO] 2023―Apr―03 The added effect of non-pharmaceutical interventions and lifestyle behaviors on vaccine effectiveness against severe COVID-19 in Chile: A matched case-double control study Cinthya Urquidi, Emilio Santelices, Anne J. Lagomarcino, María Teresa Valenzuela, Nicolás Larrañaga, Emilio Gonzalez, et al. (+7)
662 [GO] 2023―Apr―03 Pediatricians’ Perceptions, Practices, and Barriers Regarding COVID-19 Vaccine for Children: A Cross-Sectional Survey in Ontario, Canada Yamna Ali, Pierre-Philippe Piche-Renaud, Elahe Karimi-Shahrbabak, Daniel S. Farrar, Sarah Abu Fadaleh, Sharon Burey, Shaun K. Morris
663 [GO] 2023―Apr―01 Lack of association between vaccination rates and excess mortality in Cyprus during the COVID-19 pandemic Theodore Lytras, Maria Athanasiadou, Anna Demetriou, Despina Stylianou, Alexandros Heraclides, Olga Kalakouta
664 [GO] 2023―Mar―31 Factors associated with COVID-19 vaccination during June-October, 2021: a multi-site prospective study Reva S. Datar, Lida M. Fette, Amy N. Hinkelman, E. Adrianne Hammershaimb, DeAnna J. Friedman-Klabanoff, Morgana Mongraw-Chaffin, et al. (+9)
665 [GO] 2023―Mar―30 Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: a meta-analysis of the heterologous COVID-19 vaccination outcomes Yuxuan Hu, Yanning Wang, Taihang Shao, Wenxi Tang, Kerong Hu, Yujie Zhou, et al. (+4)
666 [GO] 2023―Mar―29 Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS Study Haruhisa Fukuda, Megumi Maeda, Fumiko Murata
667 [GO] 2023―Mar―28 Real-life safety profile of mRNA vaccines for COVID-19: an analysis of VAERS database Greta Santi Laurini, Nicola Montanaro, Massimiliano Broccoli, Giulia Bonaldo, Domenico Motola
668 [GO] 2023―Mar―28 Acute Reactions After a Homologous Primary COVID-19 Vaccination Series: Analysis of Taiwan V-Watch Data Wei-Ju Su, K Arnold Chan, Jen-Hsiang Chuang, Ting-Ann Wang, Shu-Fong Chen, Yun-Cheng Chang, et al. (+3)
669 [GO] 2023―Mar―27 Conspiracies, Misinformation and Resistance to Public Health Measures During COVID-19 in White Nationalist Online Communication Dror Walter, Yotam Ophir, Hui Ye
670 [GO] 2023―Mar―27 Impact of vitamin D3 supplementation on COVID-19 vaccine response and immunoglobulin G antibodies in deficient women: A randomized controlled trial Fatih Cesur, Zeynep Atasever, Yavuz Özoran
671 [GO] 2023―Mar―27 Determinants of COVID-19 vaccine acceptance in Mozambique: The role of institutional trust Bo Hu, Wei Yang, Paul Bouanchaud, Yolanda Chongo, Jennifer Wheeler, Sergio Chicumbe, Marcos Chissano
672 [GO] 2023―Mar―27 Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis Agustín Ciapponi, Mabel Berrueta, Edward P. K. Parker, Ariel Bardach, Agustina Mazzoni, A. Steven Anderson, et al. (+15)
673 [GO] 2023―Mar―27 Comparison of culture-competent virus shedding duration of SARS-CoV-2 omicron variant in regard to vaccination status: a prospective cohort study Sung-Woon Kang, Heedo Park, Ji Yeun Kim, Joon-Yong Bae, Man-Seong Park, Sung-Han Kim
674 [GO] 2023―Mar―27 Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Daphnée Georges, Sarah Houben, Véronique Olislagers, et al. (+19)
675 [GO] 2023―Mar―27 First hepatitis B vaccine uptake in neonates prior to and during the COVID-19 pandemic Anna M. Dugovich, Toby H. Cox, Erin R. Weeda, Sandra S. Garner
676 [GO] 2023―Mar―22 Divergent COVID-19 vaccine policies: Policy mapping of ten European countries Robin van Kessel, Rebecca Forman, Ricarda Milstein, Alicja Mastylak, Katarzyna Czabanowska, Thomas Czypionka, et al. (+10)
677 [GO] 2023―Mar―21 Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWETM Senyu Xu, Huixin Duan, Yaling An, Xiyue Jin, Minrun Duan, Patrice M Dubois, et al. (+6)
678 [GO] 2023―Mar―21 Vaccine hesitancy against COVID-19 vaccine over time in Nigeria Ryoko Sato
679 [GO] 2023―Mar―21 Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques Jinling Yang, Xinqian Huo, Qinfang Jiang, Yun Liao, Caixing Zhang, Li Yu, et al. (+12)
680 [GO] 2023―Mar―21 Effectiveness of second booster compared to first booster and protection conferred by previous SARS-CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France Cynthia Tamandjou, Vincent Auvigne, Justine Schaeffer, Sophie Vaux, Isabelle Parent du Châtelet
681 [GO] 2023―Mar―21 Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant Waranyoo Phoolcharoen, Balamurugan Shanmugaraj, Narach Khorattanakulchai, Piyanate Sunyakumthorn, Sathit Pichyangkul, Pornnarin Taepavarapruk, et al. (+9)
682 [GO] 2023―Mar―15 Serologic Responses to COVID-19 Vaccination in Children with History of Multisystem Inflammatory Syndrome (MIS-C) Maria A. Perez, Hui-Mien Hsiao, Xuemin Chen, Amber Kunkel, Nadine Baida, Laila Hussaini, et al. (+11)
683 [GO] 2023―Mar―13 Immunocompromise among vaccinated versus unvaccinated COVID-19 cases admitted to critical care in Ireland, July to October 2021 David Kelly, Kate O'Donnell, Louise Marron, Rory Dwyer, Michael Power, Chantal Migone, et al. (+2)
684 [GO] 2023―Mar―13 Latent Class Analysis of Medical Mistrust and COVID-19 Vaccine Hesitancy Among Adults in the United States Just Prior to FDA Emergency Use Authorization Phoebe A. Lamuda, Ariel Azar, Bruce G. Taylor, Elizabeth Flanagan Balawajder, Harold A. Pollack, John A. Schneider
685 [GO] 2023―Mar―09 Estimated COVID-19 Vaccine Effectiveness Against Seroconversion from SARS-CoV-2 Infection, March-October, 2021 Ian D. Plumb, Lida M. Fette, Ashley H. Tjaden, Leora Feldstein, Sharon Saydah, Amina Ahmed, et al. (+12)
686 [GO] 2023―Mar―08 Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management Nobunao Ikewaki, Gene Kurosawa, Gary A. Levy, Senthilkumar Preethy, Samuel J.K. Abraham
687 [GO] 2023―Mar―07 Pharmacy-based immunization in rural USA during the COVID-19 pandemic: A survey of community pharmacists from five southeastern states Sura O. AlMahasis, Brent Fox, David Ha, Jingjing Qian, Chih-hsuan Wang, Salisa C. Westrick
688 [GO] 2023―Mar―06 Factors associated with US caregivers’ uptake of pediatric COVID-19 vaccine by race and ethnicity Rebecca J. Hart, Shannon Baumer-Mouradian, Jeffrey N Bone, Prasra Olson, Stephanie Schroter, Rachel M. Weigert, et al. (+6)
689 [GO] 2023―Mar―03 A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 Protein Vaccine Lila Estephan, Luke Tzu-Chi Liu, Chia En Lien, Emily R. Smith, Marc Gurwith, Robert T. Chen
690 [GO] 2023―Mar―03 From COVID-19 Vaccines Candidates to Compulsory Vaccination: The Attitudes of Italian Citizens in the Key 7-month of Vaccination Campaign Andrea Grignolio Corsini, Roberta Martina Zagarella, Massimiliano Adamo, Cinzia Caporale
691 [GO] 2023―Mar―02 fvWillingness to Vaccinate Children against COVID-19 Declined During the Pandemic RD. Goldman, RJ. Hart, JN. Bone, M. Seiler, PG. Olson, k. Keitel, et al. (+18)
692 [GO] 2023―Mar―02 COVID-19 mRNA BNT162b2 vaccine safety and B-cell and T-cell reactogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) - preliminary study Kamila M. Ludwikowska, Aneta Popiel, Agnieszka Matkowska-Kocjan, Mateusz J. Olbromski, Mateusz Biela, Marta Wójcik, et al. (+6)
693 [GO] 2023―Mar―02 The mediating effect of health literacy on COVID-19 vaccine confidence among a diverse sample of urban adults in Boston and Chicago Emily E. Hurstak, Michael K Paasche-Orlow, Elizabeth A Hahn, Lori E. Henault, Michelle A. Taddeo, Patricia I. Moreno, et al. (+5)
694 [GO] 2023―Mar―02 Placing a value on increased flexible vaccine manufacturing capacity for future pandemics Anthony T. Newall, Philippe Beutels, Zoltán Kis, Adrian Towse, Mark Jit
695 [GO] 2023―Mar―01 Mediators of racial and ethnic disparities in COVID-19 vaccine uptake Ling Na, Sativa Banks, Peizhong Wang
696 [GO] 2023―Feb―27 Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort Masae Itamochi, Shunsuke Yazawa, Noriko Inasaki, Yumiko Saga, Emiko Yamazaki, Takahisa Shimada, et al. (+9)
697 [GO] 2023―Feb―27 Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France Cynthia Raissa TAMANDJOU, Vincent AUVIGNE, Sophie VAUX, Charline MONTAGNAT, Juliette PAIREAU, Stéphanie MONNIER BESNARD, et al. (+5)
698 [GO] 2023―Feb―27 Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: analysis of data reported to EudraVigilance Helena C. Maltezou, Sophia Hatziantoniou, Kalliopi Theodoridou, Konstantinos Vasileiou, Cleo Anastassopoulou, Athanasios Tsakris
699 [GO] 2023―Feb―27 Immunogenicity of adjuvanted plant-produced SARS-CoV-2 Beta spike VLP vaccine in New Zealand white rabbits Martha M O'Kennedy, Celia Abolnik, Tanja Smith, Thopisang Motlou, Kruger Goosen, Kamogelo M Sepotokele, et al. (+9)
700 [GO] 2023―Feb―26 Erratum to “Parental intentions to vaccinate children against COVID-19: Findings from a U.S. National Survey” [Vaccine 41(1) (2023) 101-108 Rebecca J. Guerin, Arash Naeim, Ryan Baxter-King, Andrea H. Okun, Derek Holliday, Lynn Vavreck
701 [GO] 2023―Feb―23 COVID-19 vaccine hesitancy among people living with HIV (PLHIV) in a low-resource setting: a multi-center study of prevalence, correlates and reasons Sahabi Kabir Sulaiman, Muhammad Sale Musa, Fatimah Isma'il Tsiga-Ahmed, Farouq Muhammad Dayyab, Abdulwahab Kabir Sulaiman, Bashir Dabo, et al. (+27)
702 [GO] 2023―Feb―23 A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452 Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma, Yannick van Sleen, Debbie van Baarle, David G. Alleva, et al. (+19)
703 [GO] 2023―Feb―21 The time is now for committed and comprehensive action to attain more broadly protective coronavirus vaccines: The coronavirus vaccines R&D roadmap Margaret Hamburg, Gregory A. Poland
704 [GO] 2023―Feb―21 A Research and Development (R&D) Roadmap for Broadly Protective Coronavirus Vaccines: A Pandemic Preparedness Strategy Kristine A. Moore, Tabitha Leighton, Julia T. Ostrowsky, Cory J. Anderson, Richard N. Danila, Angela K. Ulrich, et al. (+12)
705 [GO] 2023―Feb―20 Erroneous Consonance. How inaccurate beliefs about physician opinion influence COVID-19 vaccine hesitancy Matt Motta, Timothy Callaghan, Kristin Lunz-Trujillo, Alee Lockman
706 [GO] 2023―Feb―17 Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England Carly Meyer, Louis Goffe, Vivi Antonopoulou, Fiona Graham, Mei Yee Tang, Jan Lecouturier, et al. (+3)
707 [GO] 2023―Feb―16 Trusted Messengers and Trusted Messages: The Role for Community-Based Organizations in Promoting COVID-19 and Routine Immunizations Angela K. Shen, Safa Browne, Tuhina Srivastava, Melanie L. Kornides, Andy S.L. Tan
708 [GO] 2023―Feb―16 Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities Peter D Smits, Samuel Gratzl, Michael Simonov, Senthil K Nachimuthu, Brianna M Goodwin Cartwright, Michael D Wang, et al. (+5)
709 [GO] 2023―Feb―16 The social and socio-political embeddedness of COVID-19 vaccination decision-making: A five-country qualitative interview study from Europe Bettina M. Zimmermann, Katharina T. Paul, Emília R. Araújo, Alena Buyx, Sebastian Ferstl, Amelia Fiske, et al. (+7)
710 [GO] 2023―Feb―13 The impact of side effect framing on COVID-19 booster vaccine intentions in an Australian sample K. Barnes, K. Faasse
711 [GO] 2023―Feb―13 Examining confidence and hesitancy towards COVID-19 vaccines: a cross-sectional survey using in-person data collection in rural Ghana Afreh OK, P. Angwaawie, E. Attivor, LA. Boateng, K. Brackstone, MG. Head, et al. (+2)
712 [GO] 2023―Feb―13 Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: a cross-sectional analysis of the HELIUS study Sophie L. Campman, Gwen van Rossem, Anders Boyd, Liza Coyer, Janke Schinkel, Charles Agyemang, et al. (+12)
713 [GO] 2023―Feb―13 Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis Durgesh Wankhede, Sandeep Grover, Paul Hofman
714 [GO] 2023―Feb―13 Minority Health Social Vulnerability Index and COVID-19 vaccination coverage - The United States, December 14, 2020-January 31, 2022 Ryan Saelee, Neil Chandra Murthy, Bhavini Patel Murthy, Elizabeth Zell, Lauren Shaw, Lynn Gibbs-Scharf, et al. (+2)
715 [GO] 2023―Feb―10 Did the temporary suspension of Vaxzveria vaccinations influence COVID-19 vaccination intentions, vaccination perceptions and trust in the vaccination campaign? A repeated survey study in the Netherlands Marion de Vries, Liesbeth Claassen, Mattijs S. Lambooij, Aura Timen
716 [GO] 2023―Feb―10 Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: a phase 2/3, double-blind, randomized study Romana Hosain, Peter Aquino, Carmen Baccarini, Igor Smolenov, Ping Li, Haijing Qin, et al. (+4)
717 [GO] 2023―Feb―09 Persuading the “Movable Middle”: Characteristics of Effective Messages to Promote Routine and COVID-19 Vaccinations for Adults and Children - The Impact of COVID-19 on Beliefs and Attitudes Angela K. Shen, Safa Browne, Tuhina Srivastava, Melanie L. Kornides, Andy S.L. Tan
718 [GO] 2023―Feb―09 Persistent SARS-COV-2 infection in vaccinated individual with three doses of COVID-19 vaccine Germana Silva Vasconcelos, Maria da Conceição Rodrigues Fernandes, Tamires Cardoso Matsui, Maria Claudia dos Santos Luciano, Cecilia Leite Costa, Clarissa Perdigão Mello Ferraz, et al. (+4)
719 [GO] 2023―Feb―09 Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization Daniel R. Feikin, Melissa M. Higdon, Nick Andrews, Shirley Collie, Maria Deloria Knoll, Jeffrey C. Kwong, et al. (+3)
720 [GO] 2023―Feb―09 Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study Erik Buntinx, Leonardo Brochado, Charissa Borja-Tabora, Charles Y. Yu, Edison R Alberto, May E.B. Montellano, et al. (+13)
721 [GO] 2023―Feb―08 Make it or break it: On-time Vaccination intent at the time of Covid-19 Jacques Bughin, Michele Cincera, Kelly Peters, Dorota Reykowska, Marcin Żyszkiewicz, Rafal Ohmed
722 [GO] 2023―Feb―08 Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis Atsuyuki Watanabe, Masao Iwagami, Jun Yasuhara, Hisato Takagi, Toshiki Kuno
723 [GO] 2023―Feb―07 Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants Hye Won Kwak, Hyo-Jung Park, Seo-Yeon Jung, Eun Young Oh, Sang-In Park, Yeonhwa Kim, et al. (+21)
724 [GO] 2023―Feb―03 mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia Rui Li, Hanting Liu, Christopher K Fairley, Jason J Ong, Yuming Guo, Pengyi Lu, et al. (+6)
725 [GO] 2023―Feb―03 Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December 2021: a population-based retrospective cohort study Deshayne B. Fell, Eszter Török, Ann E. Sprague, Annette K. Regan, Tavleen Dhinsa, Gillian D. Alton, et al. (+15)
726 [GO] 2023―Feb―03 Unlocking Infodemics and Mysteries in COVID-19 Vaccine Hesitancy: Nexus of Conspiracy Beliefs, Digital Informational Support, Psychological Well-being, and Religious Fatalism Syed Hassan Raza, Muhammad Yousaf, Umer Zaman, Sanan Waheed Khan, Rachel Core, Aqdas Malik
727 [GO] 2023―Feb―02 Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece Helena C. Maltezou, Dimitrios Basoulis, Konstantinos Bonelis, Maria N. Gamaletsou, Theodoros V. Giannouchos, Eleni Karantoni, et al. (+14)
728 [GO] 2023―Feb―01 Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: a registry-linkage study Kristin L. Andrejko, Jennifer F. Myers, Nozomi Fukui, Lauren Nelson, Rui Zhao, John Openshaw, et al. (+4)
729 [GO] 2023―Feb―01 The societal value of SARS-CoV-2 booster vaccination in Indonesia Rob Johnson, Bimandra Djaafara, David Haw, Patrick Doohan, Giovanni Forchini, Matteo Pianella, et al. (+3)
730 [GO] 2023―Jan―27 Ethics of age de-escalation in pediatric vaccine trials: Attending to the case of COVID-19 Ami Harbin, Naomi Laventhal, Mark Navin
731 [GO] 2023―Jan―27 Influenza and pneumococcal vaccine prescription for adults during COVID-19 first wave in three regions of Argentina María Gabriela Matta, Laura Pulido, Juan José Herrera-Paz, José M. Picco, Sebastian Wolff, Gary Tse, Sebastian Garcia-Zamora
732 [GO] 2023―Jan―27 Impact of COVID-19 vaccination in post-COVID cardiac complications Josefina B. Parodi, Agustín Indavere, Pamela Bobadilla Jacob, Guillermo C. Toledo, Rubén G. Micali, Gabriel Waisman, et al. (+3)
733 [GO] 2023―Jan―23 The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response Tanya R. Myers, Paige L. Marquez, Julianne M. Gee, Anne M. Hause, Lakshmi Panagiotakopoulos, Bicheng Zhang, et al. (+11)
734 [GO] 2023―Jan―23 Safety and Efficacy of COVID-19 Prime-Boost Vaccinations: Homologous BBIBP-CorV versus Heterologous BNT162b2 Boosters in BBIBP-CorV-Primed Individuals Saad I. Mallah, Abdulla Alawadhi, Jaleela Jawad, Pearl Wasif, Basma Alsaffar, Ejlal Alalawi, et al. (+12)
735 [GO] 2023―Jan―23 Psychological determinants of COVID-19 vaccine acceptance: A comparison between immigrants and the host population in Japan Yuanyuan Teng, Tomoya Hanibuchi, Masaki Machida, Tomoki Nakaya
736 [GO] 2023―Jan―23 Health Belief Model and parents' acceptance of the Pfizer-BioNTech and Sinopharm COVID-19 vaccine for children aged 5-18 years Old: A national survey Pasitpon Vatcharavongvan, Napat Boonyanitchayakul, Panpassorn Khampachuea, Isawan Sinturong, Vanida Prasert
737 [GO] 2023―Jan―23 COVID-19 Vaccine Hesitancy Scale and its Association with Actual COVID-19 Vaccine Uptake in Israel Ariella Grossman-Giron, Dana Tzur Bitan, Sharon Shemesh, Yael Mayer, Noga Shiffman, Yuval Bloch
738 [GO] 2023―Jan―23 Education increases COVID-19 vaccine uptake among people in Canadian federal prisons in a prospective randomized controlled trial: The EDUCATE study Tetiana Zolotarova, Camille Dussault, Hyejin Park, Olivia Varsaneux, Nicole E. Basta, Lorena Watson, et al. (+8)
739 [GO] 2023―Jan―23 Predictors of COVID-19 vaccine uptake among people who inject drugs Steffanie A. Strathdee, Daniela Abramovitz, Carlos F. Vera, Irina Artamonova, Thomas L. Patterson, Davey M. Smith, et al. (+2)
740 [GO] 2023―Jan―23 Comparative performance of between-population vaccine allocation strategies with applications for emerging pandemics Keya Joshi, Eva Rumpler, Lee Kennedy-Shaffer, Rafia Bosan, Marc Lipsitch
741 [GO] 2023―Jan―21 COVID-19 vaccination hesitancy and uptake: Perspectives from people released from the Federal Bureau of Prisons Camille Kramer, Minna Song, Carolyn B. Sufrin, Gabriel B. Eber, Leonard S. Rubenstein, Brendan Saloner
742 [GO] 2023―Jan―20 COVID-19 Vaccination among Different Types of US Healthcare Personnel Matthew Z. Dudley, Holly B. Schuh, Jana Shaw, Rajiv N. Rimal, Steven A. Harvey, Kristian R. Balgobin, et al. (+2)
743 [GO] 2023―Jan―20 COVID-19 vaccination hesitancy in people affected by diabetes and strategies to increase vaccine compliance: A systematic narrative review and meta-analysis Francesco Paolo Bianchi, Pasquale Stefanizzi, Andrea Martinelli, Nazario Brescia, Silvio Tafuri
744 [GO] 2023―Jan―20 SARS-CoV-2 vaccine breakthrough infections in Virginia, January 17, 2021 - June 30, 2021 Brandy Darby, Victoria Alexander, Julia Murphy
745 [GO] 2023―Jan―16 COVID-19 Vaccine Hesitancy among Pregnant Women and their Reported Reasons for Vaccine Refusal- A Prospective Study in Tehran, Iran Ashraf Moini, Maryam Rabiei, Reihaneh Pirjani, Amene Abiri, Arezoo Maleki-Hajiagha
746 [GO] 2023―Jan―13 COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study Stuart Bedston, Emily Lowthian, Christopher I Jarvis, Ashley Akbari, Jillian Beggs, Declan Bradley, et al. (+13)
747 [GO] 2023―Jan―13 Association of death or illness from COVID-19 among family and friends on vaccine uptake within four months of the Emergency Use Authorization. Findings from a national survey in the United States Saurabh Kalra, Deepak Kalra, Irina Grafova, Julia Sass Rubin, Alan Monheit, Joel Cantor, et al. (+2)
748 [GO] 2023―Jan―13 Decline in reported measles cases in Italy in the COVID-19 era, January 2020 - July 2022: the need to prevent a resurgence upon lifting non-pharmaceutical pandemic measures Giacomo Facchin, Antonino Bella, Martina Del Manso, Maria Cristina Rota, Antonietta Filia
749 [GO] 2023―Jan―13 Safety of primary immunization using inactivated SARS-CoV-2 vaccine (CoronaVac®) among population aged 3 years and older in a large-scale use: a multi-center open-label study in China Haitao Yang, Zhen Li, Ruizhi Zhang, Shicheng Guo, Binbing Wang, Xing Fang, et al. (+8)
750 [GO] 2023―Jan―09 Safety of Co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the Vaccine Adverse Event Reporting System (VAERS) during July 1, 2021 - June 30, 2022 Pedro L. Moro, Bicheng Zhang, Carol Ennulat, Margaret Harris, Rachel McVey, Gina Woody, et al. (+3)
751 [GO] 2023―Jan―09 School immunization coverage in adolescents during the COVID-19 pandemic: A retrospective cohort study Hannah Sell, Yuba Raj Paudel, Donald Voaklander, Shannon E. MacDonald
752 [GO] 2023―Jan―09 Experiences, risk perceptions, and COVID-19 vaccination outcomes among hospital workers Abram L. Wagner, Michelle H. Moniz, Molly J. Stout, Courtney Townsel, Sarah T. Hawley, Brian J. Zikmund-Fisher
753 [GO] 2023―Jan―09 Breastfeeding women’s attitudes towards and acceptance and rejection of COVID-19 vaccination: Implementation research Saifon Chawanpaiboon, Sanitra Anuwutnawin, Attapol Kanjanapongporn, Julaporn Pooliam, Vitaya Titapant
754 [GO] 2023―Jan―09 COVID-19 vaccine hesitancy in care home staff: a survey of Liverpool care homes John S P Tulloch, Karen Lawrenson, Adam L Gordon, Sam Ghebrehewet, Matthew Ashton, Steve Peddie, Paula Parvulescu
755 [GO] 2023―Jan―06 Baculoviral COVID-19 Delta DNA vaccine cross-protects against SARS-CoV2 variants in K18-ACE2 transgenic mice Yuyeon Jang, Hansam Cho, Jungmin Chun, Kihoon Park, Aleksandra Nowakowska, Jinha Kim, et al. (+6)
756 [GO] 2023―Jan―06 CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines: a case series Narges Ebrahimi, Mahsa Mazdak, Vahid Shaygannejad, Omid Mirmosayyeb
757 [GO] 2023―Jan―05 Safety, Reactogenicity, and Immunogenicity of Ad26.COV2.S: Results of a Phase 1, Randomized, Double-blind, Placebo-controlled COVID-19 Vaccine Trial in Japan Yumi Tsuchiya, Hiroshi Tamura, Koji Fujii, Hirotaka Numaguchi, Kiichiro Toyoizumi, Tina Liu, et al. (+3)
758 [GO] 2023―Jan―03 COVID-19 vaccination refusal trends in Kenya over 2021 Ryan T Rego, Brooke Kenney, Anthony K Ngugi, Leon Espira, James Orwa, Geoffrey H Siwo, et al. (+13)
759 [GO] 2023―Jan―02 Assessment of a COVID-19 Vaccination Protocol for Persons Experiencing Homelessness in the Emergency Department James S. Ford, Sam G. Rouleau, Jenny L. Wagner, Christopher B. Adams, Larissa S. May, Aman K. Parikh, James F. Holmes
760 [GO] 2023―Jan―02 A Longitudinal Assessment of Variability in COVID-19 Vaccine Hesitancy and Psychosocial Correlates in a National United States Sample Natalie J. Shook, Benjamin Oosterhoff, Barış Sevi
761 [GO] 2022―Dec―29 Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants Sergio A. Rodriguez-Aponte, Neil C. Dalvie, Ting Y. Wong, Ryan S. Johnston, Christopher A. Naranjo, Sakshi Bajoria, et al. (+20)
762 [GO] 2022―Dec―26 COVID-19 booster vaccination in rural community pharmacies Abigail Gamble, Tessa J. Hastings, Salisa C. Westrick, Megan Smith, Ashley N. Hannings, Jessica M. Robinson, et al. (+4)
763 [GO] 2022―Dec―25 Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naïve and previously-infected individuals Timothy G Kuzel, Jia Fu, Mark Anderson, Michael Stec, Michael Boler, Dylan Behun, et al. (+4)
764 [GO] 2022―Dec―23 Association of dual COVID-19 and seasonal influenza vaccination with COVID-19 infection and disease severity Zhigang Xie, Hanadi Y. Hamadi, Arch G. Mainous, Young-Rock Hong
765 [GO] 2022―Dec―23 Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season Kristin L. Andrejko, Jennifer F. Myers, John Openshaw, Nozomi Fukui, Sophia Li, James P. Watt, et al. (+5)
766 [GO] 2022―Dec―21 Cellular and Humoral Immune Response to the Fourth Pfizer-BioNTech COVID-19 Vaccine Dose in Individuals Aged 60 Years and Older Esther Saiag, Yifat Alcalay, Or Marudi, Avi Orr-Urtreger, David Hagin
767 [GO] 2022―Dec―21 One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine Ori Wand, Anna Breslavsky, Amir Bar-Shai, Chezy Levy, Shlomo Maayan, Avi Rimler, et al. (+5)
768 [GO] 2022―Dec―20 Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care setting Madhura S. Rane, McKaylee Robertson, Sarah Kulkarni, Daniel Frogel, Chris Gainus, Denis Nash
769 [GO] 2022―Dec―20 A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination Stanley Xu, Runxin Huang, Lina S. Sy, Vennis Hong, Sungching C. Glenn, Denison S. Ryan, et al. (+10)
770 [GO] 2022―Dec―16 Changes in hepatitis B vaccine perception in response to the COVID-19 pandemic: Development of the Shift in Vaccine Confidence (SVC) survey tool Alix Boisson, Camille Morgan, Angela Stover, Patrick Ngimbi, Nana Mbonze, Sarah Ntambua, et al. (+7)
771 [GO] 2022―Dec―16 Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults Takuhiro Sonoyama, Satoshi Iwata, Masaharu Shinkai, Naoko Iwata-Yoshikawa, Nozomi Shiwa-Sudo, Takuya Hemmi, et al. (+11)
772 [GO] 2022―Dec―16 A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink W. Katherine Yih, Matthew F. Daley, Jonathan Duffy, Bruce Fireman, David McClure, Jennifer Nelson, et al. (+7)
773 [GO] 2022―Dec―15 The impact of seasonal influenza vaccination uptake on COVID-19 vaccination attitudes in a rural area in Greece Andria Papazachariou, Constantinos Tsioutis, Theodore Lytras, Onoufrios Malikides, Maria Stamatelatou, Nektaria Vasilaki, et al. (+3)
774 [GO] 2022―Dec―14 Impact of prenatal COVID-19 vaccination on delivery and neonatal outcomes: Results from a New York City cohort Erona Ibroci, Xiaoqin Liu, Whitney Lieb, Rebecca Jessel, Frederieke A.J. Gigase, Kyle Chung, et al. (+19)
775 [GO] 2022―Dec―14 Association Between Caregiver Opposition to Topical Fluoride and COVID-19 Vaccines Sapna J. Saini, Adam C. Carle, Anna R. Forsyth, Donald L. Chi
776 [GO] 2022―Dec―13 Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July-August 2021 Phillip P. Salvatore, Christine C. Lee, Sadia Sleweon, David W. McCormick, Lavinia Nicolae, Kristen Knipe, et al. (+23)
777 [GO] 2022―Dec―13 Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity Evgeny Faizuloev, Anastasiia Gracheva, Ekaterina Korchevaya, Daria Smirnova, Roman Samoilikov, Andrey Pankratov, et al. (+8)
778 [GO] 2022―Dec―12 Social cognitive predictors of vaccination status, uptake and mitigation behaviors in the Canadian COVID-19 Experiences Survey Peter A. Hall, Gang Meng, Christian Boudreau, Anna Hudson, Anne C.K. Quah, Thomas Agar, Geoffrey T. Fong
779 [GO] 2022―Dec―12 Patient flow time data of COVID-19 vaccination clinics in 23 sites, United States, April and May 2021 Bo-Hyun Cho, Heba M. Athar, Laurel G. Bates, Benjamin O. Yarnoff, LaTreace Q. Harris, Michael L. Washington, et al. (+2)
780 [GO] 2022―Dec―09 Willingness of Brazilian caregivers in having their children and adolescents vaccinated against Covid-19 Marcio Fernandes Nehab, Karla Gonçalves Camacho, Adriana Teixeira Reis, Maria de Fátima Junqueira-Marinho, Dimitri Marques Abramov, Zina Maria Almeida de Azevedo, et al. (+8)
781 [GO] 2022―Dec―09 Prior Immunization Status of COVID-19 Patients and Disease Severity: A Multicenter Retrospective Cohort Study Assessing the Different Types of Immunity Javaria Aslam, Faisal Shehzad, Muhammad Talha Haris, Hewad Hewadmal, Maryam Khalid, Mohammad Y. Alshahrani, et al. (+3)
782 [GO] 2022―Dec―06 Trusted information sources in the early months of the COVID-19 pandemic predict vaccination uptake over one year later Carl Latkin, Lauren Dayton, Jacob Miller, Evan Eschliman, Jingyan Yang, Amelia Jamison, Xiangrong Kong
783 [GO] 2022―Dec―05 A case-crossover study of the effect of vaccination on SARS-CoV-2 transmission relevant behaviours during a period of national lockdown in England and Wales Aimee Serisier, Sarah Beale, Yamina Boukari, Susan Hoskins, Vincent Nguyen, Thomas Byrne, et al. (+7)
784 [GO] 2022―Dec―02 Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: population-based cohort study in Norway Ida Henriette Caspersen, Lene K Juvet, Berit Feiring, Ida Laake, Anna Hayman Robertson, Siri Mjaaland, et al. (+2)
785 [GO] 2022―Dec―02 Inequalities in infant vaccination coverage during the COVID-19 pandemic: a population-based study in Peru Ali Al-kassab-Córdova, Claudia Silva-Perez, Carolina Mendez-Guerra, Lucero Sangster-Carrasco, Iván Arroyave, Báltica Cabieses, Edward Mezones-Holguin
786 [GO] 2022―Dec―02 Exploring key informants’ perceptions of Covid-19 vaccine hesitancy in a disadvantaged urban community in Ireland: emergence of a ‘4Cs’ model Carolyn Ingram, Mark Roe, Vicky Downey, Lauren Phipps, Carla Perrotta
787 [GO] 2022―Dec―02 Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022 Anna Stoliaroff-Pepin, Caroline Peine, Tim Herath, Johannes Lachmann, Delphine Perriat, Achim Dörre, et al. (+25)
788 [GO] 2022―Dec―01 Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older Hui-Lee Wong, Ellen Tworkoski, Cindy Ke Zhou, Mao Hu, Deborah Thompson, Bradley Lufkin, et al. (+10)
789 [GO] 2022―Nov―29 Education level modifies parental hesitancy about COVID-19 vaccinations for their children Shuning Tang, Xin Liu, Yingnan Jia, Hao Chen, Pinpin Zheng, Hua Fu, Qianyi Xiao
790 [GO] 2022―Nov―29 What Attributes Influence Rural Household’s Willingness to Get Vaccinated for COVID-19? Perspectives from Six Chinese Townships Yingying Sun, Shih-Kai Huang, Sudha Arlikatti, Michael K. Lindell
791 [GO] 2022―Nov―25 “I won’t be a guinea pig”: Rethinking public health communication and vaccine hesitancy in the context of COVID-19 S. Michelle Driedger, Gabriela Capurro, Jordan Tustin, Cindy G. Jardine
792 [GO] 2022―Nov―25 What impact does the attitude toward COVID-19 vaccination have on physicians as vaccine providers? A cross sectional study from the German outpatient sector Arno Stöcker, Jan Hoffmann, Laura Mause, Julia Neufeind, Tim Ohnhäuser, Nadine Scholten
793 [GO] 2022―Nov―25 Spirituality is associated with Covid-19 vaccination scepticism Natalia Zarzeczna, Tisa Bertlich, Bojana Većkalov, Bastiaan T. Rutjens
794 [GO] 2022―Nov―24 Tree-based data mining for safety assessment of first COVID-19 BOOSTER doses in the Vaccine Safety Datalink W. Katherine Yih, Matthew F. Daley, Jonathan Duffy, Bruce Fireman, David McClure, Jennifer Nelson, et al. (+7)
795 [GO] 2022―Nov―24 Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers Hidenori Tanaka, Junji Mukai, Kenichi Kushibiki, Sayuri Mizushima, Kyoko Maeda, Yuko Fujimoto, et al. (+9)
796 [GO] 2022―Nov―24 The impact of the COVID-19 pandemic on parents’ perceptions and acceptance of routine childhood vaccination in Canada: A national longitudinal study Robin M. Humble, Shannon D. Scott, Eve Dubé, Joanne Olson, Shannon E. MacDonald
797 [GO] 2022―Nov―22 Background rates of 41 Adverse Events of Special Interest for COVID-19 vaccines in 10 European healthcare databases - An ACCESS cohort study C Willame, C Dodd, CE Durán, RJHJ Elbers, R Gini, C Bartolini, et al. (+28)
798 [GO] 2022―Nov―22 Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials Aykut Ozdarendeli, Zafer Sezer, Shaikh Terkis Islam Pavel, Ahmet Inal, Hazel Yetiskin, Busra Kaplan, et al. (+11)
799 [GO] 2022―Nov―21 Assessing the long-stand antibody response induced by COVID-19 vaccines: A study in an educational cohort in San Luis, Argentina Ricardo Javier Elicabe, Matías Nicolás Distel, Brenda Lucila Jofré, Marianela Leporati, Juan Eduardo Silva, José Luis Arias, et al. (+6)
800 [GO] 2022―Nov―18 COVID-19 vaccination coverage in patients with chronic obstructive pulmonary disease - A cross-sectional study in Hungary Monika Fekete, Alpar Horvath, Balazs Santa, Gabor Tomisa, Gergo Szollosi, Zoltan Ungvari, et al. (+4)
801 [GO] 2022―Nov―18 SARS-CoV-2 viral shedding in vaccinated and unvaccinated persons: A case series David W. McCormick, Liesl M. Hagan, Phillip P. Salvatore, Reed Magleby, Christine Lee, Sadia Sleweon, et al. (+19)
802 [GO] 2022―Nov―17 COVID-19 vaccine policy development in a sample of 44 countries- Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs) Anna-Lea Kahn, Christoph A Steffen, Louise Henaff, Noni E MacDonald, Christopher Morgan, Ruth Faden, et al. (+2)
803 [GO] 2022―Nov―14 Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study Massimo Fabiani, Alberto Mateo-Urdiales, Chiara Sacco, Maria Cristina Rota, Daniele Petrone, Marco Bressi, et al. (+12)
804 [GO] 2022―Nov―14 COVID-19 vaccine coverage disparities in rural and farm children Jeffrey J. VanWormer, Gabriella Alicea, Bryan P. Weichelt, Richard L. Berg, Maria E. Sundaram
805 [GO] 2022―Nov―14 Misinformation and COVID-19 Vaccine Hesitancy Tara Zimmerman, Kristina Shiroma, Kenneth R Fleischmann, Bo Xie, Chenyan Jia, Nitin Verma, Min Kyung Lee
806 [GO] 2022―Nov―10 COVID-19 vaccine acceptance and its socio-demographic and emotional determinants: a multi-country cross-sectional study A. de Figueiredo, C. Simas, H.J. Larson
807 [GO] 2022―Nov―08 Background Rates of Adverse Events of Special Interest for COVID-19 Vaccine Safety Monitoring in the United States, 2019-2020 Keran Moll, Bradley Lufkin, Kathryn R. Fingar, Cindy Ke Zhou, Ellen Tworkoski, Chianti Shi, et al. (+30)
808 [GO] 2022―Nov―08 Homologous and heterologous booster vaccinations of S-268019-b, a recombinant S protein-based vaccine with a squalene-based adjuvant, enhance neutralization breadth against SARS-CoV-2 Omicron subvariants in cynomolgus macaques Masayuki Hashimoto, Shinpei Aoe, Yusuke Kawazu, Naomi M. Seki, Kumi Hashimoto, Ken Yoshihara, et al. (+3)
809 [GO] 2022―Nov―07 A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan Yoshinori Takeuchi, Masao Iwagami, Sachiko Ono, Nobuaki Michihata, Kohei Uemura, Hideo Yasunaga
810 [GO] 2022―Nov―07 Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway Paz Lopez-Doriga Ruiz, Nina Gunnes, Jon Michael Gran, Øystein Karlstad, Randi Selmer, Jesper Dahl, et al. (+9)
811 [GO] 2022―Nov―07 Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study Sarah Beale, Rachel Burns, Isobel Braithwaite, Thomas Byrne, Wing Lam Erica Fong, Ellen Fragaszy, et al. (+10)
812 [GO] 2022―Nov―07 Demographic disparities in COVID-19 vaccine hesitancy among U.S. adults: Analysis of household pulse survey data from Jul 21 to Oct 11 in 2021 Yan Yan Wu, Wei Zhang
813 [GO] 2022―Nov―07 Parental Intentions to Vaccinate Children against COVID-19: Findings from a U.S. National Survey Rebecca J. Guerin, Arash Naeim, Ryan Baxter-King, Andrea H. Okun, Derek Holliday, Lynn Vavreck
814 [GO] 2022―Nov―07 Frequency and temporal evolution of COVID-19 vaccination rate among oncological patients undergoing 18F-FDG-PET Stephan Skawran, Helen Schiesser, Alexander Maurer, Thomas Sartoretti, Manuel Dittli, Cäcilia Mader, et al. (+4)
815 [GO] 2022―Nov―07 Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia Joshua Osowicki, Hannah J. Morgan, Adele Harris, Hazel J. Clothier, Jim P. Buttery, Lynette Kiers, Nigel W. Crawford
816 [GO] 2022―Nov―04 Perceived Threat and Coping Responses during the COVID-19 Pandemic: Prospective Associations with Vaccine Hesitancy Talia Morstead, Jason Zheng, Nancy L. Sin, Anita DeLongis
817 [GO] 2022―Nov―03 Reactions Following Pfizer-BioNTech COVID-19 mRNA Vaccination and Related Healthcare Encounters Among 7,077 Children Aged 5-11 Years Within an Integrated Healthcare System Deborah E. Malden, Julianne Gee, Sungching Glenn, Zhuoxin Li, Cheryl Mercado, Oluwaseye A Ogun, et al. (+7)
818 [GO] 2022―Nov―01 The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: a retrospective cohort study R.K. Lucinde, B. Karia, N. Ouma, D. Amadi, C. Nyundo, C. Mataza, et al. (+4)
819 [GO] 2022―Nov―01 Association Between History of SARS-CoV-2 Infection and Severe Systemic Adverse Events After mRNA COVID-19 Vaccination Among U.S. Adults Lindsay K. Tompkins, James Baggs, Tanya R. Myers, Julianne M. Gee, Paige L. Marquez, Sharon B. Kennedy, et al. (+8)
820 [GO] 2022―Nov―01 Preferences and Willingness of Accepting COVID-19 Vaccine Booster: Results from a Middle-Income Country Chang Chee Tao, Lim Xin Jie, Chew Chii Chii, Philip Rajan, Chan Huan Keat, Muhammad Radzi Abu Hassan, et al. (+2)
821 [GO] 2022―Oct―31 The early evolution of COVID-19 incidence and mortality among people aged under 80 years or 80 years and above after COVID-19 vaccine implementation in the state of Bahia, Brazil Mariana C. Cruz, Cristiana M. Nascimento-Carvalho
822 [GO] 2022―Oct―31 Is vaccine confidence an unexpected victim of the COVID-19 pandemic? Alessandro Siani, Amy Tranter
823 [GO] 2022―Oct―31 “They're trying to bribe you and taking away your freedoms”: COVID-19 vaccine hesitancy in communities with traditionally low vaccination rates Gabriela Capurro, Ryan Maier, Jordan Tustin, Cindy G. Jardine, S. Michelle Driedger
824 [GO] 2022―Oct―31 A socio-ecological exploration to identify factors influencing the COVID-19 vaccine decision-making process among pregnant and lactating women: Findings from Kenya Rupali J. Limaye, Alicia Paul, Rachel Gur-Arie, Eleonor Zavala, Clarice Lee, Berhaun Fesshaye, et al. (+9)
825 [GO] 2022―Oct―31 The role of trust in COVID-19 vaccine hesitancy and acceptance among Black and White Americans Amber Marie Reinhart, Yan Tian, Amanda E. Lilly
826 [GO] 2022―Oct―27 Strategic silences, eroded trust: The impact of divergent COVID-19 vaccine sentiments on healthcare workers' relations with peers and patients Leonardo W Heyerdahl, Stef Dielen, Hélène Dodion, Carla Van Riet, ToTran Nguyen, Clarissa Simas, et al. (+7)
827 [GO] 2022―Oct―26 The resurgence risk of COVID-19 in China in the presence of immunity waning and ADE: a mathematical modelling study Weike Zhou, Biao Tang, Yao Bai, Yiming Shao, Yanni Xiao, Sanyi Tang
828 [GO] 2022―Oct―26 Mandatory COVID-19 vaccination for healthcare personnel in the era of new SARS-CoV-2 variants Helena C. Maltezou, Caterina Ledda, Amandine Gagneux-Brunon, Elisabeth Botelho-Nevers
829 [GO] 2022―Oct―26 Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: A prospective, multicenter study Helena C. Maltezou, Maria N. Gamaletsou, Dimitra-Maria Koukou, Theodoros V. Giannouchos, Flora Sourri, Natalia Syrimi, et al. (+9)
830 [GO] 2022―Oct―26 Parental Attitudes in the Pediatric Emergency Department about the COVID-19 Vaccine Jared Schiff, Anita R. Schmidt, Phung K. Pham, Jocelyn B. Pérez, Pia S. Pannaraj, Pradip P. Chaudhari, Danica B. Liberman
831 [GO] 2022―Oct―25 Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients Anand V Kulkarni, Shashidhar Jaggaiahgari, Sowmya Iyengar, Venu Simhadri, Deepika Gujjarlapudi, Hardik Rugwani, et al. (+8)
832 [GO] 2022―Oct―24 Comparison of Test-Negative and Syndrome-Negative Controls in SARS-CoV-2 Vaccine Effectiveness Evaluations for Preventing COVID-19 Hospitalizations in the United States Caitlin Turbyfill, Katherine Adams, Mark W. Tenforde, Nancy L. Murray, Manjusha Gaglani, Adit A. Ginde, et al. (+48)
833 [GO] 2022―Oct―21 Negative sentiments toward novel coronavirus (COVID-19) vaccines Ruoyan Sun, Henna Budhwani
834 [GO] 2022―Oct―21 Identifying early adopters of COVID-19 vaccines in Latin America Alejandro Arrieta, Ariadna García-Prado, Juan Pablo Sarmiento, Carmen Paz Castro
835 [GO] 2022―Oct―21 The quest for more effective vaccine markets - Opportunities, challenges, and what has changed with the SARS-CoV-2 pandemic Tania Cernuschi, Stefano Malvolti, Shanelle Hall, Luc Debruyne, Hanne Bak Pedersen, Helen Rees, Emer Cooke
836 [GO] 2022―Oct―20 Do the unvaccinated perform more distancing, mask wearing and hand hygiene? A test of the risk compensation hypothesis in a representative sample during the COVID-19 pandemic Peter A. Hall, Gang Meng, Mohammad N. Sakib, Anne C. K. Quah, Thomas Agar, Geoffrey T. Fong
837 [GO] 2022―Oct―20 The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study Hanqing He, Yao Zhu, Mingjuan Jin, Yang Zhou, Xuewen Tang, Rui Yan, et al. (+2)
838 [GO] 2022―Oct―20 Using narratives to inform the development of a digital health intervention related to COVID-19 vaccination in Black young adults in Georgia, North Carolina and Alabama Marie C.D. Stoner, David Tweedy, Maria G. Leonora Comello, Christina Toval, Audrey E. Pettifor, Margo Adams Larsen, et al. (+8)
839 [GO] 2022―Oct―20 Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants Sebastián Blanco, Lorena Spinsanti, Juan Javier Aguilar, Adrián Diaz, María Elisa Rivarola, Mauricio Beranek, et al. (+4)
840 [GO] 2022―Oct―20 Where are children ages 5-17 years receiving their COVID-19 vaccinations? Variations over time and by sociodemographic characteristics, United States Tammy A. Santibanez, Carla L. Black, Tara M. Vogt, Kevin Chatham-Stephens, Tianyi Zhou, Jessica P. Lendon, James A. Singleton
841 [GO] 2022―Oct―17 Identifying COVID-19 optimal vaccine dose using mathematical Immunostimulation/Immunodynamic Modelling Sophie Rhodes, Neal Smith, Thomas Evans, Richard White
842 [GO] 2022―Oct―17 Measuring the impact of COVID-19 vaccination and immunity waning: a modelling study for Portugal Constantino Caetano, Maria Luísa Morgado, Paula Patrício, Andreia Leite, Ausenda Machado, André Torres, et al. (+5)
843 [GO] 2022―Oct―17 A Retrospective Evaluation of Side-Effects Associated with the Booster Dose of Pfizer-BioNTech/BNT162b2 COVID-19 Vaccine among females in Eastern Province, Saudi Arabia Yousif A. M. Hassan, Mohammad Daud Ali, Rawan Rashad Al-Eid, Fatimah Ali Al Ghuraya, Zainab Essa Alqasimi, Ayaz Ahmad, et al. (+2)
844 [GO] 2022―Oct―17 Evaluating correlates of protection for mix-match vaccine against COVID-19 VOCs with potential of evading immunity Sih-Han Liao, Wei-Jung Chang, Chen-Yang Hsu, Amy Ming-Fang Yen, Ting-Yu Lin, Sam Li-Sheng Chen, Tony Hsiu-Hsi Chen
845 [GO] 2022―Oct―17 COVID-19 vaccine literacy and vaccine hesitancy among pregnant women and mothers of young children in Japan Yoko Takahashi, Kazue Ishitsuka, Makiko Sampei, Sumiyo Okawa, Yoshihiko Hosokawa, Akira Ishiguro, et al. (+2)
846 [GO] 2022―Oct―13 Cognitive predictors of COVID-19 mitigation behaviors in vaccinated and unvaccinated general population members Anna Hudson, Peter A. Hall, Sara C. Hitchman, Gang Meng, Geoffrey T. Fong
847 [GO] 2022―Oct―05 COVID-19 Vaccine Perceptions & Hesitancy amongst Parents of School-aged Children during the Pediatric Vaccine Rollout Alexandra Byrne, Lindsay A. Thompson, Stephanie L. Filipp MPH, Kathleen Ryan
848 [GO] 2022―Oct―04 COVID-19 outbreak in an elderly care home: very low vaccine effectiveness and late impact of booster vaccination campaign Catharina E. van Ewijk, Elizabeth I. Hazelhorst, Susan J. M. Hahné, Mirjam J. Knol
849 [GO] 2022―Oct―03 Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in Brazil Leonardo Souto Ferreira, Gabriel Berg de Almeida, Marcelo Eduardo Borges, Lorena Mendes Simon, Silas Poloni, Ângela Maria Bagattini, et al. (+7)
850 [GO] 2022―Oct―03 Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California Chun R. Chao, Lanfang Xu, Nancy Cannizzaro, David Bronstein, Yunsun Choi, Robert Riewerts, et al. (+7)
851 [GO] 2022―Oct―03 A queueing Network approach for capacity planning and patient Scheduling: A case study for the COVID-19 vaccination process in Colombia Carlos Franco, Nilson Herazo-Padilla, Jaime Andrés Castañeda
852 [GO] 2022―Oct―03 Counselling of non-communicable diseases’ patients for COVID-19 vaccine uptake in Jordan: Evaluating the intervention Ala'a Al-Shaikh, Refqi Ismail Mahmoud, Hala Boukerdenna, Nazeema Muthu, Chinara Aidyralieva, Saverio Bellizzi
853 [GO] 2022―Sep―28 With established safe and effective use, protein vaccines offer another choice against COVID-19 Anthony M. Marchese, Hadi Beyhaghi, Walter A. Orenstein
854 [GO] 2022―Sep―28 Immune response after COVID-19 vaccination among patients with chronic kidney disease and kidney transplant Thananda Trakarnvanich, Tanun Ngamvitchukorn, Uraporn Phumisantiphong, Kittisak Pholtawornkulchai, Krittima Phochanasomboon, Anan Manomaipiboon
855 [GO] 2022―Sep―28 Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer Cassandra A. Hathaway, Erin M. Siegel, Brian D. Gonzalez, Laura B. Oswald, Anita R. Peoples, Cornelia M. Ulrich, et al. (+3)
856 [GO] 2022―Sep―28 Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the Omicron wave in Peru: A nested case-control study using national population data Silva-Valencia Javier, Soto-Becerra Percy, Escobar-Agreda Stefan, Fernandez-Navarro Manuel, Elorreaga-Reyes Oliver Antonio, Mayta-Tristán Percy, et al. (+2)
857 [GO] 2022―Sep―28 An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: a nationwide register-based study in Sweden M. Spetz, L. Lundberg, C. Nwaru, H. Li, A. Santosa, N. Ng, et al. (+5)
858 [GO] 2022―Sep―27 Near Real-Time Surveillance of Safety Outcomes in US COVID-19 Vaccine Recipients aged 12 to 64 years Patricia C. Lloyd, Mao Hu, Hui-Lee Wong, Azadeh Shoaibi, Cindy Ke Zhou, An-Chi Lo, et al. (+21)
859 [GO] 2022―Sep―27 Towards the development of an epitope-focused vaccine for SARS-CoV-2 Jacquelynne Cervantes-Torres, Sergio Rosales, Carlos Cabello, Laura Montero, Juan Hernandez-Aceves, Guillermo Granados, et al. (+38)
860 [GO] 2022―Sep―26 Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation Tingting Deng, Tingting Li, Gege Chen, Yuhe Zhu, Lang Xu, Yanlin Lin, et al. (+18)
861 [GO] 2022―Sep―26 Prayer frequency and COVID-19 vaccine hesitancy among older adults in Europe Christian Tolstrup Wester, Lasse Lybecker Scheel-Hincke, Tine Bovil, Karen Andersen-Ranberg, Linda Juel Ahrenfeldt, Niels Christian Hvidt
862 [GO] 2022―Sep―23 Parental health beliefs, intention, and strategies about covid-19 vaccine for their children: A cross-sectional analysis from five Arab countries in the Middle East Ali Haider Mohammed, Bassam Abdul Rasool Hassan, Abdulrasool M. Wayyes, Ansam Qassim Gadhban, Ali Blebil, Sara Abu Alhija, et al. (+8)
863 [GO] 2022―Sep―22 Misinformation about vaccine safety and uptake of COVID-19 vaccines among adults and 5-11-year-olds in the United States Daniel Romer, Kenneth M. Winneg, Patrick E. Jamieson, Colleen Brensinger, Kathleen H. Jamieson
864 [GO] 2022―Sep―21 Association between Social Vulnerability and COVID-19 Vaccination Hesitancy and Vaccination in Pregnant and Postpartum Individuals Miranda K Kiefer, Rebecca Mehl, Kara M Rood, Katherine Germann, Divya Mallampati, Tracy Manuck, et al. (+4)
865 [GO] 2022―Sep―21 Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection Bette Liu, Heather Gidding, Sandrine Stepien, Michelle Cretikos, Kristine Macartney
866 [GO] 2022―Sep―20 The intersection of gender and race in older adults’ decision to receive COVID-19 vaccines Janna R. Shapiro, Lois Privor-Dumm, Erica N. Rosser, Sean X. Leng, Sabra L. Klein, Rosemary Morgan
867 [GO] 2022―Sep―19 Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers Fotinie Ntziora, Evangelia Georgia Kostaki, Amalia Karapanou, Maria Mylona, Ioulia Tseti, Nikolaos V. Sipsas, et al. (+2)
868 [GO] 2022―Sep―14 COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: a cross-sectional national survey Dvora Frankenthal, Miri Zatlawi, Ziv Karni-Efrati, Lital Keinan-Boker, Osnat Luxenburg, Michal Bromberg
869 [GO] 2022―Sep―13 Impact of the COVID-19 pandemic on uptake of immunization services in rural Gambia Isaac Osei, Golam Sarwar, Ilias Hossain, Kemo Sonko, Lamin Ceesay, B뫊rr Baldeh, et al. (+2)
870 [GO] 2022―Sep―12 Vaccine-induced seroconversion in participants in the North Carolina COVID-19 Community Research Partnership DeAnna J. Friedman-Klabanoff, Ashley H. Tjaden, Michele Santacatterina, Iqra Munawar, John W. Sanders, David M. Herrington, et al. (+2)
871 [GO] 2022―Sep―12 Declining Influenza Vaccines in an Underserved Primary Care Center in the COVID-19 Pandemic Melissa E. Day, Melissa Klein, Heidi Sucharew, Mary Carol Burkhardt, Allison Reyner, Destiney Giles, et al. (+2)
872 [GO] 2022―Sep―12 The connection between COVID-19 vaccine abundance, vaccination coverage, and public trust in government across the globe Ida G. Monfared
873 [GO] 2022―Sep―12 The impact of COVID-19 vaccines on fertility-A systematic review and metanalysis D. Zaçe, E. La Gatta, L. Petrella, M.L. Di Pietro
874 [GO] 2022―Sep―12 Strategies to increase the intention to get vaccinated against COVID-19: Findings from a nationally representative survey of US adults, October 2020 to October 2021 Arash Naeim, Rebecca J. Guerin, Ryan Baxter-King, Andrea H. Okun, Neil Wenger, Karen Sepucha, et al. (+5)
875 [GO] 2022―Sep―08 Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates Joshua Teperowski Monrad, Sebastian Q꫞, Timothy Powell-Jackson
876 [GO] 2022―Sep―08 A Research and Development (R&D) Roadmap for Broadly Protective Coronavirus Vaccines: Setting a Path to Address Coronavirus Threats Kristine A. Moore, Michael T. Osterholm, Eve M. Lackritz, Gregory A. Poland
877 [GO] 2022―Sep―07 Covid-19 Vaccine Hesitancy and Resistance Amongst Parents of Children Under 18 Years of Age in Ireland Ruth Ceannt, Frederique Vallieres, Heather Burns, Jamie Murphy, Philip Hyland
878 [GO] 2022―Sep―06 How health workers can make a difference in the public COVID-19 vaccination response Katrine B Habersaat, Sideeka Narayan, Siff Malue Nielsen, Martha Scherzer, Cristiana Salvi, Holly Seale
879 [GO] 2022―Sep―06 SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients Quentin Perrier, Julien Lupob, Théophile Gerster, Caroline Augier, Loïc Falque, Lionel Rostaing, et al. (+8)
880 [GO] 2022―Sep―06 Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus Chi Chiu Mok, Kar Li Chan, Sau Mei Tse
881 [GO] 2022―Aug―31 Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults Joseph Fraiman, Juan Erviti, Mark Jones, Sander Greenland, Patrick Whelan, Robert M. Kaplan, Peter Doshi
882 [GO] 2022―Aug―31 Development and validation of a COVID-19 vaccine hesitancy scale for adults in the United States Matthew L. Hrin, Veronica K. Emmerich, Edward H. Ip, Steven R. Feldman
883 [GO] 2022―Aug―30 Can financial incentives and other nudges increase COVID-19 vaccinations among the vaccine hesitant? A randomized trial Mireille Jacobson, Tom Y. Chang, Manisha Shah, Rajiv Pramanik, Samir B. Shah
884 [GO] 2022―Aug―30 Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral sars-cov-2 Erin Williams, Jordan Colson, Ranjini Valiathan, Juan Manuel Carreño, Florian Krammer, Michael Hoffer, et al. (+3)
885 [GO] 2022―Aug―29 COVID-19 vaccine hesitancy among health care worker-parents (HCWP) in Puducherry, India and its implications on their children: a cross sectional descriptive study Pratik Sarkar, Venkatesh Chandrasekaran, Dhandapany Gunasekaran, Palanivel Chinnakali
886 [GO] 2022―Aug―29 Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain Francisco Sánchez-Saez, Salvador Peiró, Llanos Cuenca-Gonzalez, Hermelinda Vanaclocha, Ramón Limón, Dolores Salas, et al. (+9)
887 [GO] 2022―Aug―29 Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody Xiaoling Cao, Junjie Zai, Qingzhen Zhao, Lilan Xie, Yaoming Li
888 [GO] 2022―Aug―26 Strengthened belief in vaccine effectiveness predicted increased COVID-19 vaccination intention and behaviour: Results from a nationally representative longitudinal survey of U.S. adults from July 2020 to April/May 2021 Ava Kikut, Danielle Clark, Emma Jesch, Robert Hornik
889 [GO] 2022―Aug―26 Determinants of COVID-19 vaccine hesitancy and resistance in Russia Yana Roshchina, Sergey Roshchin, Ksenia Rozhkova
890 [GO] 2022―Aug―26 Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology Takuya Hemmi, Akira Ainai, Takao Hashiguchi, Minoru Tobiume, Takayuki Kanno, Naoko Iwata-Yoshikawa, et al. (+12)
891 [GO] 2022―Aug―26 Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection Maria Teresa Vietri, Giovanna D'Elia, Gemma Caliendo, Luana Passariello, Luisa Albanese, Anna Maria Molinari, Italo Francesco Angelillo
892 [GO] 2022―Aug―25 Vasovagal reactions after COVID-19 vaccination in Japan Mai Okuyama, Saeko Morino, Kaori Tanaka, Haruna Nakamura-Miwa, Sayaka Takanashi, Satoru Arai, et al. (+6)
893 [GO] 2022―Aug―22 Advanced vaccinology training globally: Update and impact of the COVID-19 crisis Carine Dochez, Philippe Duclos, Noni MacDonald, Christoph Steffen, Paul-Henri Lambert
894 [GO] 2022―Aug―22 The impact of a vaccine mandate and the COVID-19 pandemic on influenza vaccination uptake in Western Australian health care students G.A. Willis, L. Bloomfield, M. Berry, C. Bulsara, M. Bulsara, G. Chaney, et al. (+5)
895 [GO] 2022―Aug―22 No Significant Increase in Guillain-Barré Syndrome after COVID-19 Vaccination in Adults: A Vaccine Adverse Event Reporting System Study M. Jaffry, F. Mostafa, K. Mandava, S. Rosario, Y. Jagarlamudi, K. Jaffry, et al. (+4)
896 [GO] 2022―Aug―22 Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study Elisa Stivanello, Chiara Beghelli, Francesco Cardoni, Chiara Giansante, Paolo Marzaroli, Muriel Assunta Musti, et al. (+3)
897 [GO] 2022―Aug―22 Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents Louise Marron, Annamaria Ferenczi, Katie M O'Brien, Suzanne Cotter, Lucy Jessop, Yvonne Morrissey, Chantal Migone
898 [GO] 2022―Aug―22 Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong, Jira Chansaenroj, Chompoonut Auphimai, Pornjarim Nilyanimit, et al. (+14)
899 [GO] 2022―Aug―22 Safety of the Fiocruz ChAdOx COVID-19 vaccine used in a mass vaccination campaign in Botucatu, Brazil Sue Ann Costa Clemens, Carlos Magno Castelo Branco Fortaleza, Madeleine Crowe, Andrew Pollard, Karen Ingrid Tasca, Rejane Maria Tommasini Grotto, et al. (+5)
900 [GO] 2022―Aug―22 Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: an observational cohort study Xiaoqi Wang, Yao Deng, Li Zhao, Lei Wang, Zhenwang Fu, Lin Tang, et al. (+13)
901 [GO] 2022―Aug―22 Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination Kazuyoshi Kurashima, Tsuyoshi Numano, Atsuki Yoshino, Akiko Osawa, Yotaro Takaku, Naho Kagiyama, Tsutomu Yanagisawa
902 [GO] 2022―Aug―22 Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients Liz Toapanta-Yanchapaxi, Erwin Chiquete, Esmeralda Ávila-Rojo, Silvia López-Yánez, Sonia Luna del Villar Velasco, Sergio Rivera Monroy, et al. (+19)
903 [GO] 2022―Aug―19 Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations Michael A Laffan, Sue Rees, Madhavi Yadavalli, Lisa Beth Ferstenberg, Nirmal Kumar Shankar, Jennie Medin, et al. (+5)
904 [GO] 2022―Aug―19 Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection Loukia Psaridi, Helena C. Maltezou, Sofia Simonidou, Ioanna Lialliou, Despina Athanasopoulou, Zoi Haila, et al. (+8)
905 [GO] 2022―Aug―18 Challenges, Best Practices, and Lessons Learned from Cholera Mass vaccination campaign in Urban Cameroon during COVID-19 era Adidja AMANI, Solange NGO BAMA, Mariette DIA, Skinner NGUEFACK LEKELEM, Abdou LINJOUOM, Hans MOSSI MAKEMBE, et al. (+5)
906 [GO] 2022―Aug―18 Stamping the vaccine passport? Public support for lifting COVID-19 related restrictions for vaccinated citizens in France, Germany, and Sweden Florian Stoeckel, Sabrina Stöckli, Joseph Phillips, Benjamin Lyons, Vittorio Mérola, Matthew Barnfield, et al. (+3)
907 [GO] 2022―Aug―15 People’s perspectives about COVID-19 vaccination certificate: Findings from a representative Italian sample Marta Caserotti, Teresa Gavaruzzi, Paolo Girardi, Roberta Sellaro, Enrico Rubaltelli, Alessandra Tasso, Lorella Lotto
908 [GO] 2022―Aug―15 Parents’ views on the acceptability of a COVID-19 vaccine for their children: A cross-sectional study in Abu Dhabi-United Arab Emirates Latifa Mohammad Baynouna AlKetbi, Farida Al Hosani, Shammah Al Memari, Shereena Al Mazrouei, Badreyya Al Shehhi, Noura AlShamsi, et al. (+4)
909 [GO] 2022―Aug―15 A Historical Analysis of Vaccine Mandates in the United States Military and Its Application to the COVID-19 Vaccine Mandate Capt Brian P. Elliott, Col Steven Chambers
910 [GO] 2022―Aug―15 Reminders of existing vaccine mandates increase support for a COVID-19 vaccine mandate: Evidence from a survey experiment Filip Viskupič, David L. Wiltse, Abdallah Badahdah
911 [GO] 2022―Aug―08 COVID-19 vaccine hesitancy cannot fully explain disparities in vaccination coverage across the contiguous United States Songhua Hu, Chenfeng Xiong, Qingchen Li, Zitong Wang, Yuan Jiang
912 [GO] 2022―Aug―05 A Behavior Change Model to Address Caregiver Hesitancy around COVID-19 Vaccination in Pediatrics Jordan Yeo, Caitlyn Furr Gudmundsen, Sajjad Fazel, Alex Corrigan, Madison M. Fullerton, Jia Hu, et al. (+4)
913 [GO] 2022―Aug―05 COVID-19 vaccine confidence and reasons for vaccination among health care workers and household members Angela K Ulrich, Grace K Pankratz, Bruno Bohn, Stephanie Yendell, Timothy J Beebe, Craig W Hedberg, Ryan T Demmer
914 [GO] 2022―Aug―05 Unravelling the drivers behind COVID-19 vaccination hesitancy and refusal among teachers: A nationwide study Marta Estrela, Tânia Magalhães Silva, Vítor Roque, Eva Rebelo Gomes, Adolfo Figueiras, Fátima Roque, Maria Teresa Herdeiro
915 [GO] 2022―Aug―03 Response to mRNA COVID-19 vaccination in three XLA patients J.D. Squire, A.Y. Joshi
916 [GO] 2022―Aug―03 Crowdfunding narratives and the valuation of vaccines for COVID-19 Jeremy Snyder, Maya Goldenberg, Valorie A. Crooks, Rachel Katz
917 [GO] 2022―Aug―02 COVID-19 Vaccine Uptake Among Arkansas Public K-12 School Teachers and Staff Michael J. Cima, Donald McCormick, Austin Porter, Namvar Zohoori, Scott Alsbrook, José R. Romero
918 [GO] 2022―Aug―01 Should COVID-19 Vaccines Be Mandated in Schools? - An International Caregiver Perspective Shannon H. Baumer-Mouradian, Rebecca J. Hart, Jeffrey N. Bone, Michelle Seiler, Prasra Olson, Kristina Keitel, et al. (+17)
919 [GO] 2022―Aug―01 Longitudinal determination of BNT162b2 vaccine induced strongly binding SARS-CoV-2 IgG antibodies in a cohort of Romanian healthcare workers Mónika Korodi, István Horváth, Kinga Rákosi, Zsuzsanna Jenei, Gabriella Hudák, Melinda Kákes, et al. (+14)
920 [GO] 2022―Jul―30 Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: a multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial Haiping Chen, Zhuoying Huang, Shaoying Chang, Mei Hu, Qingbin Lu, Yuntao Zhang, et al. (+20)
921 [GO] 2022―Jul―28 COVID-19 vaccinations in German pharmacies: A survey on patient and provider satisfaction Olaf Rose, Susanne Erzkamp, Wiebke Schöbel, Marcia Grajeda, Juliane Köberlein-Neu
922 [GO] 2022―Jul―26 Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation Philip R Krause, Narendra Arora, William Dowling, César Muñoz-Fontela, Simon Funnell, Rogerio Gaspar, et al. (+7)
923 [GO] 2022―Jul―26 Safety and Immunogenicity of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: a randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China Wang Shenyu, Duan Xiaoqian, Chen Bo, Deng Xuan, Wang Zeng, Zhang Hangjie, et al. (+6)
924 [GO] 2022―Jul―18 COVID-19 Vaccine Express strategy in Malawi: An effort to Reach the Un-Reach Ghanashyam Sethy, Mike Chisema, Lokesh Sharma, Krupal Joshi, Sanjay Singhal, Patrick Omar Nicks, et al. (+7)
925 [GO] 2022―Jul―18 Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern Christopher L.D. McMillan, Alberto A. Amarilla, Naphak Modhiran, Jovin J.Y. Choo, Armira Azuar, Kate Honeyman, et al. (+4)
926 [GO] 2022―Jul―13 COVID-19 vaccination intention and activation among health care system employees: A mixed methods study Lavanya Vasudevan, Rebecca Bruening, Anna Hung, Sandra Woolson, Adrian Brown, Susan N. Hastings, et al. (+7)
927 [GO] 2022―Jul―12 Risk of Myocarditis and Pericarditis Following BNT162b2 and mRNA-1273 COVID-19 Vaccination Kristin Goddard, Ned Lewis, Bruce Fireman, Eric Weintraub, Tom Shimabukuro, Ousseny Zerbo, et al. (+13)
928 [GO] 2022―Jul―12 COVID-19 vaccination in pregnant women in Sweden and Norway Anne K. Örtqvist, Elisabeth Dahlqwist, Maria C. Magnus, Rickard Ljung, Jerker Jonsson, Bernice Aronsson, et al. (+3)
929 [GO] 2022―Jul―12 Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults Frances H. Priddy, Michael Williams, Simon Carson, Brittany Lavender, Julia Mathieson, Chris Frampton, et al. (+7)
930 [GO] 2022―Jul―11 Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipients Alexis Cuffel, Sarah Maylin, Helene Le Buanec, Constance Delaugerre, Marine Minier, David Bergerat, et al. (+8)
931 [GO] 2022―Jul―06 Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters Rik L. de Swart, Olav S. de Leeuw, Nadia Oreshkova, Nora M. Gerhards, Irina C. Albulescu, Sandra Vreman, et al. (+6)
932 [GO] 2022―Jul―04 The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men: a mathematical modelling study Maria Xiridou, Philippe Adam, Annemarie Meiberg, Maartje Visser, Amy Matser, John de Wit, Eline Op de Coul
933 [GO] 2022―Jul―04 SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021 David W. McCormick, Stacey L. Konkle, Reed Magleby, Ayan K. Chakrabarti, Blake Cherney, Kristine Lindell, et al. (+30)
934 [GO] 2022―Jul―01 Women's views and experiences of accessing pertussis vaccination in pregnancy and infant vaccinations during the COVID-19 pandemic: A multi-methods study in the UK Helen Skirrow, Sara Barnett, Sadie Bell, Sandra Mounier-Jack, Beate Kampmann, Beth Holder
935 [GO] 2022―Jul―01 Hesitancy to receive the novel coronavirus vaccine and potential influences on vaccination among a cohort of healthcare workers in the Democratic Republic of the Congo Angelica Barrall, Nicole A. Hoff, Dalau Mukadi Nkamba, Kamy Musene, Nick Ida, Anna Bratcher, et al. (+12)
936 [GO] 2022―Jun―29 The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccine Thomas Hills, Aimee Paterson, Rebecca Woodward, Francis Middleton, Lauren H. Carlton, Reuben McGregor, et al. (+18)
937 [GO] 2022―Jun―27 The impact of personal coaching on influenza vaccination among healthcare workers before and during COVID-19 pandemic Shuk-Ching Wong, Veronica Wing-Man Chan, Germaine Kit-Ming Lam, Lithia Lai-Ha Yuen, Christine Ho-Yan AuYeung, Xin Li FRCPath, et al. (+4)
938 [GO] 2022―Jun―27 Employer Requirements and COVID-19 Vaccination and Attitudes among Healthcare Personnel in the U.S.: Findings from National Immunization Survey Adult COVID Module, August - September 2021 James T. Lee, S. Sean Hu, Tianyi Zhou, Kim Bonner, Jennifer L. Kriss, Elisabeth Wilhelm, et al. (+7)
939 [GO] 2022―Jun―27 Vaccine innovation model: A technology transfer perspective in pandemic contexts Maurício Z. Medeiros, Priscila F. Soares, Beatriz C. Fialho, Leandro Gauss, Fábio S. Piran, Daniel P. Lacerda
940 [GO] 2022―Jun―24 Artificial intelligence and clinical data suggest the T cell mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity Murat Seyran
941 [GO] 2022―Jun―24 COVID-19 Vaccine Safety monitoring in low and middle income countries - Time for a bold new approach Walter Straus, Harvey Rubin
942 [GO] 2022―Jun―24 Considerations for the Chemistry, Manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA) Ragini Shivji, Roberto Conocchia, Evdokia Korakianiti, Veronika Jekerle
943 [GO] 2022―Jun―23 COVID-19 differentiated measures for unvaccinated individuals: The need for clear goals and strong justifications Teck Chuan Voo, Julian Savulescu, Owen Schaefer, Abel Ho Zhi Ling, Clarence C. Tam
944 [GO] 2022―Jun―23 A national survey of COVID-19 vaccine acceptance in Nigeria Ahmad Ibrahim Al-Mustapha, Ochulor Okechukwu, Ademola Olayinka, Oyeniyi Rasheed Muhammed, Muftau Oyewo, Samuel A. Owoicho, et al. (+8)
945 [GO] 2022―Jun―23 Relationship between double covid-19 vaccine uptake and trust in effectiveness and safety of vaccination in 23 european member states: an ecological study Àurea Cartanyà-Hueso, Jose M Martínez-Sánchez, Juan Carlos Martín-Sánchez, Cristina Lidón-Moyano, Hipólito Pérez-Martín, Adrián González-Marrón
946 [GO] 2022―Jun―21 Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis Caroline Korves, Hector S. Izurieta, Jeremy Smith, Gabrielle M. Zwain, Ethan I. Powell, Abirami Balajee, et al. (+2)
947 [GO] 2022―Jun―20 BCG vaccine safety in COVID-19 convalescent adults: BATTLE a randomized controlled trial Franciele A.V. Dionato, Mehrsa Jalalizadeh, Keini Buosi, Marília B. Visacri, Luciana S.B. Dal Col, Cristiane F. Giacomelli, et al. (+4)
948 [GO] 2022―Jun―16 Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil Patricia Mouta Nunes de Oliveira, Daniela P. Mendes-de-Almeida, Victor Bertollo Gomes Porto, Catherine Crespo Cordeiro, Gabriellen Vitiello Teixeira, Renata Saraiva Pedro, et al. (+15)
949 [GO] 2022―Jun―15 Estimating the number of US children susceptible to measles resulting from COVID-19-related vaccination coverage declines Ashley Gambrell, Maria Sundaram, Robert A. Bednarczyk
950 [GO] 2022―Jun―15 Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design Rima Moghnieh, Dania Abdallah, Mohamed H. Sayegh, Abdul Rahman Bizri
951 [GO] 2022―Jun―15 Immunophenotyping of SARS-CoV-2 and vaccine design Nevio Cimolai
952 [GO] 2022―Jun―13 COVID-19 vaccination coverage and intent among women aged 18-49 years by pregnancy status, United States, April-November 2021 Hilda Razzaghi, David Yankey, Kushagra Vashist, Peng-jun Lu, Jennifer L. Kriss, Kimberly H Nguyen, et al. (+8)
953 [GO] 2022―Jun―13 RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice Abhishek Phatarphekar, G.E.C. Vidyadhar Reddy, Abhiram Gokhale, Gopala Karanam, Pushpa Kuchroo, Ketaki Shinde, et al. (+10)
954 [GO] 2022―Jun―09 A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273) Brett Leav, Walter Straus, Phil White, Alison Leav, Tashawnee Gaines, Grace Maggiacomo, et al. (+4)
955 [GO] 2022―Jun―08 The effect of health literacy on COVID-19 vaccine hesitancy among community population in China: The moderating role of stress Huiqiao Zhang, Yue Li, Sihui Peng, Yue Jiang, Huihui Jin, Fan Zhang
956 [GO] 2022―Jun―08 Safety and Protective Capability of an Inactivated SARS-CoV-2 Vaccine on Pregnancy, Lactation and the Growth of offspring in hACE2 Mice Kaili Lin, Meixuan Liu, Linlin Bao, Qi Lv, Hua Zhu, Dan Li, et al. (+17)
957 [GO] 2022―Jun―08 Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands: a test-negative case-control study F.A. Niessen, J. Mirjam Knol, J.M. Susan Hahné, VECTOR study group, M.J.M. Bonten, P.C.J.L. Bruijning-Verhagen
958 [GO] 2022―Jun―08 Shoulder Injury Related to Vaccine Administration (SIRVA) After COVID-19 Vaccination Jessica R. Bass, Gregory A. Poland
959 [GO] 2022―Jun―08 Corowa-kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021 Takaaki Kobayashi, Yuka Nishina, Hana Tomoi, Ko Harada, Kyuto Tanaka, Eiyu Matsumoto, et al. (+8)
960 [GO] 2022―Jun―07 The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study Elke Wynberg, Alvin X. Han, Anders Boyd, Hugo D.G. van Willigen, Anouk Verveen, Romy Lebbink, et al. (+8)
961 [GO] 2022―Jun―07 Safety of COVID-19 vaccination and acute neurological events: a self-controlled case series in England using the OpenSAFELY platform Jemma L Walker, Anna Schultze, John Tazare, Arina Tamborska, Bhagteshwar Singh, Katherine Donegan, et al. (+31)
962 [GO] 2022―Jun―06 A socio-ecological perspective on parents’ intention to vaccinate their children against COVID-19 Lauren Dayton, Jacob Miller, Justin Strickland, Melissa Davey-Rothwell, Carl Latkin
963 [GO] 2022―Jun―06 Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak Rabeh El-Shesheny, Ahmed El Taweel, Mokhtar R. Gomaa, Wael H. Roshdy, Ahmed Kandeil, Richard J. Webby, et al. (+2)
964 [GO] 2022―Jun―06 Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys Masayuki Hashimoto, Noriyo Nagata, Tomoyuki Homma, Hiroki Maeda, Keiji Dohi, Naomi M. Seki, et al. (+14)
965 [GO] 2022―Jun―06 Preclinical Evaluation of a Plant-derived SARS-CoV-2 Subunit Vaccine: Protective Efficacy, Immunogenicity, Safety, and Toxicity Balamurugan Shanmugaraj, Narach Khorattanakulchai, Chalisa Panapitakkul, Ashwini Malla, Rawiwan Im-erbsin, Manutsanun Inthawong, et al. (+13)
966 [GO] 2022―Jun―03 A “step too far” or “perfect sense”? A qualitative study of British adults’ views on mandating COVID-19 vaccination and vaccine passports Martine Stead, Allison Ford, Douglas Eadie, Hannah Biggs, Claire Elliott, Michael Ussher, et al. (+6)
967 [GO] 2022―May―30 COVID-19 IMPACT ON ROUTINE IMMUNISATIONS FOR VACCINE-PREVENTABLE DISEASES: PROJECTING THE EFFECT OF DIFFERENT ROUTES TO RECOVERY Jaspreet Toor, Xiang Li, Mark Jit, L. Caroline Trotter, Susy Echeverria-Londono, Anna-Maria Hartner, et al. (+5)
968 [GO] 2022―May―30 COVID-19 management landscape- A need for an affordable to manufacture safe and efficacious bio-therapeutic and prophylactic for developing countries Vyankatesh Pidiyar, Ganesh Kumraj, Kafil Ahmed, Syed Ahmed, Sanket Shah, Bhawna Verma, et al. (+2)
969 [GO] 2022―May―30 Comparative Effectiveness of Mandates and Financial Policies Targeting COVID-19 Vaccine Hesitancy: A Randomized, Controlled Survey Experiment Jessica Fishman, Mandy K. Salmon, Daniel Scheitrum, K. Aleks Schaefer, Christopher T. Robertson
970 [GO] 2022―May―30 Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: reports to the Vaccine Adverse Event Reporting System Emily Jane Woo, Rositsa B. Dimova
971 [GO] 2022―May―30 Nanomedicine to deliver biological macromolecules for treating COVID-19 Barnabas Wilson, Kannoth Mukundan Geetha
972 [GO] 2022―May―30 Utilizing Google trends to monitor coronavirus vaccine interest and hesitancies Emily Merrick, Joshua P. Weissman, Sameer J. Patel
973 [GO] 2022―May―27 Relationship Between the Use of Nonpharmaceutical Interventions and COVID-19 Vaccination Among U.S. Child Care Providers: A Prospective Cohort Study Kavin M. Patel, Mehr Shafiq, Amyn A. Malik, Ayse Cobanoglu, Madeline Klotz, John Eric Humphries, et al. (+10)
974 [GO] 2022―May―27 Benefit-Risk Evaluation of COVID-19 Vaccination in Special Population Groups of Interest Paul Moss, Francis Berenbaum, Giuseppe Curigliano, Ayelet Grupper, Thomas Berg, Shanti Pather
975 [GO] 2022―May―27 Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2 Gatot Soegiarto, Laksmi Wulandari, Dewajani Purnomosari, Karin Dhia Fahmita, Hendra Ikhwan Gautama, Satrio Tri Hadmoko, et al. (+20)
976 [GO] 2022―May―27 Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines Charlotte Dubé, Sarah Paris-Robidas, Guadalupe Andreani, Cindy Gutzeit, Marc-André D'Aoust, Brian J. Ward, Sonia Trépanier
977 [GO] 2022―May―27 COVID-19 and seasonal flu vaccination hesitancy: Links to personality and general intelligence in a large, UK cohort Isaac N. Halstead, Ryan T. McKay, Gary J. Lewis
978 [GO] 2022―May―25 Between persuasion and compulsion: The case of COVID-19 vaccination in Canada Eve Dubé, Dominique Gagnon, Noni MacDonald
979 [GO] 2022―May―25 Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: a Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines Natalia Abraham, Sarah Spruin, Tanya Rossi, Bruce Fireman, Joseline Zafack, Christine Blaser, et al. (+3)
980 [GO] 2022―May―20 A log-odds system for waning and boosting of COVID-19 vaccine effectiveness Joshua Szanyi, Tim Wilson, Nick Scott, Tony Blakely
981 [GO] 2022―May―19 Risk-based cost-benefit analysis of alternative vaccines against COVID-19 in Brazil: Coronavac vs. Astrazeneca vs. Pfizer Paulo Gabriel Siqueira, Heitor Oliveira Duarte, Márcio das Chagas Moura
982 [GO] 2022―May―19 Jabbing together? The complementarity between social capital, formal public health rules, and COVID-19 vaccine rates in the United States Byron Carson, Justin Isaacs, Tony Carilli
983 [GO] 2022―May―17 Parental socioeconomic and psychological determinants of the 2009 pandemic influenza A(H1N1) vaccine uptake in children Krista Salo-Tuominen, Tamara Teros-Jaakkola, Laura Toivonen, Helena Ollila, Päivi Rautava, Minna Aromaa, et al. (+3)
984 [GO] 2022―May―16 Experimental pre-tests of public health communications on the COVID-19 vaccine: A null finding for medical endorsement, risk and altruism Deirdre A. Robertson, Kieran S. Mohr, Martina Barjaková, Peter D. Lunn
985 [GO] 2022―May―14 Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam Anh Duc Dang, Thiem Dinh Vu, Ha Hai Vu, Van Thanh Ta, Anh Thi Van Pham, Mai Thi Ngoc Dang, et al. (+27)
986 [GO] 2022―May―14 Effects of vaccination status in the United States on willingness to undergo surgery during a pandemic: A prospective survey study Anna Clebone Ruskin, Stephen Rice, Michael O'Connor, Keith J. Ruskin
987 [GO] 2022―May―13 Catch-up vaccination campaign in children between 6 and 8 years old during COVID-19 pandemic: The experience in a COVID hub in Milan, Italy Matteo Mancarella, Federica Natarelli, Caterina Bertolini, Antonino Zagari, Maria Enrica Bettinelli, Silvana Castaldi
988 [GO] 2022―May―13 Phase 1/2 Clinical Trial of COVID-19 Vaccine in Japanese Participants: A Report of Interim Findings Satoshi Iwata, Takuhiro Sonoyama, Akari Kamitani, Risa Shibata, Tomoyuki Homma, Shinya Omoto, et al. (+2)
989 [GO] 2022―May―13 COVID-19 vaccine uptake and its associated factors among Palestinian healthcare workers: Expectations beaten by reality Walaa Abu Alia, Beesan Maraq, Zaher Nazzal, Mahmoud Odeh, Rabee Makhalfa, Ali Nassif, Mousa Aabed
990 [GO] 2022―May―12 Safety of Pfizer-BioNTech vaccine in a cohort of healthcare providers: differences between naïve and previously infected by SARS-CoV-2 Andrea Chong-Valbuena, Isabel De-Jesús-María, Adriana Agurto-Ramírez, Francesc Puchades-Gimeno, Mercedes Melero-García
991 [GO] 2022―May―11 Acceptability of COVID-19 vaccine mandates among New York City parents, November 2021 Chloe A. Teasdale, Scott Ratzan, Hannah Stuart Lathan, Lauren Rauh, Spencer Kimball, Ayman El-Mohandes
992 [GO] 2022―May―11 Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measures Frederic Reicherz, Liam Golding, Pascal M Lavoie, Bahaa Abu-Raya
993 [GO] 2022―May―08 Impact of National Covid-19 Vaccination Campaign, South Korea Seonju Yi, Young June Choe, Do Sang Lim, Hye Roen Lee, Jia Kim, Yoo-Yeon Kim, et al. (+6)
994 [GO] 2022―May―08 Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern Jeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, Leroy Versteeg, Brian Keegan, Bin Zhan, et al. (+16)
995 [GO] 2022―May―07 Flu and pertussis vaccination during pregnancy in Geneva during the COVID-19 pandemic: A multicentric, prospective, survey-based study M. Lumbreras Areta, A. Valiton, A. Diana, M. Morales, J. Wiederrecht-Gasser, S. Jacob, et al. (+5)
996 [GO] 2022―May―06 Building population and health system resilience: Using lessons learned during the COVID pandemic to implement life-course immunisation policy Sandra Evans, Daphné Holt, Catherine Weil-Olivier, Gary Finnegan, Vytautas Usonis
997 [GO] 2022―May―05 Measuring parents’ readiness to vaccinate themselves and their children against COVID-19 Franziska Rees, Mattis Geiger, Lau Lilleholt, Ingo Zettler, Cornelia Betsch, Robert Böhm, Oliver Wilhelm
998 [GO] 2022―May―05 COVID-19 and seasonal influenza: The potential 2021-22 “Twindemic” Saverio Bellizzi, Catello M. Panu Napodano, Sergio Pinto, Giuseppe Pichierri
999 [GO] 2022―May―05 Prevalence and factors of influenza vaccination during the COVID-19 pandemic among university students in China Yanqiu Yu, Yee-ling Ma, Sitong Luo, Suhua Wang, Junfeng Zhao, Guohua Zhang, et al. (+3)
1000 [GO] 2022―May―05 Characteristics associated with the willingness to receive a COVID-19 vaccine and an exploration of the general public's perceptions: A mixed-methods approach Norina Gasteiger, Chiara Gasteiger, Kavita Vedhara, Elizabeth Broadbent
1001 [GO] 2022―May―05 Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries Jeanna Parsons Leigh, Stephana J. Moss, Trenton M. White, Camila A. Picchio, Kenneth H. Rabin, Scott C. Ratzan, et al. (+3)
1002 [GO] 2022―May―05 Covid-19 vaccine immunogenicity in people living with HIV-1 Lauriane Nault, Lorie Marchitto, Guillaume Goyette, Daniel Tremblay-Sher, Claude Fortin, Valérie Martel-Laferrière, et al. (+6)
1003 [GO] 2022―May―03 Readability of COVID-19 Vaccine Information for the General Public Luke S. Bothun, Scott E. Feeder, Gregory A. Poland
1004 [GO] 2022―May―02 Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization Daniel R. Feikin, Laith J. Abu-Raddad, Nick Andrews, Mary-Ann Davies, Melissa M. Higdon, Walter A. Orenstein, Minal K. Patel
1005 [GO] 2022―Apr―28 Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies Basharat Hussain, Asam Latif, Stephen Timmons, Kennedy Nkhoma, Laura B. Nellums
1006 [GO] 2022―Apr―27 Commentary: “The vaccine Selfie” and its influence on COVID-19 vaccine acceptance Netana H. Markovitz, Arianna L. Strome, Payal K. Patel
1007 [GO] 2022―Apr―27 Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients Erol Demir, Hamad Dheir, Seda Safak, Ayse Serra Artan, Savas Sipahi, Aydin Turkmen
1008 [GO] 2022―Apr―27 Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance Sharifa Nasreen, Andrew Calzavara, Sarah A. Buchan, Nisha Thampi, Caitlin Johnson, Sarah E. Wilson, Jeffrey C. Kwong
1009 [GO] 2022―Apr―23 War, pandemic and vaccination - Upcoming health problems by the refugee wave in Europe? Antonio Perciaccante, Victor Asensi, Andrei I. Cucu, Philippe Charlier, Simon T. Donell, Andreas G. Nerlich, Raffaella Bianucci
1010 [GO] 2022―Apr―22 Self-Reported COVID-19 Vaccination Acceptance and Hesitancy among Autistic Adults Lindsay L. Shea, Alec Becker, Brian K. Lee, Kaitlin Koffer Miller, Dylan Cooper, Kristy Anderson, et al. (+2)
1011 [GO] 2022―Apr―22 COVID-19 vaccinations in Bhutan - Mix-and-Match to Boosters: an experience Saran Tenzin Tamang, Thinley Dorji
1012 [GO] 2022―Apr―22 SARS-CoV-2 immunogenicity: is S protein the best target for vaccination? Tania Antonopoulou, Irene Athanassakis
1013 [GO] 2022―Apr―22 Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: a population-based register study with implications to vaccinations Heini Salo, Toni Lehtonen, Kari Auranen, Ulrike Baum, Tuija Leino
1014 [GO] 2022―Apr―18 Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers Anastasia Saade, Leo Cha, Emilie Tadié, Bruno Jurado, Alix Le Bihan, Pauline Baron-Latouche, et al. (+5)
1015 [GO] 2022―Apr―18 De-escalation of asymptomatic testing and potential of future COVID-19 outbreaks in U.S. nursing homes amidst rising community vaccination coverage: a modeling study Brajendra K. Singh, Joseph Walker, Prabasaj Paul, Sujan Reddy, Camden D. Gowler, John Jernigan, Rachel B. Slayton
1016 [GO] 2022―Apr―18 Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic Stanley Xu, Vennis Hong, Lina S. Sy, Sungching C. Glenn, Denison S. Ryan, Kerresa Morrissette, et al. (+10)
1017 [GO] 2022―Apr―18 Impact of COVID-19 Vaccine-Associated Side Effects on Health Care Worker Absenteeism and Future Booster Vaccination Ara A. Chrissian, Udochukwu E. Oyoyo, Pranjal Patel, W. Lawrence Beeson, Lawrence K. Loo, Shahriyar Tavakoli, Alex Dubov
1018 [GO] 2022―Apr―18 Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: real-world data Nasamon Wanlapakorn, Nungruthai Suntronwong, Harit Phowatthanasathian, Ritthideach Yorsaeng, Thanunrat Thongmee, Preeyaporn Vichaiwattana, et al. (+5)
1019 [GO] 2022―Apr―18 Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters Lei Li, Yoshikazu Honda-Okubo, Jeremy Baldwin, Richard Bowen, Helle Bielefeldt-Ohmann, Nikolai Petrovsky
1020 [GO] 2022―Apr―12 Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the Vaccine Adverse Event Reporting System (VAERS), December 2020 - October 2021 Pedro L. Moro, Christine K. Olson, Elizabeth Clark, Paige Marquez, Penelope Strid, Sascha Ellington, et al. (+5)
1021 [GO] 2022―Apr―12 Screening for SARS-CoV-2 antibodies to save vaccine doses Florence Fenollar, Laurence Thomas, Didier Raoult, Philippe Gautret
1022 [GO] 2022―Apr―12 Increased Delta variant SARS-CoV-2 infections in a highly vaccinated medical center in Japan Yan Yan, Toshio Naito, Yoko Tabe, Kanami Ito, Shuko Nojiri, Gautam A. Deshpande, et al. (+2)
1023 [GO] 2022―Apr―12 VACCINE EFFECTIVENESS AGAINST ONWARD TRANSMISSION OF SARS-COV2-INFECTION BY VARIANT OF CONCERN AND TIME SINCE VACCINATION, BELGIAN CONTACT TRACING, 2021 Toon Braeye, Lucy Catteau, Ruben Brondeel, Joris van Loenhout, Kristiaan Proesmans, Laura Cornelissen, et al. (+9)
1024 [GO] 2022―Apr―11 A Case Of Myocarditis And Isolated Hypopotassemia After Biontech-Pfizer Vaccine For Covid-19 Mehmet Emin Ceylan, Barış Önen Ünsalver, Aslıhan Dönmez, Fatma Duygu Kaya Yertutanol, Alper Evrensel, Hatice Zeynep Ceylan
1025 [GO] 2022―Apr―11 Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era Masayoshi Shinjoh, Munehiro Furuichi, Hisato Kobayashi, Yoshio Yamaguchi, Naonori Maeda, Mizuki Yaginuma, et al. (+18)
1026 [GO] 2022―Apr―11 Evaluation of weekly Covid-19 vaccination and case data supports negative correlation between incidence and vaccination in German federal states and cities during 4th wave Steffen Springer, Martin Kaatz, Michael Zieger
1027 [GO] 2022―Apr―11 Patterns and influencing factors of COVID-19 vaccination willingness among college students in China Xi-Mei Zhu, Wei Yan, Jie Sun, Lin Liu, Yi-Miao Zhao, Yong-Bo Zheng, et al. (+15)
1028 [GO] 2022―Apr―11 Need for a contingency dimension when planning vaccine development in a pandemic environment Paul Beninger
1029 [GO] 2022―Apr―11 Differences by region of birth in SARS-CoV-2 vaccine coverage and positive SARS-CoV-2 test among 400 000 healthcare workers and the general population in Sweden Rickard Ljung, Maria Feychting, Bo Burström, Jette Möller
1030 [GO] 2022―Apr―08 Impact of COVID-19 immunisation on COVID-19 incidence, hospitalisations, and deaths by age group in Germany from December 2020 to October 2021 Nita Perumal, Annika Steffen, Alexander Ullrich, Anette Siedler
1031 [GO] 2022―Apr―08 Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine Helen J. Mayfield, Colleen L. Lau, Jane E. Sinclair, Samuel J. Brown, Andrew Baird, John Litt, et al. (+4)
1032 [GO] 2022―Apr―08 Ask Me Anything”: Lessons learned in implementing a COVID-19 vaccine information initiative in Massachusetts jails Parsa Erfani, Raquel Sofia Sandoval, Katherine M. Rich, Ayotomiwa Ojo, Liz Walker MDiv, Gloria White-Hammond, et al. (+2)
1033 [GO] 2022―Apr―08 Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink Tat'Yana A. Kenigsberg, Anne M. Hause, Michael M. McNeil, Jennifer C. Nelson, Jo Ann Shoup, Kristin Goddard, et al. (+4)
1034 [GO] 2022―Apr―07 Extended Reporting Guidance for Vaccine Effectiveness Studies for Variants of Concern for COVID-19 Lori-Ann Linkins, Alfonso Iorio, Julian Little, John Lavis
1035 [GO] 2022―Apr―07 Factors associated with the intention to participate in COVID-19 vaccine clinical trials: A cross-sectional study in Peru Abraham De-Los-Rios-Pinto, Daniel Fernandez-Guzman, David R. Soriano-Moreno, Lucero Sangster-Carrasco, Noelia Morocho-Alburqueque, Antony Pinedo-Soria, et al. (+5)
1036 [GO] 2022―Apr―05 Factors associated with COVID-19 vaccination intent in Singapore, Australia and Hong Kong Shimoni Shah, Hao Gui, Pearleen Ee Yong Chua, Jing-Yu Benjamin Tan, Lorna Kwai-ping Suen, Sally Wai-chi Chan, Junxiong Pang
1037 [GO] 2022―Apr―04 Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates Jewell N. Walters, Blake Schouest, Ami Patel, Emma L. Reuschel, Katherine Schultheis, Elizabeth Parzych, et al. (+18)
1038 [GO] 2022―Apr―01 Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: evidence from an outbreak in Yunnan, China, 2021 Chao Ma, Weiwei Sun, Tingting Tang, Manhong Jia, Yonghua Liu, Yongfang Wan, et al. (+12)
1039 [GO] 2022―Apr―01 A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model Rebecca Frise, Laury Baillon, Jie Zhou, Ruthiran Kugathasan, Thomas P. Peacock, Jonathan C. Brown, et al. (+4)
1040 [GO] 2022―Apr―01 Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for Vaccine Strategies MA. Sughayer, L. Souan, MM. Abu Alhowr, D. Al Rimawi, M. Siag, S. Albadr. M. Owdeh, T. Al Atrash
1041 [GO] 2022―Mar―29 Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic Kun Li, Tianzhou Yu, Seth A. Seabury, Avi Dor
1042 [GO] 2022―Mar―29 Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination Hideaki Kato, Kei Miyakawa, Norihisa Ohtake, Yutaro Yamaoka, Satoshi Yajima, Etsuko Yamazaki, et al. (+4)
1043 [GO] 2022―Mar―29 The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden Catherine Isitt, Daniel Sjöholm, Maria-Pia Hergens, Fredrik Granath, Pontus Nauclér
1044 [GO] 2022―Mar―28 Supporting Immunization Programs to Address COVID-19 Vaccine Hesitancy: Recommendations for National and Community-Based Stakeholders Katelyn Wells, Kelly L. Moore, Robert Bednarczyk
1045 [GO] 2022―Mar―28 Benefit-Risk Assessment of COVID-19 Vaccine, mRNA (Comirnaty) for Age 16-29 years Patrick R. Funk, Osman N. Yogurtcu, Richard A. Forshee, Steve A. Anderson, Peter W. Marks, Hong Yang
1046 [GO] 2022―Mar―28 Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine Vanessa Juddoo, Sonia Juddoo, Bruno Mégarbane
1047 [GO] 2022―Mar―25 Disparities in COVID-19 Vaccine Uptake Among Health Care Workers Wigdan Farah, Laura Breeher, Vishal Shah, Caitlin Hainy, Christopher P. Tommaso, Melanie D. Swift
1048 [GO] 2022―Mar―25 Understanding COVID-19 Vaccine Uptake during Pregnancy:‘Hesitance’, Knowledge, and Evidence-Based Decision-Making Leigh Ann Simmons, Mackenzie DM Whipps, Jennifer E Phipps, Nikita S Satish, Geeta K. Swamy
1049 [GO] 2022―Mar―24 IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine Derar H. Abdel-Qader, Issa Hazza Alkhatatbeh, Wail Hayajneh, Hassan Annab, Ahmad Z. Al Meslamani, Reem A. Elmusa
1050 [GO] 2022―Mar―22 Decreasing routine vaccination rates in children in the COVID-19 era Helena C. Maltezou, Snezana Medic, Dimitrios C. Cassimos, Evgnosia Effraimidou, Gregory A. Poland
1051 [GO] 2022―Mar―22 Effectiveness of the Comirnaty and the Vaxzevria vaccines in preventing SARS-CoV-2 infection among residents in Lazio region (Italy) Valeria Fano, Alessia Crielesi, Enzo Coviello, Massimo Fabiani, Antonio Salvatore Miglietta, Giovanni Colaiocco, et al. (+5)
1052 [GO] 2022―Mar―21 SIRVA (Shoulder Injury Related to Vaccine Administration) following mRNA COVID-19 Vaccination: Case discussion and literature review Wen Loong Paul Yuen, Sir Young James Loh, Dehao Bryan Wang
1053 [GO] 2022―Mar―21 Why do Hong Kong parents have low intention to vaccinate their children against COVID-19? testing health belief model and theory of planned behavior in a large-scale survey Jian-Bin Li, Eva Yi Hung Lau, Derwin King Chung Chan
1054 [GO] 2022―Mar―18 The Effect of Immunization with Inactivated SARS-CoV-2 Vaccine (CoronaVac) and/or SARS-CoV-2 Infection on Antibody Levels, Plasmablasts, Long-lived-plasma-cells, and IFN-γ Release by Natural Killer Cells Huseyin Bilgin, Marisa Marku, Sultan Seval Yilmaz, Aysegul Karahasan Yagci, Uluhan Sili, Baris Can, et al. (+5)
1055 [GO] 2022―Mar―17 Erratum to ““Cultivating” acceptance of a COVID-19 vaccination program: Lessons from Italy” [Vaccine 38(48) (2020) 7585-7586] Guendalina Graffigna, Lorenzo Palamenghi, Serena Barello, Stefania Boccia
1056 [GO] 2022―Mar―17 A candidate multi-epitope vaccine against porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae induces robust humoral and cellular response in mice Zhisong Gao, Lingxiao Chen, Tao Song, Xuan Pan, Xiaojing Li, Guangzong Lu, et al. (+4)
1057 [GO] 2022―Mar―15 Hesitancy towards COVID-19 vaccines on social media in Canada Bobbi Rotolo, Eve Dubé, Maryline Vivion, Shannon E. MacDonald, Samantha B. Meyer
1058 [GO] 2022―Mar―15 SARS-CoV-2 outbreak in a nursing home after vaccination with BNT162b2: a role for the quantification of circulating antibodies Jordi Càmara, Aida González-Díaz, Irene Barrabeig, Miguel Fernández-Huerta, Laura Calatayud, Jordi Niubó, et al. (+3)
1059 [GO] 2022―Mar―14 Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy and resistance in the young adult population in Italy Ughetta Moscardino, Pasquale Musso, Cristiano Inguglia, Chiara Ceccon, Diana Miconi, Cécile Rousseau
1060 [GO] 2022―Mar―09 Healthcare Worker Perspectives on COVID-19 Vaccines: Implications for Increasing Vaccine Acceptance among Healthcare Workers and Patients Christine M. Thomas, Kelly Searle, Alma Galván, Amy K Liebman, Erin M. Mann, Jonathan D. Kirsch, William M. Stauffer
1061 [GO] 2022―Mar―09 Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination? Lotus L. van den Hoogen, Gaby Smits, Cheyenne C.E. van Hagen, Denise Wong, Eric R.A. Vos, Michiel van Boven, et al. (+15)
1062 [GO] 2022―Mar―07 Political Attitudes and Efficacy of Health Expert Communication on the Support for COVID-19 Vaccination Program: Findings from a Survey in Hong Kong Vera Wing Han YUEN
1063 [GO] 2022―Mar―07 COVID-19 vaccine preferences in India Prateek Bansal, Alok Raj, Dhirendra Mani Shukla, Naveen Sunder
1064 [GO] 2022―Mar―03 COVID-19 vaccine intention among young adults: Comparative results from a cross-sectional study in Canada and France Pierre-julien Coulaud, Aidan Ablona, Naseeb Bolduc, Danya Fast, Karine Bertrand, Jeremy Ward, et al. (+3)
1065 [GO] 2022―Mar―03 Public opinion on global distribution of COVID-19 vaccines: evidence from two nationally representative surveys in Germany and the United States Matthias Klumpp, Ida G. Monfared, Sebastian Vollmer
1066 [GO] 2022―Mar―03 IgG antibody production and persistence to 6 months following SARS-CoV-2 vaccination: a Northern Ireland observational study Louise J. Robertson, Ruth Price, Julie S. Moore, Grace Curry, John Farnan, Amy Black, et al. (+4)
1067 [GO] 2022―Mar―02 How do COVID-19 vaccine mandates affect attitudes toward the vaccine and participation in mandate-affected activities? Evidence from the United States S.E. Kreps, D.L. Kriner
1068 [GO] 2022―Mar―01 The impact of COVID-19 on routine pediatric vaccination delivery in Brazil Carolina Moura, Paul Truche, Lucas Sousa Salgado, Thiaro Meireles, Vitor Santana, Alexandra Buda, et al. (+3)
1069 [GO] 2022―Feb―28 Aggregating human judgment probabilistic predictions of the safety, efficacy, and timing of a COVID-19 vaccine Thomas McAndrew, Juan Cambeiro, Tamay Besiroglu
1070 [GO] 2022―Feb―28 WHO Guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: ethical considerations Jerome Amir Singh, Sonali Kochhar, Jonathan Wolff, Caesar Atuire, Anant Bhan, Ezekiel Emanuel, et al. (+10)
1071 [GO] 2022―Feb―28 Nepal Measles outbreak response immunization during COVID-19: a risk-based intervention strategy Anindya Sekhar Bose, Pasang Rai, Binod Prasad Gupta, Rahul Pradhan, Mona Lacoul, Sushil Shakya, et al. (+10)
1072 [GO] 2022―Feb―25 Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2 Takahiro Kageyama, Shigeru Tanaka, Keishi Etori, Koto Hattori, Kazusa Miyachi, Tadamichi Kasuya, et al. (+5)
1073 [GO] 2022―Feb―22 Monitoring COVID-19 vaccine use in Italian Long Term Care Centers: the GeroCovid VAX Study Angela Marie Abbatecola, Raffaele Antonelli Incalzi, Alba Malara, Annapina Palmieri, Anna Di Lonardo, Giorgio Fedeli, et al. (+19)
1074 [GO] 2022―Feb―22 Understanding the Influence of Political Orientation, Social Network, and Economic Recovery on COVID-19 Vaccine Uptake among Americans Feng Hao, Wanyun Shao
1075 [GO] 2022―Feb―21 Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, et al. (+3)
1076 [GO] 2022―Feb―18 Couples and COVID-19 Vaccination: Frequency and Reasons for Discordance Karen B. Schmaling
1077 [GO] 2022―Feb―17 The correlates and dynamics of COVID-19 vaccine-specific hesitancy Eric Merkley, Peter John Loewen
1078 [GO] 2022―Feb―17 Localising vaccination services: Qualitative insights on public health and minority group collaborations to co-deliver coronavirus vaccines Ben Kasstan, Sandra Mounier-Jack, Louise Letley, Katherine M. Gaskell, Chrissy H. Roberts, Neil R.H. Stone, et al. (+4)
1079 [GO] 2022―Feb―17 The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats Bartlomiej Kalaska, Joanna Miklosz, Justyna Swieton, Aleksandra Jakimczuk, Dariusz Pawlak, Andrzej Mogielnicki
1080 [GO] 2022―Feb―16 Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by Sars-CoV-2 infection: an Italian prospective observational study Pasquale Stefanizzi, Angela Maria Vittoria Larocca, Andrea Martinelli, Savino Soldano, Maria Dell'Aera, Giovanni Migliore, et al. (+4)
1081 [GO] 2022―Feb―15 Influenza virus vaccine compliance among pregnant women during the COVID-19 pandemic (pre-vaccine era) in Israel and future intention to uptake BNT162b2 mRNA COVID-19 vaccine Ola Ali Saleh, Ofra Halperin
1082 [GO] 2022―Feb―15 A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies Franciscary Pi-Estopiñan, Maria Teresa Pérez, Anitza Fraga, Gretchen Bergado, Geidy D. Diaz, Ivette Orosa, et al. (+12)
1083 [GO] 2022―Feb―15 How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situation Mic McGoldrick, Thierry Gastineau, Diane Wilkinson, Cristiana Campa, Norbert De Clercq, Andrea Mallia-Milanes, et al. (+14)
1084 [GO] 2022―Feb―15 How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation Mic McGoldrick, Thierry Gastineau, Diane Wilkinson, Cristiana Campa, Norbert De Clercq, Andrea Mallia-Milanes, et al. (+15)
1085 [GO] 2022―Feb―14 Ethics review of COVID-19 human challenge studies: a joint HRA/WHO workshop Eloise Williams, Kathrine Craig, Christopher Chiu, Hugh Davies, Stephanie Ellis, Claudia Emerson, et al. (+15)
1086 [GO] 2022―Feb―14 Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine Shohei Yamamoto, Ami Fukunaga, Akihito Tanaka, Junko S. Takeuchi, Yosuke Inoue, Moto Kimura, et al. (+6)
1087 [GO] 2022―Feb―14 Promoting Immunization Equity in Latin America and the Caribbean: Case Studies, Lessons Learned and their Implication for COVID-19 Vaccine Equity Isabella L. Chan, Robin Mowson, Juan Pedro Alonso, Javier Roberti, Marcela Contreras, Martha Velandia-González
1088 [GO] 2022―Feb―14 Mumps to COVID-19: Vaccinated Persons Remain Vulnerable When Community Uptake Is Low Kristin K. Gaffney, M. Jana Broadhurst, David M. Brett-Major
1089 [GO] 2022―Feb―14 The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals Yoshifumi Uwamino, Takashi Yokoyama, Takako Shimura, Tomoyasu Nishimura, Yasunori Sato, Masatoshi Wakui, et al. (+3)
1090 [GO] 2022―Feb―14 Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine Fan Gao, Chaoqiang An, Lianlian Bian, Yiping Wang, Jialu Zhang, Bopei Cui, et al. (+12)
1091 [GO] 2022―Feb―14 Unmet need for COVID-19 vaccination coverage in Kenya Samuel K. Muchiri, Rose Muthee, Hellen Kiarie, Joseph Sitienei, Ambrose Agweyu, Peter M. Atkinson, et al. (+3)
1092 [GO] 2022―Feb―11 “On the last day of the last month, I will go”: A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults Natalie Tibbels, Abdul Dosso, Corinne Fordham, William Benie, Jeanne Aka Brou, Diarra Kamara, et al. (+2)
1093 [GO] 2022―Feb―11 Public perceptions and the willingness to get vaccinated against COVID-19: Lessons from Israel Oren Heller, Yung Chun, Yaniv Shlomo, Ateret Gewirtz-Meydan, Mary Acri, Saneel Kulkarni, Michal Grinstein-Weiss
1094 [GO] 2022―Feb―10 Impact of vaccination status on mortality among symptomatic COVID-19 patients during the second wave of the pandemic: a cohort study Kundavaram Paul Prabhakar Abhilash, Ponnivalavan Mathiyalagan, Vivek Raja K. Krishnaraj, Saravanan Selvan, Rohini Kanagarajan, Narmadha P. Reddy, et al. (+17)
1095 [GO] 2022―Feb―09 How frequent are acute reactions to COVID-19 vaccination and who is at risk? Nancy Dreyer, Matthew W Reynolds, Lisa Albert, Emma Brinkley, Tom Kwon, Christina Mack, Stephen Toovey
1096 [GO] 2022―Feb―09 Effectiveness of Covishield vaccine in preventing Covid-19 - A test-negative case-control study Stuti Pramod, Dhanajayan Govindan, Premkumar Ramasubramani, Sitanshu Sekhar Kar, Rakesh Aggarwal
1097 [GO] 2022―Feb―08 Impact of the COVID-19 pandemic on routine immunization coverage in children under 2 years old in Ontario, Canada: A retrospective cohort study Catherine Ji, Pierre-Philippe Piché-Renaud, Jemisha Apajee, Ellen Stephenson, Milena Forte, Jeremy N. Friedman, et al. (+4)
1098 [GO] 2022―Feb―08 A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: safety, reactogenicity and immunogenicity Sonia Pérez-Rodríguez, Meiby de la Caridad Rodríguez-González, Rolando Ochoa-Azze, Yanet Climent-Ruiz, Carlos Alberto González-Delgado, Beatriz Paredes-Moreno, et al. (+22)
1099 [GO] 2022―Feb―08 A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: an interim report Taisei Masuda, Kyoko Murakami, Kenkichi Sugiura, Sho Sakui, Ron Philip Schuring, Mitsuhiro Mori
1100 [GO] 2022―Feb―07 Conspiracy theories and misinformation about COVID-19 in Nigeria: implications for vaccine demand generation communications Chizoba Wonodi, Chisom Obi-Jeff, Funmilayo Adewumi, Somto Chloe Keluo-Udeke, Rachel Gur-Arie, Carleigh Krubiner, et al. (+4)
1101 [GO] 2022―Feb―07 The impact of COVID-19 on income and employment and willingness to become vaccinated among African Americans enrolled in a smoking cessation randomized trial Erica Cruvinel, Kimber Richter, Taneisha Scheuermann, Nathalia Munck Machado, Matthew S. Mayo, Alexandra Brown, Nikki Nollen
1102 [GO] 2022―Feb―07 Attitude toward a mandatory COVID-19 vaccination policy and its determinants: Evidence from serial cross-sectional surveys conducted throughout the pandemic in Germany Philipp Sprengholz, Lars Korn, Sarah Eitze, Lisa Felgendreff, Regina Siegers, Laura Goldhahn, et al. (+4)
1103 [GO] 2022―Feb―07 Myocarditis following mRNA Covid-19 vaccination: a pooled analysis Ioannis Bellos, Vasilios Karageorgiou, Dana Viskin
1104 [GO] 2022―Feb―07 Towards a Predictive Model of COVID-19 Vaccine Hesitancy among American Adults Jack Mewhirter, Mustafa Sagir, Rebecca Sanders
1105 [GO] 2022―Feb―07 Effect of the 2020/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers Alexander Domnich, Andrea Orsi, Laura Sticchi, Donatella Panatto, Guglielmo Dini, Allegra Ferrari, et al. (+7)
1106 [GO] 2022―Feb―07 Modeling Strategies for the Allocation of SARS-CoV-2 Vaccines in the United States Joseph Walker, Prabasaj Paul, Kathleen Dooling, Sara Oliver, Pragati Prasad, Molly Steele, et al. (+4)
1107 [GO] 2022―Feb―04 Exploring the attitudes, concerns, and knowledge regarding COVID-19 vaccine by the parents of children with rheumatic disease: Cross-sectional online survey Özlem Akgün, Gülşah Kavrul Kayaalp, Fatma Gül Demirkan, Figen Çakmak, Ayşe Tanatar, Vefa Guliyeva, et al. (+2)
1108 [GO] 2022―Feb―04 Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC Tool Justice Nonvignon, Richmond Owusu, Brian Asare, Alex Adjagba, Wei Aund, Yeung Karene Hoi Ting, et al. (+9)
1109 [GO] 2022―Feb―03 Italy’s rollout of COVID-19 vaccinations: the crucial contribution of the first experimental mass vaccination site in Lombardy Francesco Oliani, Antonella Savoia, Giulia Gallo, Navpreet Tiwana, Matteo Letzgus, Flaminia Gentiloni, et al. (+5)
1110 [GO] 2022―Feb―01 COVID-19 vaccination intention and behavior in a large, diverse, U.S. refugee population Jana Shaw, Kathryn B. Anderson, Rachel E. Fabi, Carlie A. Thompson, Megan Harris, Nidaa Aljabbarin, et al. (+6)
1111 [GO] 2022―Feb―01 Looking Ahead: Caregivers’ COVID-19 vaccination intention for children 5 years old and younger using the health belief model Morgan E. Ellithorpe, Fashina Aladé, Robyn B. Adams, Glen J. Nowak
1112 [GO] 2022―Feb―01 Conditionality of COVID-19 vaccine acceptance in European countries Leonardo W. Heyerdahl, Muriel Vray, Benedetta Lana, Nastassia Tvardik, Nina Gobat, Marta Wanat, et al. (+4)
1113 [GO] 2022―Feb―01 Immunity Debt or Vaccination Crisis? A Multi-Method Evidence on Vaccine Acceptance and Media Framing for Emerging COVID-19 Variants Muhammad Yousaf, Syed Hassan Raza, Nasir Mahmood, Rachel Core, Umer Zaman, Aqdas Malik
1114 [GO] 2022―Jan―31 Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452 Yester F. Janssen, Eline A. Feitsma, Hendrikus H. Boersma, David G. Alleva, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, et al. (+17)
1115 [GO] 2022―Jan―26 Worldwide routine immunisation coverage regressed during the first year of the COVID-19 pandemic Beth Evans, Thibaut Jombart
1116 [GO] 2022―Jan―26 The Role of Perceived Social Norms in College Student Vaccine Hesitancy: Implications for COVID-19 Prevention Strategies Anna E. Jaffe, Scott Graupensperger, Jessica A. Blayney, Jennifer C. Duckworth, Cynthia A. Stappenbeck
1117 [GO] 2022―Jan―24 B-CELL CYTOPENIA AND TIME TO LAST B-CELL-DEPLETING THERAPY PREDICT RESPONSE TO SARS-COV-2 VACCINES IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS Mégane Tanguay, Marianne Boutin, Annemarie Laumaea, Matthew Salaciak, Alma Mendoza, Chantal Cassis, et al. (+6)
1118 [GO] 2022―Jan―20 Priming with social benefit information of vaccination to increase acceptance of COVID-19 vaccines Qiuyan Liao, Benjamin J Cowling, Jingyi Xiao, Jiehu Yuan, Meihong Dong, Michael Y Ni, et al. (+2)
1119 [GO] 2022―Jan―20 An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines Fei Liu, Canbin Feng, Shiqi Xu, Qiang Wu, Jian Tang, Yan Chen, et al. (+9)
1120 [GO] 2022―Jan―19 Reducing the Rates of Household Transmission: The Impact of COVID-19 Vaccination in Healthcare Workers with a Known Household Exposure Catherine L. Passaretti, Jennifer S. Priem, Tammie G. Agner, Lewis McCurdy
1121 [GO] 2022―Jan―19 Impact of Prior SARS-CoV-2 Infection on Incidence of Hospitalization and Adverse Events Following mRNA SARS-CoV-2 vaccination: A Nationwide, Retrospective Cohort Study Lucy Li, Chunlei Zheng, Jennifer La, Nhan Do, Paul Monach, Judith Strymish, et al. (+2)
1122 [GO] 2022―Jan―19 A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice Laura Lazo, Monica Bequet-Romero, Gilda Lemos, Alexis Musacchio, Ania Cabrales, Andy J. Bruno, et al. (+8)
1123 [GO] 2022―Jan―19 Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine Jacob Pitcovski, Nady Gruzdev, Anna Abzach, Chen Katz, Ran Ben-Adiva, Michal Brand-Shwartz, et al. (+15)
1124 [GO] 2022―Jan―17 COVID-19 vaccine reactogenicity - A cohort event monitoring study in the Netherlands using patient reported outcomes Leàn Rolfes, Linda Härmark, Agnes Kant, Leontine van Balveren, Wil Hilgersom, Florence van Hunsel
1125 [GO] 2022―Jan―15 COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales Stuart Bedston, Ashley Akbari, Christopher I. Jarvis, Emily Lowthian, Fatemeh Torabi, Laura North, et al. (+19)
1126 [GO] 2022―Jan―12 Adolescents’ attitudes to the COVID-19 Vaccination W.H.S. Wong, D. Leung, G.T. Chua, J.S.R. Duque, S. Peare, H.K. So, et al. (+4)
1127 [GO] 2022―Jan―10 Factors Associated with COVID-19 Vaccination Intentions among Adults in the Deep South Casey L. Daniel, Jacob Williams, Rachel Legg, Chelsea Green, Jesse Stutzman
1128 [GO] 2022―Jan―10 Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine Kah-Whye Peng, Timothy Carey, Patrycja Lech, Rianna Vandergaast, Miguel Á. Muñoz-Alía, Nandakumar Packiriswamy, et al. (+24)
1129 [GO] 2022―Jan―07 Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and university staff Yoshifumi Uwamino, Toshinobu Kurafuji, Yasunori Sato, Yukari Tomita, Ayako Shibata, Akiko Tanabe, et al. (+12)
1130 [GO] 2022―Jan―05 Understanding COVID-19 vaccination willingness among youth: A survey study in the Netherlands Saskia Euser, Floor M. Kroese, Mare Derks, Marijn de Bruin
1131 [GO] 2022―Jan―01 Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: A database analysis Stephanie A. Kujawski, Lixia Yao, Echo Wang, Cristina Da Silva Carias, Ya-Ting Chen
1132 [GO] 2021―Dec―31 Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice Amy V. Paschall, Ahmet Ozdilek, Sydney L. Briner, Melinda A. Brindley, Fikri Y. Avci
1133 [GO] 2021―Dec―30 Protection against avian coronavirus conferred by oral vaccination with live bacteria secreting LTB-fused viral proteins Avishai Lublin, Chen Katz, Nady Gruzdev, Itamar Yadid, Itai Bloch, Yigal Farnoushi, et al. (+5)
1134 [GO] 2021―Dec―30 Intranasal immunization with a Middle East respiratory syndrome-coronavirus antigen conjugated to the M-cell targeting ligand Co4B enhances antigen-specific mucosal and systemic immunity and protects against infection Ye Lin Yang, Ju Kim, Yongsu Jeong, Yong-Suk Jang
1135 [GO] 2021―Dec―27 Optimizing vaccine distribution via mobile clinics: a case study on COVID-19 vaccine distribution to long-term care facilities Samta Shukla, Francois Fressin, Michelle Un, Henriette Coetzer, Sreekanth K. Chaguturu
1136 [GO] 2021―Dec―24 COVID-19 and Routine Childhood and Adolescent Immunizations: Evidence from Louisiana Medicaid Brigham Walker, Andrew Anderson, Charles Stoecker, Yixue Shao, Thomas A. LaVeist, Kevin Callison
1137 [GO] 2021―Dec―24 Safety and Effectiveness of BNT162b2 mRNA Covid-19 Vaccine in Adolescents Young June Choe, Seonju Yi, Insob Hwang, Jia Kim, Young-Joon Park, Eunhee Cho, et al. (+3)
1138 [GO] 2021―Dec―24 Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial Stephen J. Thomas, John L. Perez, Stephen P. Lockhart, Subramanian Hariharan, Nicholas Kitchin, Ruth Bailey, et al. (+10)
1139 [GO] 2021―Dec―22 COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhône-Alpes region (France): an ecological study Nicolas Romain-Scelle, Christelle Elias, Philippe Vanhems
1140 [GO] 2021―Dec―22 Immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 with 12-dose vials: An interim analysis Anan Manomaipiboon, Uraporn Phumisantiphong, Jakravoot Maneerit, Yupin Chalearmchai, Warissara Jirawathin, Achiraya Prajongsai, et al. (+2)
1141 [GO] 2021―Dec―21 COVID-19 and missed or delayed vaccination in 26 middle- and high-income countries: An observational survey Gilla K. Shapiro, Nisha Gottfredson, Julie Leask, Kerrie Wiley, Francine E. Ganter-Restrepo, Sarah P. Jones, et al. (+2)
1142 [GO] 2021―Dec―21 Did the European suspension of the AstraZeneca vaccine decrease vaccine acceptance during the COVID-19 pandemic? Michael Bang Petersen, Frederik Jørgensen, Marie Fly Lindholt
1143 [GO] 2021―Dec―20 Evaluation of the Gam-COVID-Vac and vaccine-induced neutralizing response against SARS-CoV-2 lineage P.1 variant in an Argentinean cohort Sebastián Blanco, Brenda Salomé Konigheim, Adrian Diaz, Lorena Spinsanti, Juan Javier Aguilar, María Elisa Rivarola, et al. (+6)
1144 [GO] 2021―Dec―18 Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021 Eero Poukka, Ulrike Baum, Arto A. Palmu, Toni O. Lehtonen, Heini Salo, Hanna Nohynek, Tuija Leino
1145 [GO] 2021―Dec―17 Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein Nai-Hsiang Chung, Ying-Chin Chen, Shiu-Ju Yang, Yu-Ching Lin, Horng-Yunn Dou, Lily Hui-Ching Wang, et al. (+2)
1146 [GO] 2021―Dec―16 Does a major change to a COVID-19 vaccine program alter vaccine intention? A qualitative investigation Samantha J. Carlson, Lara McKenzie, Leah Roberts, Christopher C. Blyth, Katie Attwell
1147 [GO] 2021―Dec―15 Levels and Factors derived from the Health Action Process Approach of Behavioral Intentions to Take up COVID-19 Vaccination: a random Population-based study Yanqiu Yu, Wanru Jia, Mason M.C. Lau, Joseph T.F. Lau
1148 [GO] 2021―Dec―15 Towards A Population-Based Threshold of Protection for COVID-19 Vaccines David Goldblatt, Andrew Fiore-Gartland, Marina Johnson, Adam Hunt, Christopher Bengt, Dace Zavadska, et al. (+10)
1149 [GO] 2021―Dec―14 On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine Xiang Chen, Hui Wang
1150 [GO] 2021―Dec―11 Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines Jérémie Botton, Rosemary Dray-Spira, Bérangère Baricault, Jérôme Drouin, Marion Bertrand, Marie-Joëlle Jabagi, et al. (+2)
1151 [GO] 2021―Dec―11 Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States Yuli Lily Hsieh, Summer Rak, Gillian K SteelFisher, Sebastian Bauhoff
1152 [GO] 2021―Dec―11 COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers Karen Lutrick, Holly Groom, Ashley L. Fowlkes, Kimberly D Groover, Manjusha Gaglani, Patrick Rivers, et al. (+12)
1153 [GO] 2021―Dec―11 Humoral response to the SARS-CoV-2 BTN161b2 mRNA vaccine: Real-world data from a large cohort of healthcare workers Joana Oliveira-Silva, Teresa Reis, Cristiana Lopes, Ricardo Batista-Silva, Ricardo Ribeiro, Gilberto Marques, et al. (+7)
1154 [GO] 2021―Dec―10 Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI) Mark A. Katz, Efrat Bron Harlev, Bibiana Chazan, Michal Chowers, David Greenberg, Alon Peretz, et al. (+23)
1155 [GO] 2021―Dec―09 Adverse event of Sinovac Coronavirus vaccine: Deafness Hai Zhao, Yongtuan Li, Zhiyuan Wang
1156 [GO] 2021―Dec―04 Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine Rachael K. Raw, Jon Rees, Clive Kelly, Caroline Wroe, David R. Chadwick
1157 [GO] 2021―Dec―04 oInfluenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal Study on Aging (CLSA) Giorgia Sulis, Nicole E. Basta, Christina Wolfson, Susan A. Kirkland, Jacqueline McMillan, Lauren E. Griffith, Parminder Raina
1158 [GO] 2021―Dec―04 Willingness to Vaccinate Against SARS-CoV-2: The Role of Reasoning Biases and Conspiracist Ideation Michael V. Bronstein, Erich Kummerfeld, Angus MacDonald, Sophia Vinogradov
1159 [GO] 2021―Dec―03 Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults Ritthideach Yorsaeng, Nungruthai Suntronwong, Harit Phowatthanasathian, Suvichada Assawakosri, Sitthichai Kanokudom, Thanunrat Thongmee, et al. (+9)
1160 [GO] 2021―Dec―03 Correlation of Anti-SARS-CoV-2 S1-specific IgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 Vaccine in healthcare workers Marina Izak, Evgeniy Stoyanov, Keren Dezuraev, Eilat Shinar
1161 [GO] 2021―Dec―03 SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study Jonas Herzberg, Tanja Vollmer, Bastian Fischer, Heiko Becher, Ann-Kristin Becker, Human Honarpisheh, et al. (+3)
1162 [GO] 2021―Dec―02 Pacific Eclipse - A tabletop exercise on smallpox pandemic response C. Raina MacIntyre, David J. Heslop, Phi Nguyen, Dillon Adam, Mallory Trent, Brian J. Gerber
1163 [GO] 2021―Dec―02 AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice Richard Stebbings, Gillian Armour, Vivian Pettis, Joanne Goodman
1164 [GO] 2021―Dec―01 COVID-19 from a polio perspective Robert Hill
1165 [GO] 2021―Dec―01 Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July-December 2020) Sara Valckx, Jonas Crèvecoeur, Frederik Verelst, Maren Vranckx, Greet Hendrickx, Niel Hens, et al. (+4)
1166 [GO] 2021―Nov―30 COVID-19 vaccine Mandates: An Australian attitudinal study Katie Attwell, Marco Rizzi, Lara McKenzie, Samantha J Carlson, Leah Roberts, Sian Tomkinson, Chris Blyth
1167 [GO] 2021―Nov―27 Predicting Vaccine Uptake during COVID-19 Crisis: A Motivational Approach Mathias Schmitz, Olivier Luminet, Olivier Klein, Sofie Morbée, Omer Van den Bergh, Pascaline Van Oost, et al. (+3)
1168 [GO] 2021―Nov―27 Mass vaccination campaign during the 2016 influenza outbreak in Panama: challenges and implications for COVID-19 vaccination efforts Franz Castro, Juan Miguel Pascale, Itzel Slocum Hewitt, Arlene Calvo
1169 [GO] 2021―Nov―27 Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines Helena C. Maltezou, Cleo Anastassopoulou, Sophia Hatziantoniou, Gregory A. Poland, Athanasios Tsakris
1170 [GO] 2021―Nov―22 A Retrospective Analysis of Social Media posts pertaining to COVID-19 vaccination side effects Max-Philipp Lentzen, Viola Huebenthal, Rolf Kaiser, Matthias Kreppel, Joachim E. Zoeller, Matthias Zirk
1171 [GO] 2021―Nov―22 Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection Harika Oyku Dinc, Nese Saltoglu, Gunay Can, Ilker Inanc Balkan, Beyhan Budak, Dogukan Ozbey, et al. (+9)
1172 [GO] 2021―Nov―20 Moving the Needle on Racial Disparity: COVID-19 Vaccine Trust and Hesitancy Cheryl Lin, Pikuei Tu, Thomas C. Terry
1173 [GO] 2021―Nov―19 Perceived Facilitators and Barriers to Intentions of Receiving the COVID-19 Vaccines among Elderly Chinese Adults Tianen Chen, Minhao Dai, Shilin Xia
1174 [GO] 2021―Nov―19 Increasing acceptance of a vaccination program for coronavirus disease 2019 in france: a challenge for one of the world’s most vaccine-hesitant countries L. Cambon, M. Schwarzinger, F. Alla
1175 [GO] 2021―Nov―18 Inclusiveness of prisons in COVID-19 vaccination deployment: Evidence from Jordan Saverio Bellizzi, Chinara Aidyralieva, Ala'a Al-Shaikh, Nazeema Muthu, Anwar Al-Sadder, Jamela Al-Raiby
1176 [GO] 2021―Nov―18 Disparities in national and state estimates of COVID-19 vaccination receipt and intent to vaccinate by race/ethnicity, income, and age group among adults ≥ 18 years, United States Kimberly H. Nguyen, Elyssa Anneser, Alexander Toppo, Jennifer D. Allen, J. Scott Parott, Laura Corlin
1177 [GO] 2021―Nov―17 Acceptance, attitude, and factors affecting the intention to accept COVID-19 vaccine among Thai people and expatriates living in Thailand Amornphat Kitro, Wachiranun Sirikul, Chanodom Piankusol, Pawaruj Rirermsoonthorn, Mathuramat Seesen, Kampanat Wangsan, et al. (+4)
1178 [GO] 2021―Nov―15 A Meta-Analysis of Influenza Vaccination Following Correspondence: Considerations for COVID-19 Robert P. Murphy, Carol Taaffe, Elayne Ahern, Grace McMahon, Orla Muldoon
1179 [GO] 2021―Nov―15 Trends in COVID-19 vaccination intent and factors associated with deliberation and reluctance among adult homeless shelter residents and staff, 1 November 2020 to 28 February 2021 - King County, Washington Julia H. Rogers, Sarah N. Cox, James P. Hughes, Amy C. Link, Eric J. Chow, Idabelle Fosse, et al. (+10)
1180 [GO] 2021―Nov―15 The seductive allure of technical language and its effect on covid-19 vaccine beliefs and intentions Jonathan Silas, Alexander Jones, Leonardo Weiss-Cohen, Peter Ayton
1181 [GO] 2021―Nov―13 Influence of Rapid COVID-19 Vaccine Development on Vaccine Hesitancy Sonny Rosenthal, Christopher L. Cummings
1182 [GO] 2021―Nov―11 A Long Shot: The Importance of Needle Length in Vaccinating Patients with Obesity Against COVID-19 Shradha Chhabria, Fatima Cody Stanford
1183 [GO] 2021―Nov―11 BNT162b2 mRNA COVID-19 Vaccine Reactogenicity: The Key Role of Immunity Pilar Vizcarra, Johannes Haemmerle, Hector Velasco, Tamara Velasco, Marina Fernández-Escribano, Alejandro Vallejo, José L. Casado
1184 [GO] 2021―Nov―08 Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada Britt McKinnon, Caroline Quach, Ève Dubé, Cat Tuong Nguyen, Kate Zinszer
1185 [GO] 2021―Nov―08 Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice Kai Wu, Angela Choi, Matthew Koch, Sayda Elbashir, LingZhi Ma, Diana Lee, et al. (+19)
1186 [GO] 2021―Nov―06 SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface Khan Sharun, Ruchi Tiwari, AbdulRahman A. Saied, Kuldeep Dhama
1187 [GO] 2021―Nov―06 Early Experience with COVID-19 Vaccine in a Federally-Qualified Healthcare Center for the Homeless Jean-Venable R. Goode, Patricia Cook, Stephanie Cuttino, Sharon B. S. Gatewood
1188 [GO] 2021―Nov―04 Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework Colleen L Lau, Helen J Mayfield, Jane E Sinclair, Samuel J Brown, Michael Waller, Anoop K Enjeti, et al. (+4)
1189 [GO] 2021―Nov―03 Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: a cross-sectional survey in France Anna Ribera-Cano, Maud Dupont, Charles-Henri Houzé-Cerfon, Vanessa Houzé-Cerfon, Alexander Hart, Attila J. Hertelendy, et al. (+2)
1190 [GO] 2021―Nov―02 Vaccination of healthcare personnel in the COVID-19 era: a call for actions Helena C. Maltezou
1191 [GO] 2021―Nov―01 Multicomponent vaccines to fight sars-cov-2 variants of concern Antonio Cassone, Roberto Cauda
1192 [GO] 2021―Oct―30 COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: a prospective multicenter study Helena C. Maltezou, Periklis Panagopoulos, Flora Sourri, Theodoros V. Giannouchos, Vasilios Raftopoulos, Maria N. Gamaletsou, et al. (+9)
1193 [GO] 2021―Oct―30 COVID-19 Vaccine - Long Term Immune Decline and breakthrough infections Johad Khoury, Ronza Najjar Debbiny, Ayman Hanna, Adel Jabbour, Yara Abu Ahmad, Aamir Saffori, et al. (+4)
1194 [GO] 2021―Oct―30 Development of Recombinant COVID-19 Vaccine based on CHO-produced, prefusion Spike Trimer and Alum/CpG Adjuvants Haitao Liu, Chenliang Zhou, Jiao An, Yujiao Song, Ping Yu, Jiadai Li, et al. (+24)
1195 [GO] 2021―Oct―29 Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study Miguel García-Grimshaw, Santa Elizabeth Ceballos-Liceaga, Anaclara Michel-Chávez, Mario García-Alanis, Arturo Cadena-Fernández, Javier Andrés Galnares-Olalde, et al. (+14)
1196 [GO] 2021―Oct―28 “Any idea how fast ‘It’s just a mask!’ can turn into ‘It’s just a vaccine!’”: From mask mandates to vaccine mandates during the COVID-19 pandemic Sam Martin, Samantha Vanderslott
1197 [GO] 2021―Oct―28 COVAX No Fault Compensation Program for COVID-19 Vaccine Injuries in 92 Low and Middle Income Countries Anne Mazur, Stefanie Benitez, Stéphanie Chuffart-Finsterwald, Rafael La Rotta, Lee M. Hampton
1198 [GO] 2021―Oct―25 Changes in COVID-19 Vaccine Acceptance Rate Among Recovered Critically Ill atients: A 12 Month Follow-up Study Titilope Olanipekun, Temidayo Abe, Valery Effoe, Gloria Westney, Richsard Snyder
1199 [GO] 2021―Oct―22 The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities Brent Burkholder, Zubair Wadood, Ahmed M. Kassem, Derek Ehrhardt, Delayo Zomahoun
1200 [GO] 2021―Oct―22 Would COVID-19 vaccination willingness increase if mobile technologies prohibit unvaccinated individuals from public spaces? A nationwide discrete choice experiment from China Jing Wang, Abram L. Wagner, Ying Chen, Etienne Jaime, Xinwen Hu, Shiqiang Wu, et al. (+3)
1201 [GO] 2021―Oct―22 Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate Arik Makovitzki, Elad Lerer, Yaron Kafri, Yaakov Adar, Lilach Cherry, Edith Lupu, et al. (+15)
1202 [GO] 2021―Oct―22 Covid-19 vaccine hesitancy, conspiracist beliefs, paranoid ideation and perceived ethnic discrimination in a sample of University students in Venezuela Gabriel Andrade
1203 [GO] 2021―Oct―22 Persuasive Messaging to Increase COVID-19 Vaccine Uptake Intentions Erin K. James, Scott E. Bokemper, Alan S. Gerber, Saad B. Omer, Gregory A. Huber
1204 [GO] 2021―Oct―22 Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine Shengtao Fan, Dandan Li, Heng Zhao, Li Yu, Pingfang Cui, Lichun Wang, et al. (+5)
1205 [GO] 2021―Oct―19 Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system Johanna Chapin-Bardales, Tanya Myers, Julianne Gee, David K. Shay, Paige Marquez, James Baggs, et al. (+3)
1206 [GO] 2021―Oct―19 Resource Allocation for Different Types of Vaccines against COVID-19: Tradeoffs and Synergies between Efficacy and Reach Daniel Kim, Pelin Pekgün, İnci Yildirim, Pınar Keskinocak
1207 [GO] 2021―Oct―19 Effect of Inactivated Influenza Vaccination on Human Coronavirus Infection: Secondary Analysis of a Randomized Trial in Hutterite Colonies Andrew T Chen, Hannah D Stacey, Art Marzok, Pardeep Singh, Jann Ang, Matthew S Miller, Mark Loeb
1208 [GO] 2021―Oct―09 Canadian parents’ perceptions of COVID-19 vaccination and intention to vaccinate their children: results from a cross-sectional national survey Robin M. Humble, Hannah Sell, Eve Dubé, Noni E. MacDonald, Joan Robinson, S. Michelle Driedger, et al. (+6)
1209 [GO] 2021―Oct―09 A Self-administered Virtual Reality Intervention Increases COVID-19 Vaccination Intention Aske Mottelson, Clara Vandeweerdt, Michael Atchapero, Tiffany Luong, Christian Holz, Robert Böhm, Guido Makransky
1210 [GO] 2021―Oct―09 Trends, patterns and psychological influences on COVID-19 vaccination intention: findings from a large prospective community cohort study in England and Wales (Virus Watch) Thomas Byrne, Parth Patel, Madhumita Shrotri, Sarah Beale, Susan Michie, Jabeer Butt, et al. (+25)
1211 [GO] 2021―Oct―06 Development of an IgG-Fc Fusion COVID-19 Subunit Vaccine, AKS-452 David G. Alleva, Andrea R. Delpero, Melanie M. Scully, Sylaja Murikipudi, Ramya Ragupathy, Emma K. Greaves, et al. (+16)
1212 [GO] 2021―Oct―06 A Case Series of Acute Pericarditis following COVID-19 Vaccination in the Context of Recent Reports from Europe and the United States George Lazaros, Cleo Anastassopoulou, Sophia Hatziantoniou, Theodoros Kalos, Stergios Soulaidopoulos, Emilia Lazarou, et al. (+4)
1213 [GO] 2021―Oct―02 Christian Nationalism and COVID-19 Vaccine Hesitancy and Uptake Katie E. Corcoran, Christopher P. Scheitle, Bernard D. DiGregorio
1214 [GO] 2021―Sep―29 History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects Celeste J. Romano, Clinton Hall, Zeina G. Khodr, Anna T. Bukowinski, Gia R. Gumbs, Ava Marie S. Conlin
1215 [GO] 2021―Sep―27 Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic Natalia A Molodecky, Hamid Jafari, Rana M Safdar, Jamal A Ahmed, Abdirahman Mahamud, Ananda S Bandyopadhyay, et al. (+6)
1216 [GO] 2021―Sep―27 Parental consent for vaccination of minors against COVID-19 Nina Shevzov-Zebrun, Arthur Caplan
1217 [GO] 2021―Sep―27 Preferences for COVID-19 vaccination information and location: Associations with vaccine hesitancy, race and ethnicity Kimberly A. Fisher, Ngoc Nguyen, Sybil Crawford, Hassan Fouayzi, Sonal Singh, Kathleen M. Mazor
1218 [GO] 2021―Sep―27 Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study Inna Bleicher, Einav Kadour-Peero, Lena Sagi-Dain, Shlomi Sagi
1219 [GO] 2021―Sep―27 Characteristics associated with COVID-19 vaccine hesitancy: A nationwide survey of 1000 patients with immune-mediated inflammatory diseases Rodrigo Poubel Vieira Rezende, Alessandra S. Braz, Maria Fernanda B. Guimarães, Sandra Lúcia E. Ribeiro, Rejane Maria R. Abreu Vieira, Blanca E. Bica, et al. (+14)
1220 [GO] 2021―Sep―24 Title: Antibody Response after First and Second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among Health Care Workers in India: The Final Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study Awadhesh Kumar Singh, Sanjeev Ratnakar Phatak, Ritu Singh, Kingshuk Bhattacharjee, Nagendra Kumar Singh, Arvind Gupta, Arvind Sharma
1221 [GO] 2021―Sep―24 A Phase III, Observer-blind, Randomized, Placebo-controlled Study of the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 Years: An Interim Analysis in Indonesia Eddy Fadlyana, Kusnandi Rusmil, Rodman Tarigan, Andri Reza Rahmadi, Susantina Prodjosoewojo, Yulia Sofiatin, et al. (+14)
1222 [GO] 2021―Sep―17 COVID-19 diagnosis in a Senegalese company: a model for COVID-19 vaccination? Jean Michel MANSUY, Asséga Sylvain SAGNA, Michael LAURENT, Jacques IZOPET
1223 [GO] 2021―Sep―16 Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform Liudmila Mosina, Wiebe Külper-Schiek, Lisa Jacques-Carroll, Andrew Earnshaw, Thomas Harder, Federico Martinón-Torres, et al. (+3)
1224 [GO] 2021―Sep―08 Inequalities in coverage of COVID-19 vaccination: a population register based cross-sectional study in Wales, UK Malorie Perry, Ashley Akbari, Simon Cottrell, Michael B Gravenor, Richard Roberts, Ronan A Lyons, et al. (+3)
1225 [GO] 2021―Sep―07 UAE Efforts in Promoting COVID-19 Vaccination and Building Vaccine Confidence Duaa Mohamed Suliman, Faisal A. Nawaz, Parvathy Mohanan, Mohamed Abdul Kareem Adam Modber, Muhammad Kabir Musa, Mohamed Babiker Musa, et al. (+6)
1226 [GO] 2021―Sep―07 Prenatal maternal COVID-19 vaccination and pregnancy outcomes Tamar Wainstock, Israel Yoles, Ruslan Sergienko, Eyal Sheiner
1227 [GO] 2021―Sep―07 Predicting COVID-19 Vaccination Intention Using Protection Motivation Theory and Conspiracy Beliefs Judith Eberhardt, Jonathan Ling
1228 [GO] 2021―Sep―07 Racial differences in anticipated COVID-19 vaccine acceptance among religious populations in the US Christopher Justin Jacobi, Brandon Vaidyanathan
1229 [GO] 2021―Sep―07 Low COVID-19 Vaccine Hesitancy in Brazil Daniella Campelo Batalha Cox Moore, Marcio Fernandes Nehab, Karla Gonçalves Camacho, Adriana Teixeira Reis, Maria de Fátima Junqueira-Marinho, Dimitri Marques Abramov, et al. (+10)
1230 [GO] 2021―Sep―04 Myocarditis following COVID-19 vaccination - a case series Dan Levin, Gil Shimon, Maggie Fadlon-Derai, Liron Gershovitz, Amiram Shovali, Anat Sebbag, et al. (+3)
1231 [GO] 2021―Sep―03 Unmethylated CpG Motif-Containing Genomic DNA Fragments of Bacillus Calmette-Guerin Improves Immune Response towards a DNA Vaccine for COVID-19 Zehua Zhou, Xinyu Zhang, Qianqian Li, Lili Fu, Meiyu Wang, Shuo Liu, et al. (+11)
1232 [GO] 2021―Sep―03 Legal and Regulatory Processes for Japan’s COVID-19□Immunization Program Norihisa Yamamoto, Yuichi Takahashi, Shuichiro Hayashi
1233 [GO] 2021―Sep―02 COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout Mazin Barry, Mohamad-Hani Temsah, Fadi Aljamaan, Basema Saddik, Ayman Al-Eyadhy, Shuliweeh Alenezi, et al. (+12)
1234 [GO] 2021―Sep―02 Collaboration in Times of Crisis: A Study on COVID-19 Vaccine R&D Partnerships Louise C. Druedahl, Timo Minssen, W. Nicholson Price
1235 [GO] 2021―Aug―31 The Impact of COVID-19 Vaccination Delay: A Data-Driven Modelling Analysis for Chicago and New York City Vinicius V.L. Albani, Jennifer Loria, Eduardo Massad, Jorge P. Zubelli
1236 [GO] 2021―Aug―31 Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study Lill Trogstad, Anna Hayman Robertson, Siri Mjaaland, Per Magnus
1237 [GO] 2021―Aug―30 Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19 Tal Brosh-Nissimov, Nadav Sorek, Michal Yeshayahu, Irena Zherebovich, Maria Elmaliach, Amos Cahan, et al. (+2)
1238 [GO] 2021―Aug―30 Association of Flu specific and SARS-CoV-2 specific CD4 T cell responses in SARS-CoV-2 infected asymptomatic heath care workers Suresh Pallikkuth, Erin Williams, Rajendra Pahwa, Michael Hoffer, Savita Pahwa
1239 [GO] 2021―Aug―26 SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1 John Lok Man Law, Michael Logan, Michael A. Joyce, Abdolamir Landi, Darren Hockman, Kevin Crawford, et al. (+13)
1240 [GO] 2021―Aug―25 A Hub-and-spoke Design for Ultra-cold COVID-19 Vaccine Distribution Xinglu Xu, Mark D. Rodgers, Weihong (Grace) Guo
1241 [GO] 2021―Aug―25 COVID-19 Vaccine Safety Monitoring: Might Differential Healthcare Seeking Introduce Detection Bias Into Rates of Medical Events and Cause False Safety Signals? Rafael Harpaz
1242 [GO] 2021―Aug―24 Making COVID-19 vaccinations accessible for people with disabilities Sara Rotenberg, Matthew B Downer, Jane Cooper
1243 [GO] 2021―Aug―19 Walking the Tightrope: Reevaluating Science Communication in the Era of COVID-19 Vaccines Matthew Z. Dudley, Roger Bernier, Janesse Brewer, Daniel A. Salmon
1244 [GO] 2021―Aug―19 Vaccine effectiveness against infection and onwards transmission of COVID-19: analysis of Belgian contact tracing data, January-June 2021 Toon Braeye, Laura Cornelissen, Lucy Catteau, Freek Haarhuis, Kristiaan Proesmans, Karin De Ridder, et al. (+9)
1245 [GO] 2021―Aug―17 Public Attitudes toward COVID-19 Vaccines on English-language Twitter: A Sentiment Analysis Siru Liu, Jialin Liu
1246 [GO] 2021―Aug―16 Continuity of routine immunization programs in Canada during the COVID-19 pandemic Hannah Sell, Ali Assi, S. Michelle Driedger, Eve Dubé, Arnaud Gagneur, Samantha B. Meyer, et al. (+4)
1247 [GO] 2021―Aug―16 Immune efficacy of a candidate porcine reproductive and respiratory syndrome vaccine rHN-NP49 administered by a Needle-free intradermal delivery system in comparison with intramuscular injection Yifeng Jiang, Xianbin Li, Lingxue Yu, Wu Tong, Pengfei Chen, Shuaiyong Wang, et al. (+10)
1248 [GO] 2021―Aug―14 COVID-19 Vaccination in the Federal Bureau of Prisons, December 2020-April 2021 Liesl M. Hagan, Charles Dusseau, Michael Crockett, Tami Rodriguez, Michael J. Long
1249 [GO] 2021―Aug―13 Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review Agustín Ciapponi, Ariel Bardach, Agustina Mazzoni, Tomás Alconada, A. Steven Anderson, Fernando J. Argento, et al. (+19)
1250 [GO] 2021―Aug―11 Could live attenuated vaccines better control COVID-19? Shinya Okamura, Hirotaka Ebina
1251 [GO] 2021―Aug―11 Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination Daniel Grupel, Sivan Gazit, Licita Schreiber, Varda Nadler, Tamar Wolf, Rachel Lazar, et al. (+7)
1252 [GO] 2021―Aug―11 Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests Jamil N Kanji, Ashley Bailey, Jayne Fenton, Sean H Ling, Rafael Rivera, Sabrina Plitt, et al. (+5)
1253 [GO] 2021―Aug―11 Does BCG provide long-term protection against SARS-CoV-2 infection? A case-control study in Q, Canada Jacques Pépin, Annie-Claude Labbé, Alex Carignan, Marie-Elise Parent, Jennifer Yu, Cynthia Grenier, et al. (+4)
1254 [GO] 2021―Aug―10 The Next Frontier in Vaccine Safety and VAERS: Lessons from COVID-19 and Ten Recommendations for Action John G. Rizk, Charles E. Barr, Youssef Rizk, John C. Lewin
1255 [GO] 2021―Aug―08 From program suspension to the pandemic: A qualitative examination of Australia’s vaccine pharmacovigilance system over 10 years Anastasia Phillips, Samantha Carlson, Margie Danchin, Frank Beard, Kristine Macartney
1256 [GO] 2021―Aug―06 Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccination Sean C. Taylor, Beth Hurst, Ian Martiszus, Marvin S. Hausman, Samar Sarwat, Jeffrey M. Schapiro, et al. (+2)
1257 [GO] 2021―Aug―05 Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study) Piia Jõgi, Hiie Soeorg, Diana Ingerainen, Mari Soots, Freddy Lättekivi, Paul Naaber, et al. (+13)
1258 [GO] 2021―Aug―05 Sub-cutaneous Pfizer/BioNTech COVID-19 vaccine administration results in seroconversion among young adults Limor Friedensohn, Meital Zur, Maxim Timofeyev, Saar Burshtein, Yossi Ben Michael, Noam Fink, Elon Glassberg
1259 [GO] 2021―Aug―05 Perceived public health threat a key factor for willingness to get the COVID-19 vaccine in Australia Rachael H Dodd, Kristen Pickles, Erin Cvejic, Samuel Cornell, Jennifer MJ Isautier, Tessa Copp, et al. (+6)
1260 [GO] 2021―Aug―03 Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection Lei Li, Yoshikazu Honda-Okubo, Ying Huang, Hyesun Jang, Michael A. Carlock, Jeremy Baldwin, et al. (+11)
1261 [GO] 2021―Jul―31 Geo-prioritization framework for COVID-19 vaccine allocation in India Akshay Mahajan, Jasmine Kaur, Chirag Sidana, Shashwat Shivam, Harpreet Singh
1262 [GO] 2021―Jul―31 An overview of procurement, pricing, and uptake of COVID-19 vaccines in Pakistan Adeel Siddiqui, Ali Ahmed, Maria Tanveer, Muhammad Saqlain, Chia Siang Kow, Syed Shahzad Hasan
1263 [GO] 2021―Jul―27 Optimal Planning of the COVID-19 Vaccine Supply Chain Georgios P. Georgiadis, Michael C. Georgiadis
1264 [GO] 2021―Jul―24 COVID-19 vaccination for cancer patients: evidence, priority, and practice Shiv Rajan, Naseem Akhtar, Sonali Sharma, Deep Chakrabarti, Vijay Kumar
1265 [GO] 2021―Jul―24 Association of total and neutralizing SARS-CoV-2 spike -Receptor Binding Domain antibodies with epidemiological and clinical characteristics after immunization with the 1st and 2nd doses of the BNT162b2 vaccine Athanasios Michos, Elizabeth-Barbara Tatsi, Fillipos Filippatos, Charilaos Dellis, Dimitra Koukou, Vasiliki Efthymiou, et al. (+3)
1266 [GO] 2021―Jul―24 Quantification of SARS-CoV-2 spike and nucleocapsid proteins using isotope dilution tandem mass spectrometry Carrie Pierce-Ruiz, Wanda I. Santana, William J. H. Sutton, David A. Fischler, Hans C. Cooper, Lidoshka R. Marc, et al. (+2)
1267 [GO] 2021―Jul―23 Parental plans to vaccinate children for COVID-19 in New York City Chloe A. Teasdale, Luisa N. Borrell, Yanhan Shen, Spencer Kimball, Michael L. Rinke, Sasha A. Fleary, Denis Nash
1268 [GO] 2021―Jul―23 Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments Maria Sundaram, Sharifa Nasreen, Andrew Calzavara, Siyi He, Hannah Chung, Susan E. Bronskill, et al. (+6)
1269 [GO] 2021―Jul―23 Enablers and barriers to COVID-19 vaccine uptake: an international study of perceptions and intentions Paul F. Burke, Daniel Masters, Graham Massey
1270 [GO] 2021―Jul―22 Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine Noémie Tissot, Anne-Sophie Brunel, Fabienne Bozon, Béatrice Rosolen, Catherine Chirouze, Kevin Bouiller
1271 [GO] 2021―Jul―22 Will COVID-19 vaccine equity be possible in India? Kanagavalli Mathivathanan
1272 [GO] 2021―Jul―20 Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager Elisabeth Paul, Garrett W. Brown, Andreas Kalk, Valéry Ridde
1273 [GO] 2021―Jul―16 An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity Anne-Catherine Fluckiger, Barthelemy Ontsouka, Jasminka Bozic, Abebaw Diress, Tanvir Ahmed, Tamara Berthoud, et al. (+7)
1274 [GO] 2021―Jul―16 Vitamin D supplementation: an alternative to enhance the effectiveness of vaccines against SARS-CoV-2? Felipe Inserra, Carlos Tajer, Laura Antonietti, Javier Mariani, León Ferder, Walter Manucha
1275 [GO] 2021―Jul―13 Marketing the COVID-19 vaccine and the implications for public health Emmanuel Mogaji
1276 [GO] 2021―Jul―13 COVID-19 Vaccine Capacity: Challenges and Mitigation - The DCVMN perspective Benoit Hayman, Rajinder Suri, Sai D. Prasad
1277 [GO] 2021―Jul―13 The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism George Lazaros, Allan L. Klein, Sophia Hatziantoniou, Costas Tsioufis, Athanasios Tsakris, Cleo Anastassopoulou
1278 [GO] 2021―Jul―10 Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - a risk-benefit analysis for people <60 years in Australia Chandini Raina MacIntyre, Benjamin Veness, David Berger, Nada Hamad, Noor Bari
1279 [GO] 2021―Jul―07 Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021 Alberto Mateo-Urdiales, Martina Del Manso, Xanthi Andrianou, Matteo Spuri, Fortunato D'Ancona, Antonietta Filia, et al. (+7)
1280 [GO] 2021―Jun―30 Henoch-Schönlein Purpura Presenting Post COVID-19 Vaccination Adam M. Hines, Neal Murphy, Christine Mullin, Julia Barillas, Jacqueline C. Barrientos
1281 [GO] 2021―Jun―29 Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic Christina Banks, Allison Portnoy, Flavia Moi, Laura Boonstoppel, Logan Brenzel, Stephen C. Resch
1282 [GO] 2021―Jun―29 COVID-19 vaccine roll-out in middle-income countries: lessons learned from the Jordan experience Ala'a Al-Shaikh, Nazeema Muthu, Chinara Aidyralieva, Maria Cristina Profili, Saverio Bellizzi
1283 [GO] 2021―Jun―26 Significance of SARS-CoV-2 Specific Antibody Testing during COVID-19 Vaccine Allocation Akane B. Fujimoto, Inci Yildirim, Pinar Keskinocak
1284 [GO] 2021―Jun―26 Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding Sandra Scheiblhofer, Stephan Drothler, Werner Braun, Reinhard Braun, Maximilian Boesch, Richard Weiss
1285 [GO] 2021―Jun―25 Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site Ian A Myles, Joshua S Vinciguerra, Robert T Premus
1286 [GO] 2021―Jun―23 Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease : a case control study Aurelie Baldolli, Jocelyn Michon, Fanny Appia, Caroline Galimard, Renaud Verdon, Jean Jacques Parienti
1287 [GO] 2021―Jun―23 Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration Aditya P. Desai, Aryan P. Desai, Gregory J. Loomis
1288 [GO] 2021―Jun―23 Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: a comparative survey of five large cities in the United States, United Kingdom, and Australia Mallory Trent, Holly Seale, Abrar Ahmad Chughtai, Daniel Salmon, C. Raina MacIntyre
1289 [GO] 2021―Jun―23 One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model Karen E. Gooch, Trevor R.F. Smith, Francisco J. Salguero, Susan A. Fotheringham, Robert J. Watson, Mike J. Dennis, et al. (+19)
1290 [GO] 2021―Jun―22 Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students I-Hua Chen, Daniel Kwasi Ahorsu, Nai-Ying Ko, Cheng-Fang Yen, Chung-Ying Lin, Mark D. Griffiths, Amir H. Pakpour
1291 [GO] 2021―Jun―22 Recent MMR vaccination in Health Care Workers and Covid-19: a test negative case-control study Lisa Lundberg, Maria Bygdell, Gustaf Stukat von Feilitzen, Susanne Woxenius, Claes Ohlsson, Jenny M Kindblom, Susannah Leach
1292 [GO] 2021―Jun―21 Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis Kenneth J. Smith, Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman
1293 [GO] 2021―Jun―17 Early influenza vaccination rates in children during the COVID-19 pandemic Benjamin Fogel, Eric W. Schaefer, Steven D. Hicks
1294 [GO] 2021―Jun―17 COVID-19 Vaccination Rates Vary By Community Vulnerability: A County-level Analysis Clare C. Brown, Sean G. Young, George C. Pro
1295 [GO] 2021―Jun―15 Title: Helping patients with ethical concerns about COVID-19 vaccines in light of fetal cell lines used in some COVID-19 vaccines Richard K Zimmerman
1296 [GO] 2021―Jun―14 The Need for Broadly Protective COVID-19 Vaccines: Beyond S-Only Approaches Gregory A. Poland, Inna G. Ovsyannikova, Richard B. Kennedy
1297 [GO] 2021―Jun―12 COVID-19 RELATED IMMUNIZATION DISRUPTIONS IN RAJASTHAN, INDIA: A RETROSPECTIVE OBSERVATIONAL STUDY Radhika Jain, Ambika Chopra, Camille Falézan, Mustufa Patel, Pascaline Dupas
1298 [GO] 2021―Jun―12 Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects Davide Ferrari, Chiara Di Resta, Rossella Tomaiuolo, Eleonora Sabetta, Marina Pontillo, Andrea Motta, Massimo Locatelli
1299 [GO] 2021―Jun―10 Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries Chelsea S. Lutz, Matthew Biggerstaff, Melissa A. Rolfes, Kathryn E. Lafond, Eduardo Azziz-Baumgartner, Rachael M. Porter, et al. (+2)
1300 [GO] 2021―Jun―09 Twitter discourse reveals geographical and temporal variation in concerns about COVID-19 Vaccines in the United States Sharath Chandra Guntuku, Alison M. Buttenheim, Garrick Sherman, Raina M. Merchant
1301 [GO] 2021―Jun―08 A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated Sebastian Hoehl, Sandra Ciesek, Jürgen Graf, Sabine Wicker
1302 [GO] 2021―Jun―07 Knowledge and attitude of Kenyan healthcare workers towards pandemic influenza disease and vaccination: 9 years after the last influenza pandemic Fred Andayi, Gideon O. Emukule, Eric Osoro, Linus K. Ndegwa, Fredrick Otiato, Peter Muturi, et al. (+7)
1303 [GO] 2021―Jun―05 One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy Aviad Raz, Yael Keshet, Ariela Popper-Giveon, Maha Sabbah Karkabi
1304 [GO] 2021―Jun―04 Public trust on regulatory decisions: the European Medicines Agency and the AstraZeneca COVID-19 vaccine label Rafael Dal-Ré, Odile Launay
1305 [GO] 2021―Jun―01 Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada Pierre-Philippe Piché-Renaud, Catherine Ji, Daniel S. Farrar, Jeremy N. Friedman, Michelle Science, Ian Kitai, et al. (+3)
1306 [GO] 2021―Jun―01 Evaluation of post-introduction COVID-19 Vaccine Effectiveness: Summary of interim guidance of the World Health Organization Minal K. Patel, Isabel Bergeri, Joseph S. Bresee, Benjamin J. Cowling, Natasha S. Crowcroft, Kamal Fahmy, et al. (+21)
1307 [GO] 2021―Jun―01 Immunogenic Potential of DNA Vaccine candidate, ZyCoV-D against SARS-CoV-2 in Animal Models Ayan Dey, T.M. Chozhavel Rajanathan, Harish Chandra, Hari P.R. Pericherla, Sanjeev Kumar, Huzaifa S. Choonia, et al. (+14)
1308 [GO] 2021―May―30 The missing season: The impacts of the COVID-19 pandemic on influenza Casey M. Zipfel, Vittoria Colizza, Shweta Bansal
1309 [GO] 2021―May―28 Myocarditis following COVID-19 mRNA vaccination Saif Abu Mouch, Ariel Roguin, Elias Hellou, Amorina Ishai, Uri Shoshan, Lamis Mahamid, et al. (+4)
1310 [GO] 2021―May―28 Adverse Events Following mRNA SARS-CoV-2 Vaccination among U.S. Nursing Home Residents Barbara H. Bardenheier, Stefan Gravenstein, Carolyn Blackman, Roee Gutman, Indra Neil Sarkar, Richard A. Feifer, et al. (+4)
1311 [GO] 2021―May―27 COVID-19 vaccine hesitancy: lessons from Israel David Gurwitz
1312 [GO] 2021―May―26 Willingness to get vaccinated against Covid-19 and attitudes towards vaccination in general Roselinde Kessels, Jeroen Luyten, Sandy Tubeuf
1313 [GO] 2021―May―24 A breath of humanity in the era of Covid-19 vaccine Philippe Vanhems
1314 [GO] 2021―May―24 Evidence for antibody as a protective correlate for COVID-19 vaccines Kristen A. Earle, Donna M. Ambrosino, Andrew Fiore-Gartland, David Goldblatt, Peter B. Gilbert, George R. Siber, et al. (+2)
1315 [GO] 2021―May―21 Changes in Childhood Vaccination During the Coronavirus Disease 2019 Pandemic in Japan Yuta Aizawa, Tomohiro Katsuta, Hiroshi Sakiyama, Keiko Tanaka-Taya, Hiroyuki Moriuchi, Akihiko Saitoh
1316 [GO] 2021―May―21 Lessons from the 1656 Neapolitan Plague:Something to Learn for the Current Coronavirus Pandemic? Maurizio Bifulco, Simona Pisanti, Idamaria Fusco
1317 [GO] 2021―May―19 The first Chinese national standards for SARS-CoV-2 neutralizing antibody Lidong Guan, Yuanling Yu, Xiaohong Wu, Jianhui Nie, Jun Zhang, Zejun Wang, et al. (+10)
1318 [GO] 2021―May―18 An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose Kakon Nag, Juwel Chandra Baray, Maksudur Rahman Khan, Asif Mahmud, Jikrul Islam, Sanat Myti, et al. (+20)
1319 [GO] 2021―May―18 Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: a population-based survey Tzu Tsun LUK, Shengzhi ZHAO, Yongda WU, Janet Yuen-ha WONG, Man Ping WANG, Tai Hing LAM
1320 [GO] 2021―May―14 Operational research for the safe and effective design of COVID-19 mass vaccination centres Richard M. Wood, Ben J. Murch, Simon J. Moss, Joshua M.B. Tyler, Alexander L. Thompson, Christos Vasilakis
1321 [GO] 2021―May―14 U.S. Population-Based Background Incidence Rates of Medical Conditions for Use in Safety Assessment of COVID-19 Vaccines Diane Gubernot, Amelia Jazwa, Manette Niu, Jane Baumblatt, Julianne Gee, Pedro Moro, et al. (+12)
1322 [GO] 2021―May―12 COVID-19 vaccine hesitancy among persons living in homeless shelters in France C Longchamps, S Ducarroz, L Crouzet, N. Vignier, L. Pourtau, C Allaire, et al. (+3)
1323 [GO] 2021―May―12 Older Adolescents and Young Adults Willingness to Receive the COVID-19 Vaccine: Implications for Informing Public Health Strategies Tracie O. Afifi, Samantha Salmon, Tamara Taillieu, Ashley Stewart-Tufescu, Janique Fortier, S. Michelle Driedger
1324 [GO] 2021―May―11 Covid-19 vaccine trials: ethnic diversity and immunogenicity Hannah Jethwa, Richard Wong, Sonya Abraham
1325 [GO] 2021―May―09 Influenza and pneumococcal vaccinations are not associated to COVID-19 outcomes among patients admitted to a university hospital Roberta Pastorino, Leonardo Villani, Daniele Ignazio La Milia, Roberto Ieraci, Francesco Chini, Enrico Volpe, et al. (+5)
1326 [GO] 2021―May―06 Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines Masaharu Somiya, Sohtaro Mine, Kosuke Yasukawa, Saki Ikeda
1327 [GO] 2021―Apr―30 Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests Nir Eyal, Tobias Gerhard, Brian L. Strom
1328 [GO] 2021―Apr―30 Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS) Kerry J. Welsh, Jane Baumblatt, Wambui Chege, Ravi Goud, Narayan Nair
1329 [GO] 2021―Apr―27 Missed childhood immunizations during the COVID-19 pandemic in Brazil: analyses of routine statistics and of a national household survey Mariangela F Silveira, Cristian T Tonial, Ana Goretti K Maranhão, Antonia MS Teixeira, Pedro C Hallal, Ana Maria B Menezes, et al. (+4)
1330 [GO] 2021―Apr―27 Childhood immunization during the COVID-19 pandemic in Texas Tasmiah Nuzhath, Kobi V. Ajayi, Qiping Fan, Peter Hotez, Brian Colwell, Timothy Callaghan, Annette K. Regan
1331 [GO] 2021―Apr―27 The impact of disruptions caused by the COVID-19 pandemic on global polio eradication Dominika A. Kalkowska, Arie Voorman, Mark A. Pallansch, Steven G. F. Wassilak, Stephen L. Cochi, Kamran Badizadegan, Kimberly M. Thompson
1332 [GO] 2021―Apr―24 Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia C Raina MacIntyre, Valentina Costantino, Mallory Trent
1333 [GO] 2021―Apr―24 Factors Influencing Covid-19 Vaccine Acceptance across Subgroups in the United States: Evidence from a Conjoint Experiment S.E. Kreps, D.L. Kriner
1334 [GO] 2021―Apr―15 Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: a national cross-sectional study Chao Wang, Bingfeng Han, Tianshuo Zhao, Hanyu Liu, Bei Liu, Linyi Chen, et al. (+10)
1335 [GO] 2021―Apr―09 The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: a phase I randomized, double-blinded, controlled trial Jing Pu, Qin Yu, Zhifang Yin, Ying Zhang, Xueqi Li, Qiongzhou Yin, et al. (+41)
1336 [GO] 2021―Apr―08 Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: a mathematical modelling analysis Alexandra B. Hogan, Peter Winskill, Oliver J. Watson, Patrick G.T. Walker, Charles Whittaker, Marc Baguelin, et al. (+14)
1337 [GO] 2021―Apr―06 Impact of Reduced Human Papillomavirus Vaccination Coverage Rates Due to COVID-19 in the United States: A Model Based Analysis Vincent Daniels, Kunal Saxena, Craig Roberts, Smita Kothari, Shelby Corman, Linda Niccolai
1338 [GO] 2021―Apr―06 When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil Wladimir G. Gramacho, Mathieu Turgeon
1339 [GO] 2021―Apr―06 Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study Sophia Hatziantoniou, Helena C. Maltezou, Athanasios Tsakris, Gregory A. Poland, Cleo Anastassopoulou
1340 [GO] 2021―Mar―26 strategy to identify priority groups for covid-19 vaccination: a population based cohort STUDY Antonio Giampiero Russo, Adriano Decarli, Maria Grazia Valsecchi
1341 [GO] 2021―Mar―26 The Development of COVID-19 Vaccines in the United States: Why and How So Fast? Barbara J. Kuter, Paul Offit, Gregory A. Poland
1342 [GO] 2021―Mar―24 COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization Daniel A. Salmon, Matthew Z. Dudley, Janesse Brewer, Lilly Kan, Jennifer E. Gerber, Haley Budigan, et al. (+4)
1343 [GO] 2021―Mar―23 Are vaccines against COVID-19 tailored to the most vulnerable people? Raffaele Antonelli Incalzi, Caterina Trevisan, Susanna Del Signore, Stefano Volpato, Stefano Fumagalli, Fabio Monzani, et al. (+7)
1344 [GO] 2021―Mar―23 COVID-19 Vaccine Safety Questions and Answers for Healthcare Providers (CONSIDER) Sonali Kochhar, Eve Dubé, Janice Graham, Youngmee Jee, Ziad A. Memish, Lisa Menning, et al. (+4)
1345 [GO] 2021―Mar―23 Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines Aris Angelis, Jonathan Darrow
1346 [GO] 2021―Mar―23 The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response Ying Zhang, Dandan Li, Heng Zhao, Lichun Wang, Yun Liao, Xueqi Li, et al. (+2)
1347 [GO] 2021―Mar―23 Joining the Herd? U.S. Public Opinion and Vaccination Requirements Across Educational Settings During the COVID-19 Pandemic Simon F. Haeder
1348 [GO] 2021―Mar―20 Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada Thomas N. Vilches, Kevin Zhang, Robert Van Exan, Joanne M. Langley, Seyed M. Moghadas
1349 [GO] 2021―Mar―20 Safety monitoring of COVID-19 vaccines - Lessons learned from the 1976 national influenza immunization program about detecting rare vaccine-related severe adverse events in emergency mass-vaccination programs Alan Kendal
1350 [GO] 2021―Mar―18 Media usage predicts intention to be vaccinated against SARS-CoV-2 in the US and the UK Daniel Allington, Siobhan McAndrew, Vivienne Louisa Moxham-Hall, Bobby Duffy
1351 [GO] 2021―Mar―13 Developing standard safety outcomes for COVID-19 vaccines Jim P. Buttery
1352 [GO] 2021―Mar―11 COVID-19 vaccination and critical care capacity: perilous months ahead Leslie A Reperant, Albert DME Osterhaus
1353 [GO] 2021―Mar―11 COVID-19 vaccine intentions in the United States, a social-ecological framework Carl Latkin, Lauren Dayton, Grace Yi, Arianna Konstantopoulos, Ju Park, Catherine Maulsby, Xiangrong Kong
1354 [GO] 2021―Mar―11 The social experience of participation in a COVID-19 vaccine trial: Subjects’ motivations, others’ concerns, and insights for vaccine promotion Emily Wentzell, Ana-Monica Racila
1355 [GO] 2021―Mar―09 NIH funding for vaccine readiness before the COVID-19 pandemic Anthony E. Kiszewski, Ekaterina Galkina Cleary, Matthew J. Jackson, Fred D. Ledley
1356 [GO] 2021―Mar―09 Importance of COVID-19 vaccine efficacy in older age groups Manish Sadarangani, Bahaa Abu Raya, Jessica M. Conway, Sarafa A. Iyaniwura, Rebeca Cardim Falcao, Caroline Colijn, et al. (+2)
1357 [GO] 2021―Mar―09 U.S. Public Support for COVID-19 Vaccine Donation to Low- and Middle-Income Countries during the COVID-19 Pandemic Jeanine P.D. Guidry, Paul B. Perrin, Linnea I. Laestadius, Emily K. Vraga, Carrie A. Miller, Bernard F. Fuemmeler, et al. (+3)
1358 [GO] 2021―Mar―07 The Critical Role Background Rates of Possible Adverse Events in the Assessment of COVID-19 Vaccine Safety Steven B Black, Barbara Law, Robert T. Chen, Cornelia L. Dekker, Miriam Sturkenboom, Wan-Ting Huang, et al. (+2)
1359 [GO] 2021―Mar―07 Vaccine Hesitancy and Anti-Vaccination in the Time of COVID-19: a Google Trends Analysis Samuel Pullan, Mrinalini Dey
1360 [GO] 2021―Mar―05 Influenza Vaccination in the Time of COVID-19: A National U.S. Survey of Adults Lynne Sturm, Monica L. Kasting, Katharine J. Head, Jane A. Hartsock, Gregory D. Zimet
1361 [GO] 2021―Mar―05 Intranasal Administration of a Recombinant RBD Vaccine Induced Protective Immunity Against SARS-CoV-2 in Mouse Yingying Du, Yuhua Xu, Jin Feng, Longbo Hu, Yanan Zhang, Bo Zhang, et al. (+6)
1362 [GO] 2021―Mar―05 Assessment of SARS-CoV-2 Specific CD4(+) and CD8 (+) T Cell Responses MHC Class I and II Tetramers Yuri Poluektov, Pirouz Daftarian, Marybeth George, Marc C. Delcommenne
1363 [GO] 2021―Mar―02 Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy Deshayne B. Fell, Michelle C. Dimitris, Jennifer A. Hutcheon, Justin R. Ortiz, Robert W. Platt, Annette K. Regan, David A. Savitz
1364 [GO] 2021―Feb―27 Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use Mingwang Shen, Jian Zu, Christopher K. Fairley, José A. Pagán, Li An, Zhanwei Du, et al. (+6)
1365 [GO] 2021―Feb―27 Willingness to Pay and Financing Preferences for COVID-19 Vaccination in China Jiahao Wang, Yun Lyu, Haijun Zhang, Rize Jing, Xiaozhen Lai, Huangyufei Feng, et al. (+2)
1366 [GO] 2021―Feb―24 Building the global vaccine manufacturing capacity needed to respond to pandemics Tara Kirk Sell, Daniel Gastfriend, Matthew Watson, Crystal Watson, Lauren Richardson, Anita Cicero, et al. (+2)
1367 [GO] 2021―Feb―21 The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region Justin R. Ortiz, Joanie Robertson, Jui-Shan Hsu, Stephen L. Yu, Amanda J. Driscoll, Sarah R. Williams, et al. (+5)
1368 [GO] 2021―Feb―17 Perspectives on the Receipt of a COVID-19 Vaccine: A Survey of Employees in Two Large Hospitals in Philadelphia Barbara J. Kuter, Safa Browne, Florence M. Momplaisir, Kristen A. Feemster, Angela K. Shen, Judith Green-McKenzie, et al. (+2)
1369 [GO] 2021―Feb―10 Improving COVID-19 Vaccine Acceptance: Including Insights from Human Decision-Making Under Conditions of Uncertainty and Human-Centered Design Caroline M. Poland, Allison Matthews, Gregory A. Poland
1370 [GO] 2021―Feb―09 A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine Laurence Chu, Roderick McPhee, Wenmei Huang, Hamilton Bennett, Rolando Pajon, Biliana Nestorova, Brett Leav
1371 [GO] 2021―Feb―07 International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples Eric Robinson, Andrew Jones, India Lesser, Michael Daly
1372 [GO] 2021―Feb―03 Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries David Gurwitz
1373 [GO] 2021―Jan―31 Vaccines, masks, distancing and credibility: An urgent warning for pandemic management Paul H. Axelsen, Gregory A. Poland
1374 [GO] 2021―Jan―29 General Determination of Causation Between Covid-19 Vaccines and Possible Adverse Events Lee M. Hampton, Rakesh Aggarwal, Stephen J.W. Evans, Barbara Law
1375 [GO] 2021―Jan―22 The economics of global COVID vaccine administration during a pandemic - Why continue skin alcohol preparation as a costly but ineffective practice? Eric G. Poland, Darren K. McGuire, Tamar Ratishvili, Gregory A. Poland
1376 [GO] 2021―Jan―22 Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic G.N. Okoli, F. Racovitan, T. Abdulwahid, C.H. Righolt, S.M. Mahmud
1377 [GO] 2021―Jan―20 US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine Rafael Dal-Ré
1378 [GO] 2021―Jan―20 Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response Qiu-dong Su, Ye-ning Zou, Yao Yi, Li-ping Shen, Xiang-zhong Ye, Yang Zhang, et al. (+15)
1379 [GO] 2021―Jan―19 Immunoinformatics prediction of overlapping CD8+ T-cell, IFN-γ and IL-4 inducer CD4+ T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2) Abiodun J. Fatoba, Leah Maharaj, Victoria T. Adeleke, Moses Okpeku, Adebayo A Adeniyi, Matthew A. Adeleke
1380 [GO] 2021―Jan―13 The need for inclusion of pregnant women in COVID-19 vaccine trials Richard H. Beigi, Carleigh Krubiner, Denise J. Jamieson, Anne D. Lyerly, Brenna Hughes, Laura Riley, et al. (+2)
1381 [GO] 2021―Jan―13 Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic Andrew E. Burger, Eric N. Reither, Svenn-Erik Mamelund, Sojung Lim
1382 [GO] 2021―Jan―11 Development of Vaccines for Influenza Disease: Opportunity Costs of the COVID-19 Pandemic Timothy L. Wiemken, Ana Santos Rutschman
1383 [GO] 2021―Jan―11 Immuno-informatics approach for B-cell and T-cell Epitope based peptide vaccine design against novel COVID-19 virus Jitender Singh, Deepti Malik, Ashvinder Raina
1384 [GO] 2021―Jan―11 Predictors of Intention to Vaccinate Against COVID-19: Results of a Nationwide Survey Jeanette B. Ruiz, Robert A. Bell
1385 [GO] 2021―Jan―08 Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020 Marit Middeldorp, Alies van Lier, Nicoline van der Maas, Irene Veldhuijzen, Wieke Freudenburg, Nina M van Sorge, et al. (+3)
1386 [GO] 2021―Jan―08 Acceptance of the COVID-19 vaccine based on the Health Belief Model: a population-based survey in Hong Kong Martin CS Wong, Eliza LY Wong, Junjie Huang, Annie WL Cheung, Kevin Law, Marc KC Chong, et al. (+6)
1387 [GO] 2021―Jan―08 The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: use of cost-effectiveness modeling to inform vaccination prioritization Michele Kohli, Michael Maschio, Debbie Becker, Milton C. Weinstein
1388 [GO] 2021―Jan―08 Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines John M Kelso
1389 [GO] 2021―Jan―08 How should we conduct pandemic vaccination? Jane Williams, Chris Degeling, Jodie McVernon, Angus Dawson
1390 [GO] 2021―Jan―03 Constructing an ethical framework for priority allocation of pandemic vaccines J Fielding, S.G. Sullivan, F. Beard, K. Macartney, J. Williams, A. Dawson, et al. (+6)
1391 [GO] 2020―Dec―26 Childhood vaccinations: hidden impact of COVID-19 on children in Singapore Youjia Zhong, Hannah Eleanor Clapham, Ramkumar Aishworiya, Ying Xian Chua, Jancy Mathews, Mabel Ong, et al. (+5)
1392 [GO] 2020―Dec―17 Timing of COVID-19 Vaccine Approval and Endorsement by Public Figures Scott E. Bokemper, Gregory A. Huber, Alan S. Gerber, Erin K. James, Saad B. Omer
1393 [GO] 2020―Dec―17 Preferences for a COVID-19 vaccine in Australia Antonio Borriello, Daniel Master, Andrea Pellegrini, John M Rose
1394 [GO] 2020―Dec―17 Global production capacity of seasonal and pandemic influenza vaccines in 2019 Erin Sparrow, James G Wood, Christopher Chadwick, Anthony T. Newall, Siranda Torvaldsen, Ann Moen, Guido Torelli
1395 [GO] 2020―Dec―16 Broad cross-national public support for accelerated COVID-19 vaccine trial designs David Broockman, Joshua Kalla, Alexander Guerrero, Mark Budolfson, Nir Eyal, Nicholas P. Jewell, et al. (+2)
1396 [GO] 2020―Dec―13 BCG vaccine: worrying proposal for COVID-19 Emanuel Sarinho, Ekaterini Goudouris, Dirceu Solé
1397 [GO] 2020―Dec―13 Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries C. Degeling, J. Williams, S.M. Carter, R. Moss, P. Massey, G.L. Gilbert, et al. (+5)
1398 [GO] 2020―Dec―11 Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: Let's avoid adding epidemics to the pandemic P. Bonanni, I.F. Angelillo, A. Villani, P. Biasci, S. Scotti, R. Russo, et al. (+12)
1399 [GO] 2020―Dec―10 An Inventory-Location Optimization Model for Equitable Influenza Vaccine Distribution in Developing Countries During the COVID-19 Pandemic Mehdi Rastegar, Madjid Tavana, Afshin Meraj, Hassan Mina
1400 [GO] 2020―Dec―09 Potential impact of COVID-19 pandemic on vaccination coverage in children: A case study of measles-containing vaccine administration in the United States (US) Cristina Carias, Manjiri Pawaskar, Mawuli Nyaku, James H. Conway, Craig Roberts, Lyn Finelli, Ya-Ting Chen
1401 [GO] 2020―Dec―09 Critical Aspects of Packaging, Storage, Preparation, and Administration of mRNA and Adenovirus-vectored COVID-19 Vaccines for Optimal Efficacy Michelle Holm, Gregory Poland
1402 [GO] 2020―Dec―05 Epidemiology of COVID-19 infection in young children under five years: a systematic review and meta-analysis Mejbah Uddin Bhuiyan, Eunice Stiboy, Md. Zakiul Hassan, Mei Chan, Md. Saiful Islam, Najmul Haider, et al. (+2)
1403 [GO] 2020―Dec―05 Individual Preferences for COVID-19 Vaccination in China Anli Leng, Elizabeth Maitland, Siyuan Wang, Stephen Nicholas, Rugang Liu, Jian Wang
1404 [GO] 2020―Dec―05 PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness Ioana Ghiga, Sol Richardson, Alba Maria Ropero Álvarez, Masaya Kato, Dhamari Naidoo, Satoko Otsu, et al. (+3)
1405 [GO] 2020―Dec―04 Pregnant people deserve the protection offered by SARS-CoV-2 vaccines Melanie M. Maykin, Cara Heuser, Helen Feltovich
1406 [GO] 2020―Nov―24 A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan Taito Kitano, Hirosato Aoki
1407 [GO] 2020―Nov―24 How to ensure we can track and trace the global use of COVID-19 vaccines? Robert H Vander Stichele, Christian Hay, Malin Fladvad, Miriam CJM Sturkenboom, Robert T Chen
1408 [GO] 2020―Nov―24 New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates Takehiro Ura, Akio Yamashita, Nobuhisa Mizuki, Kenji Okuda, Masaru Shimada
1409 [GO] 2020―Nov―08 Pandemic perspectives - The invisible hurricane Carly Muller
1410 [GO] 2020―Nov―07 The demand for a COVID-19 vaccine in Ecuador Oscar Sarasty, Carlos E. Carpio, Darren Hudson, Patricia A. Guerrero-Ochoa, Ivan Borja
1411 [GO] 2020―Nov―05 Influenza vaccination among infection control teams: A EUCIC survey prior to COVID-19 pandemic Şiran Keske, Nico T. Mutters, Constantinos Tsioutis, Önder Ergönül
1412 [GO] 2020―Nov―05 COVID-19: The Worst Date to the Senior Dance Luke Bothun
1413 [GO] 2020―Oct―30 The public’s role in COVID-19 vaccination: human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States Monica Schoch-Spana, Emily K. Brunson, Rex Long, Alexandra Ruth, Sanjana J. Ravi, Marc Trotochaud, et al. (+17)
1414 [GO] 2020―Oct―28 Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group Euzebiusz Jamrozik, Katherine Littler, Susan Bull, Claudia Emerson, Gagandeep Kang, Melissa Kapulu, et al. (+7)
1415 [GO] 2020―Oct―26 “Cultivating” acceptance of a COVID-19 vaccination program: Lessons from Italy Guendalina Graffigna, Lorenzo Palamenghi, Serena Barello, Boccia Stefania
1416 [GO] 2020―Oct―26 Acceptance of a COVID-19 vaccine: A multifactorial consideration Leidy Y. García, Arcadio A. Cerda
1417 [GO] 2020―Oct―23 NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge Mimi Guebre-Xabier, Nita Patel, Jing-Hui Tian, Bin Zhou, Sonia Maciejewski, Kristal Lam, et al. (+7)
1418 [GO] 2020―Oct―21 “Expanding Global and National Influenza Vaccine Systems to match the COVID-19 Pandemic Response” Bruce A. Ruscio, Peter Hotez
1419 [GO] 2020―Oct―20 India’s cost-effective COVID-19 vaccine development initiatives Chiranjib Chakraborty, Govindasamy Agoramoorthy
1420 [GO] 2020―Oct―19 Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England Sadie Bell, Richard Clarke, Sandra Mounier-Jack, Jemma L Walker, Pauline Paterson
1421 [GO] 2020―Oct―19 Identification of a dominant CD8+ CTL epitope in the SARS-associated coronavirus 2 spike protein Daisuke Muraoka, Deng Situo, Sawada Shin-ichi, Akiyoshi Kazunari, Naozumi Harada, Hiroaki Ikeda
1422 [GO] 2020―Oct―13 Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry L. Coudeville, G.B. Gomez, O. Jollivet, R.C. Harris, E. Thommes, S. Druelles, et al. (+3)
1423 [GO] 2020―Oct―10 Caregiver willingness to vaccinate their children against COVID-19: cross sectional survey Ran D. Goldman, Tyler D. Yan, Michelle Seiler, Cristina Parra Cotanda, Julie C. Brown, Eileen J. Klein, et al. (+17)
1424 [GO] 2020―Oct―09 COVID-19 in Africa and collateral effects on health systems and their immunization programs Azucena Bardají, Quique Bassat, Graça Matsinhe, Teresa Aguado
1425 [GO] 2020―Oct―09 COVID-19 vaccine and boosted immunity: nothing ad interim to do? Luca Roncati, Maria Vadalà, Veronica Corazzari, Beniamino Palmieri
1426 [GO] 2020―Oct―09 COVID-19 vaccine trials: duty of care and standard of prevention considerations Jerome Amir Singh
1427 [GO] 2020―Oct―09 Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches Ashkan Safavi, Amirhosein Kefayat, Elham Mahdevar, Ardavan Abiri, Fatemeh Ghahremani
1428 [GO] 2020―Sep―22 Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune Enhancement Wen-Hsiang Chen, Xinrong Tao, Anurodh Agrawal, Abdullah Algaissi, Bi-Hung Peng, Jeroen Pollet, et al. (+7)
1429 [GO] 2020―Sep―22 Enhanced Elicitation of Potent Neutralizing Antibodies by the SARS-CoV-2 Spike Receptor Binding Domain Fc Fusion Protein in Mice Xianglei Liu, Aleksandra Drelich, Wei Li, Chuan Chen, Zehua Sun, Megan Shi, et al. (+4)
1430 [GO] 2020―Sep―17 Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic Maëlle Detoc, Sébastien Bruel, Paul Frappe, Bernard Tardy, Elisabeth Botelho-Nevers, Amandine Gagneux-Brunon
1431 [GO] 2020―Sep―15 Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials Natalie E. Dean, Ana Pastore y Piontti, Zachary J. Madewell, Derek A.T Cummings, Matthew D.T. Hitchings, Keya Joshi, et al. (+4)
1432 [GO] 2020―Sep―10 Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: a cross-sectional survey Kailu WANG, Eliza Lai Yi WONG, Kin Fai HO, Annie Wai Ling CHEUNG, Emily Ying-yang CHAN, Eng Kiong YEOH, Samuel Yeung-shan WONG
1433 [GO] 2020―Aug―20 Acceptability of a COVID-19 Vaccine among Adults in the United States: How Many People Would Get Vaccinated? Paul L. Reiter, Michael L. Pennell, Mira L. Katz
1434 [GO] 2020―Aug―20 BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: in silico analyses and a hypothesis Yusuke Tomita, Ryo Sato, Tokunori Ikeda, Takuro Sakagami
1435 [GO] 2020―Aug―19 The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies John Paget, Saverio Caini, Ben Cowling, Susanna Esposito, Ann R. Falsey, Angela Gentile, et al. (+4)
1436 [GO] 2020―Aug―19 Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes Uri Galili
1437 [GO] 2020―Aug―15 Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: an analysis of provincial electronic immunization registry Subhash Chandir, Danya Arif Siddiqi, Mariam Mehmood, Hamidreza Setayesh, Muhammad Siddique, Amna Mirza, et al. (+7)
1438 [GO] 2020―Aug―10 The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing sever infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic Kiddus Yitbarek, Gelila Abraham, Tsinuel Girma, Tizta Tilahun, Mirkuzie Woldie
1439 [GO] 2020―Jul―31 Ensuring access and affordability through COVID-19 vaccine research and development investments: a proposal for the Options Market for Vaccines Rebecca Forman, Michael Anderson, Mark Jit, Elias Mossialos
1440 [GO] 2020―Jul―29 Influenza immunization and COVID-19 Helena C. Maltezou, Kalliopi Theodoridou, Gregory Poland
1441 [GO] 2020―Jul―12 Vaccines based on Virus-Like nano-Particles for use against Middle East Respiratory Syndrome (MERS) coronavirus Alireza Hashemzadeh, Amir Avan, Gordon A Ferns, Majid Khazaei
1442 [GO] 2020―Jul―10 Planning for COVID-19 Vaccines Safety surveillance Sonali Kochhar, Daniel A. Salmon
1443 [GO] 2020―Jul―03 A global agenda for older adult immunization in the COVID-19 era: A roadmap for action Lois A. Privor-Dumm, Gregory A. Poland, Jane Barratt, David N. Durrheim, Maria Deloria Knoll, Prarthana Vasudevan, et al. (+3)
1444 [GO] 2020―Jul―03 Bacillus Calmette-Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality Ahmed Osama El-Gendy, Haitham Saeed, Ahmed M.A. Ali, Hossam M. Zawbaa, Dina Gomaa, Hadeer S. Harb, et al. (+4)
1445 [GO] 2020―Jun―25 Contingent assessment of the COVID-19 vaccine Leidy Y. García, Arcadio A. Cerda
1446 [GO] 2020―Jun―25 Silver Lining of COVID-19: heightened global interest in pneumococcal and influenza vaccines, an infodemiology study Joseph Alexander Paguio, Jasper Seth Yao, Edward Christopher Dee
1447 [GO] 2020―Jun―24 Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates Wenlin Ren, Hunter Sun, George F. Gao, Jianxin Chen, Sean Sun, Rongqing Zhao, et al. (+18)
1448 [GO] 2020―Jun―23 Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers Umit H. Kartoglu, Kelly L. Moore, John S. Lloyd
1449 [GO] 2020―Jun―23 Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity Wolfram Henn
1450 [GO] 2020―Jun―20 Exploring the role of mass immunisation in influenza pandemic preparedness: A modelling study for the UK context Luca Grieco, Jasmina Panovska-Griffiths, Edwin van Leeuwen, Peter Grove, Martin Utley
1451 [GO] 2020―Jun―19 Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality Deus Thindwa, Maria Garcia Quesada, Yang Liu, Julia Bennett, Cheryl Cohen, Maria Deloria Knoll, et al. (+3)
1452 [GO] 2020―Jun―10 Vaccination Against Coronaviruses In Domestic Animals Ian R Tizard
1453 [GO] 2020―Jun―04 COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies? G. Owen Schaefer, Clarence C. Tam, Julian Savulescu, Teck Chuan Voo
1454 [GO] 2020―May―25 Consensus Summary Report for CEPI/BC March 12-13, 2020 Meeting: Assessment of Risk of Disease Enhancement with COVID-19 Vaccines Paul-Henri Lambert, Donna M. Ambrosino, Svein R. Andersen, Ralph S. Baric, Steven B. Black, Robert T. Chen, et al. (+11)
1455 [GO] 2020―May―01 Tortoises, Hares, and Vaccines: A Cautionary Note for SARS-CoV-2 Vaccine Development Gregory A. Poland
1456 [GO] 2020―Apr―30 The biological characteristics of SARS-CoV-2 Spike protein Pro330-Leu650 Qiu-dong Su, Yao Yi, Ye-ning Zou, Zhi-yuan Jia, Feng Qiu, Feng Wang, et al. (+7)
1457 [GO] 2020―Apr―28 An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design C.V. Herst, S. Burkholz, J. Sidney, A. Sette, P.E. Harris, S. Massey, et al. (+10)
1458 [GO] 2020―Apr―20 Enabling Emergency Mass Vaccination: Innovations in Manufacturing and Administration During a Pandemic Divya Hosangadi, Kelsey Lane Warmbrod, Elena K Martin, Amesh Adalja, Anita Cicero, Thomas Inglesby, et al. (+3)
1459 [GO] 2020―Mar―12 Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness Bruce Ruscio, Amanda Bolster, Joseph Bresee, Atika Abelin, Philippe Boutet, Hans Christiansen, et al. (+23)
1460 [GO] 2020―Feb―21 Another coronavirus, another epidemic, another warning Gregory A. Poland
1461 [GO] 2020―Feb―11 Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity Yi Jiang, Xu Cheng, Xiumei Zhao, Yan Yu, Mingyan Gao, Sheng Zhou
1462 [GO] 2020―Jan―24 Pandemic influenza A(H1N1pdm09) vaccine induced high levels of influenza-specific IgG and IgM antibodies as analyzed by enzyme immunoassay and dual-mode multiplex microarray immunoassay methods Anna Kazakova, Laura Kakkola, Thedi Ziegler, Ritva Syrjänen, Henna Päkkilä, Matti Waris, et al. (+2)
1463 [GO] 2019―Dec―12 Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemic Rachael M. Porter, Shoshanna Goldin, Kathryn E. Lafond, Lisa Hedman, Mellissa Ungkuldee, Jordan Kurzum, et al. (+4)
 [1] 

1463 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.251 sec